T cell CD8+ central memory_XCELL in ACC (n=79):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age 
79 patients with 28 dying ( 0 missing obs. )
                                     coef    HR se(coef) 95%CI_l   95%CI_u
`T cell CD8+ central memory_XCELL` -6.639 0.001    8.529   0.000 23811.418
Age                                 0.011 1.011    0.012   0.987     1.036
                                        z     p signif
`T cell CD8+ central memory_XCELL` -0.778 0.436       
Age                                 0.904 0.366       
Rsquare = 0.019 (max possible = 9.35e-01 )
Likelihood ratio test p = 4.72e-01 
Wald test p = 4.99e-01 
Score (logrank) test p = 4.95e-01 

T cell CD8+ central memory_XCELL in BLCA (n=408):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
401 patients with 176 dying ( 7 missing obs. )
                                     coef          HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ central memory_XCELL` -2.480       0.084    1.438   0.005   1.403
Age                                 0.030       1.031    0.008   1.015   1.047
Stage2                             14.681 2376789.430 1908.589   0.000     Inf
Stage3                             15.129 3720075.896 1908.589   0.000     Inf
Stage4                             15.619 6069312.457 1908.589   0.000     Inf
                                        z     p signif
`T cell CD8+ central memory_XCELL` -1.725 0.085      ·
Age                                 3.835 0.000    ***
Stage2                              0.008 0.994       
Stage3                              0.008 0.994       
Stage4                              0.008 0.993       
Rsquare = 0.12 (max possible = 9.91e-01 )
Likelihood ratio test p = 8.1e-10 
Wald test p = 4.85e-09 
Score (logrank) test p = 1e-09 

T cell CD8+ central memory_XCELL in BRCA (n=1100):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
1057 patients with 143 dying ( 43 missing obs. )
                                     coef     HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ central memory_XCELL` -2.518  0.081    1.271   0.007   0.974
Age                                 0.033  1.034    0.007   1.020   1.048
Stage2                              0.546  1.725    0.279   0.998   2.983
Stage3                              1.195  3.303    0.294   1.856   5.879
Stage4                              2.364 10.632    0.362   5.227  21.624
                                        z     p signif
`T cell CD8+ central memory_XCELL` -1.981 0.048      *
Age                                 4.806 0.000    ***
Stage2                              1.954 0.051      ·
Stage3                              4.063 0.000    ***
Stage4                              6.526 0.000    ***
Rsquare = 0.071 (max possible = 7.87e-01 )
Likelihood ratio test p = 2.47e-15 
Wald test p = 4.36e-18 
Score (logrank) test p = 3.28e-23 

T cell CD8+ central memory_XCELL in BRCA-Basal (n=191):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
185 patients with 26 dying ( 6 missing obs. )
                                     coef           HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ central memory_XCELL` -3.863 2.100000e-02    2.608   0.000   3.485
Age                                 0.011 1.011000e+00    0.016   0.979   1.044
Stage2                             18.802 1.464094e+08 6235.724   0.000     Inf
Stage3                             20.137 5.564466e+08 6235.724   0.000     Inf
Stage4                             22.009 3.615807e+09 6235.724   0.000     Inf
                                        z     p signif
`T cell CD8+ central memory_XCELL` -1.481 0.139       
Age                                 0.685 0.493       
Stage2                              0.003 0.998       
Stage3                              0.003 0.997       
Stage4                              0.004 0.997       
Rsquare = 0.145 (max possible = 7.08e-01 )
Likelihood ratio test p = 2.36e-05 
Wald test p = 7.07e-04 
Score (logrank) test p = 1.58e-07 

T cell CD8+ central memory_XCELL in BRCA-Her2 (n=82):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
75 patients with 16 dying ( 7 missing obs. )
                                     coef     HR se(coef) 95%CI_l  95%CI_u
`T cell CD8+ central memory_XCELL` -0.411  0.663    4.649   0.000 6002.861
Age                                 0.081  1.085    0.028   1.027    1.146
Stage2                             -0.773  0.462    1.154   0.048    4.434
Stage3                              0.588  1.801    1.145   0.191   16.984
Stage4                              3.229 25.247    1.283   2.044  311.831
                                        z     p signif
`T cell CD8+ central memory_XCELL` -0.088 0.930       
Age                                 2.923 0.003     **
Stage2                             -0.670 0.503       
Stage3                              0.514 0.607       
Stage4                              2.517 0.012      *
Rsquare = 0.286 (max possible = 7.59e-01 )
Likelihood ratio test p = 1.22e-04 
Wald test p = 4.46e-04 
Score (logrank) test p = 1.04e-07 

T cell CD8+ central memory_XCELL in BRCA-LumA (n=568):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
547 patients with 62 dying ( 21 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -1.731 0.177    2.098   0.003  10.825 -0.825
Age                                 0.044 1.045    0.011   1.023   1.068  4.045
Stage2                              0.474 1.606    0.360   0.793   3.252  1.317
Stage3                              0.898 2.454    0.394   1.135   5.308  2.281
Stage4                              1.981 7.250    0.546   2.485  21.147  3.627
                                       p signif
`T cell CD8+ central memory_XCELL` 0.409       
Age                                0.000    ***
Stage2                             0.188       
Stage3                             0.023      *
Stage4                             0.000    ***
Rsquare = 0.053 (max possible = 6.7e-01 )
Likelihood ratio test p = 1.56e-05 
Wald test p = 3.9e-06 
Score (logrank) test p = 2.97e-07 

T cell CD8+ central memory_XCELL in BRCA-LumB (n=219):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
211 patients with 32 dying ( 8 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -4.680 0.009    3.119   0.000   4.188 -1.501
Age                                 0.032 1.032    0.016   1.001   1.064  2.001
Stage2                              0.682 1.978    0.768   0.439   8.903  0.889
Stage3                              1.270 3.563    0.775   0.780  16.282  1.639
Stage4                              1.950 7.027    0.897   1.212  40.740  2.174
                                       p signif
`T cell CD8+ central memory_XCELL` 0.133       
Age                                0.045      *
Stage2                             0.374       
Stage3                             0.101       
Stage4                             0.030      *
Rsquare = 0.072 (max possible = 7e-01 )
Likelihood ratio test p = 7.36e-03 
Wald test p = 1.11e-02 
Score (logrank) test p = 4.16e-03 

T cell CD8+ central memory_XCELL in CESC (n=306):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age 
293 patients with 73 dying ( 13 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -6.362 0.002    2.238   0.000   0.139 -2.843
Age                                 0.014 1.014    0.009   0.997   1.032  1.631
                                       p signif
`T cell CD8+ central memory_XCELL` 0.004     **
Age                                0.103       
Rsquare = 0.047 (max possible = 9.11e-01 )
Likelihood ratio test p = 8.58e-04 
Wald test p = 4.69e-03 
Score (logrank) test p = 4.07e-03 

T cell CD8+ central memory_XCELL in CHOL (n=36):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
36 patients with 18 dying ( 0 missing obs. )
                                      coef       HR se(coef) 95%CI_l
`T cell CD8+ central memory_XCELL`   7.530 1862.298    5.553   0.035
Age                                  0.019    1.019    0.019   0.981
Stage2                               0.935    2.548    0.616   0.763
Stage3                             -19.528    0.000 6678.942   0.000
Stage4                               1.212    3.359    0.656   0.929
                                       95%CI_u      z     p signif
`T cell CD8+ central memory_XCELL` 9.92755e+07  1.356 0.175       
Age                                1.05800e+00  0.966 0.334       
Stage2                             8.51500e+00  1.520 0.129       
Stage3                                     Inf -0.003 0.998       
Stage4                             1.21440e+01  1.848 0.065      ·
Rsquare = 0.169 (max possible = 9.46e-01 )
Likelihood ratio test p = 2.46e-01 
Wald test p = 4.22e-01 
Score (logrank) test p = 2.86e-01 

T cell CD8+ central memory_XCELL in COAD (n=458):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
267 patients with 62 dying ( 191 missing obs. )
                                    coef      HR se(coef) 95%CI_l    95%CI_u
`T cell CD8+ central memory_XCELL` 5.272 194.818    3.385   0.256 148187.159
Age                                0.035   1.035    0.012   1.012      1.059
Stage2                             0.764   2.147    0.624   0.632      7.298
Stage3                             1.398   4.048    0.622   1.195     13.709
Stage4                             2.636  13.961    0.638   3.998     48.748
                                       z     p signif
`T cell CD8+ central memory_XCELL` 1.558 0.119       
Age                                2.936 0.003     **
Stage2                             1.224 0.221       
Stage3                             2.246 0.025      *
Stage4                             4.132 0.000    ***
Rsquare = 0.13 (max possible = 8.92e-01 )
Likelihood ratio test p = 5.83e-07 
Wald test p = 6.88e-07 
Score (logrank) test p = 4.55e-08 

T cell CD8+ central memory_XCELL in DLBC (n=48):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age 
47 patients with 9 dying ( 1 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -5.150 0.006    5.751    0.00 455.816 -0.895
Age                                -0.013 0.987    0.025    0.94   1.038 -0.503
                                       p signif
`T cell CD8+ central memory_XCELL` 0.371       
Age                                0.615       
Rsquare = 0.022 (max possible = 6.72e-01 )
Likelihood ratio test p = 5.91e-01 
Wald test p = 6.11e-01 
Score (logrank) test p = 6.03e-01 

T cell CD8+ central memory_XCELL in ESCA (n=185):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
160 patients with 63 dying ( 25 missing obs. )
                                     coef     HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ central memory_XCELL` -0.252  0.777    2.563   0.005 118.141
Age                                 0.005  1.005    0.011   0.983   1.027
Stage2                              0.786  2.194    0.559   0.734   6.562
Stage3                              1.721  5.590    0.574   1.815  17.216
Stage4                              2.486 12.013    0.646   3.384  42.653
                                        z     p signif
`T cell CD8+ central memory_XCELL` -0.098 0.922       
Age                                 0.453 0.650       
Stage2                              1.406 0.160       
Stage3                              2.999 0.003     **
Stage4                              3.846 0.000    ***
Rsquare = 0.145 (max possible = 9.61e-01 )
Likelihood ratio test p = 1.37e-04 
Wald test p = 1.47e-04 
Score (logrank) test p = 2.05e-05 

T cell CD8+ central memory_XCELL in GBM (n=153):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age 
150 patients with 120 dying ( 3 missing obs. )
                                    coef       HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ central memory_XCELL` 8.739 6244.478    5.485   0.134 2.910764e+08
Age                                0.029    1.029    0.008   1.014 1.045000e+00
                                       z     p signif
`T cell CD8+ central memory_XCELL` 1.593 0.111       
Age                                3.777 0.000    ***
Rsquare = 0.11 (max possible = 9.98e-01 )
Likelihood ratio test p = 1.56e-04 
Wald test p = 2.93e-04 
Score (logrank) test p = 2.47e-04 

T cell CD8+ central memory_XCELL in HNSC (n=522):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
446 patients with 191 dying ( 76 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -4.324 0.013    1.589   0.001   0.298 -2.721
Age                                 0.023 1.023    0.007   1.009   1.037  3.307
Stage2                              0.771 2.162    0.538   0.753   6.207  1.433
Stage3                              0.857 2.356    0.535   0.825   6.723  1.602
Stage4                              1.338 3.810    0.508   1.407  10.314  2.632
                                       p signif
`T cell CD8+ central memory_XCELL` 0.007     **
Age                                0.001     **
Stage2                             0.152       
Stage3                             0.109       
Stage4                             0.008     **
Rsquare = 0.082 (max possible = 9.9e-01 )
Likelihood ratio test p = 3.76e-07 
Wald test p = 4.25e-06 
Score (logrank) test p = 2.91e-06 

T cell CD8+ central memory_XCELL in HNSC-HPV+ (n=98):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
67 patients with 24 dying ( 31 missing obs. )
                                      coef           HR se(coef) 95%CI_l
`T cell CD8+ central memory_XCELL` -14.466        0.000    4.903   0.000
Age                                 -0.023        0.977    0.022   0.936
Stage2                              17.098 26642217.146 5408.181   0.000
Stage3                              17.047 25314162.745 5408.181   0.000
Stage4                              17.336 33786719.252 5408.180   0.000
                                   95%CI_u      z     p signif
`T cell CD8+ central memory_XCELL`   0.008 -2.950 0.003     **
Age                                  1.020 -1.056 0.291       
Stage2                                 Inf  0.003 0.997       
Stage3                                 Inf  0.003 0.997       
Stage4                                 Inf  0.003 0.997       
Rsquare = 0.235 (max possible = 9.24e-01 )
Likelihood ratio test p = 3e-03 
Wald test p = 9.1e-02 
Score (logrank) test p = 2.95e-02 

T cell CD8+ central memory_XCELL in HNSC-HPV- (n=422):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
379 patients with 167 dying ( 43 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -2.582 0.076    1.764   0.002   2.402 -1.463
Age                                 0.028 1.028    0.008   1.013   1.044  3.636
Stage2                              0.505 1.657    0.545   0.569   4.827  0.926
Stage3                              0.707 2.027    0.538   0.706   5.817  1.313
Stage4                              1.218 3.382    0.509   1.246   9.178  2.392
                                       p signif
`T cell CD8+ central memory_XCELL` 0.143       
Age                                0.000    ***
Stage2                             0.354       
Stage3                             0.189       
Stage4                             0.017      *
Rsquare = 0.08 (max possible = 9.9e-01 )
Likelihood ratio test p = 7.35e-06 
Wald test p = 3.6e-05 
Score (logrank) test p = 2.67e-05 

T cell CD8+ central memory_XCELL in KICH (n=66):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
65 patients with 9 dying ( 1 missing obs. )
                                      coef           HR se(coef)      95%CI_l
`T cell CD8+ central memory_XCELL` -67.660 0.000000e+00   58.205        0.000
Age                                  0.030 1.031000e+00    0.028        0.976
Stage2                              15.477 5.265751e+06    0.852   991411.292
Stage3                              16.529 1.508823e+07    0.788  3221575.011
Stage4                              19.527 3.024500e+08    0.937 48170759.881
                                        95%CI_u      z     p signif
`T cell CD8+ central memory_XCELL` 1.444466e+20 -1.162 0.245       
Age                                1.089000e+00  1.078 0.281       
Stage2                             2.796835e+07 18.166 0.000    ***
Stage3                             7.066564e+07 20.982 0.000    ***
Stage4                             1.898995e+09 20.833 0.000    ***
Rsquare = 0.341 (max possible = 6.61e-01 )
Likelihood ratio test p = 5.54e-05 
Wald test p = 1.02e-258 
Score (logrank) test p = 3.13e-11 

T cell CD8+ central memory_XCELL in KIRC (n=533):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
526 patients with 172 dying ( 7 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -0.299 0.742    0.780   0.161   3.420 -0.383
Age                                 0.034 1.034    0.007   1.019   1.049  4.534
Stage2                              0.300 1.350    0.318   0.724   2.520  0.944
Stage3                              0.958 2.605    0.211   1.722   3.942  4.531
Stage4                              1.965 7.132    0.200   4.815  10.564  9.802
                                       p signif
`T cell CD8+ central memory_XCELL` 0.701       
Age                                0.000    ***
Stage2                             0.345       
Stage3                             0.000    ***
Stage4                             0.000    ***
Rsquare = 0.208 (max possible = 9.75e-01 )
Likelihood ratio test p = 7.58e-25 
Wald test p = 1.65e-24 
Score (logrank) test p = 1.58e-30 

T cell CD8+ central memory_XCELL in KIRP (n=290):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
255 patients with 39 dying ( 35 missing obs. )
                                     coef      HR se(coef) 95%CI_l  95%CI_u
`T cell CD8+ central memory_XCELL`  4.917 136.583    1.869   3.502 5326.894
Age                                 0.009   1.009    0.015   0.981    1.038
Stage2                             -0.352   0.703    0.808   0.144    3.425
Stage3                              1.511   4.533    0.382   2.142    9.591
Stage4                              2.865  17.549    0.452   7.234   42.571
                                        z     p signif
`T cell CD8+ central memory_XCELL`  2.630 0.009     **
Age                                 0.638 0.524       
Stage2                             -0.435 0.663       
Stage3                              3.952 0.000    ***
Stage4                              6.336 0.000    ***
Rsquare = 0.157 (max possible = 7.61e-01 )
Likelihood ratio test p = 2.93e-08 
Wald test p = 5.57e-09 
Score (logrank) test p = 3.93e-14 

T cell CD8+ central memory_XCELL in LGG (n=516):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age 
511 patients with 125 dying ( 5 missing obs. )
                                     coef          HR se(coef)   95%CI_l
`T cell CD8+ central memory_XCELL` 43.734 9.85366e+18   17.073 28893.854
Age                                 0.057 1.05800e+00    0.007     1.043
                                       95%CI_u     z    p signif
`T cell CD8+ central memory_XCELL` 3.36039e+33 2.562 0.01      *
Age                                1.07300e+00 7.801 0.00    ***
Rsquare = 0.119 (max possible = 9.13e-01 )
Likelihood ratio test p = 8.71e-15 
Wald test p = 1.84e-15 
Score (logrank) test p = 1.78e-16 

T cell CD8+ central memory_XCELL in LIHC (n=371):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
340 patients with 116 dying ( 31 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -2.293 0.101    2.135   0.002   6.634 -1.074
Age                                 0.011 1.011    0.007   0.997   1.026  1.567
Stage2                              0.311 1.364    0.251   0.834   2.231  1.238
Stage3                              0.960 2.613    0.217   1.708   3.997  4.427
Stage4                              1.655 5.234    0.600   1.613  16.976  2.757
                                       p signif
`T cell CD8+ central memory_XCELL` 0.283       
Age                                0.117       
Stage2                             0.216       
Stage3                             0.000    ***
Stage4                             0.006     **
Rsquare = 0.078 (max possible = 9.69e-01 )
Likelihood ratio test p = 4.08e-05 
Wald test p = 2.11e-05 
Score (logrank) test p = 6.57e-06 

T cell CD8+ central memory_XCELL in LUAD (n=515):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
484 patients with 177 dying ( 31 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -1.652 0.192    1.055   0.024   1.517 -1.565
Age                                 0.010 1.010    0.008   0.995   1.026  1.315
Stage2                              0.826 2.285    0.187   1.583   3.299  4.409
Stage3                              1.142 3.132    0.198   2.126   4.613  5.778
Stage4                              1.279 3.592    0.282   2.066   6.247  4.530
                                       p signif
`T cell CD8+ central memory_XCELL` 0.118       
Age                                0.189       
Stage2                             0.000    ***
Stage3                             0.000    ***
Stage4                             0.000    ***
Rsquare = 0.1 (max possible = 9.79e-01 )
Likelihood ratio test p = 8.11e-10 
Wald test p = 1.16e-09 
Score (logrank) test p = 1.33e-10 

T cell CD8+ central memory_XCELL in LUSC (n=501):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
484 patients with 209 dying ( 17 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -0.496 0.609    1.145   0.065   5.743 -0.433
Age                                 0.018 1.018    0.009   1.001   1.036  2.085
Stage2                              0.163 1.177    0.164   0.853   1.623  0.992
Stage3                              0.474 1.606    0.184   1.120   2.303  2.574
Stage4                              1.186 3.273    0.462   1.324   8.089  2.569
                                       p signif
`T cell CD8+ central memory_XCELL` 0.665       
Age                                0.037      *
Stage2                             0.321       
Stage3                             0.010      *
Stage4                             0.010      *
Rsquare = 0.028 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.75e-02 
Wald test p = 1.04e-02 
Score (logrank) test p = 7.87e-03 

T cell CD8+ central memory_XCELL in MESO (n=87):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
86 patients with 73 dying ( 1 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -0.409 0.665    1.638   0.027  16.490 -0.249
Age                                 0.019 1.019    0.015   0.989   1.049  1.252
Stage2                             -0.411 0.663    0.448   0.275   1.598 -0.915
Stage3                             -0.238 0.788    0.382   0.373   1.667 -0.623
Stage4                             -0.305 0.737    0.444   0.309   1.760 -0.687
                                       p signif
`T cell CD8+ central memory_XCELL` 0.803       
Age                                0.210       
Stage2                             0.360       
Stage3                             0.534       
Stage4                             0.492       
Rsquare = 0.033 (max possible = 9.98e-01 )
Likelihood ratio test p = 7.22e-01 
Wald test p = 7.14e-01 
Score (logrank) test p = 7.12e-01 

T cell CD8+ central memory_XCELL in OV (n=303):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age 
302 patients with 183 dying ( 1 missing obs. )
                                    coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -3.75 0.024    2.139   0.000   1.554 -1.754
Age                                 0.03 1.030    0.007   1.016   1.045  4.117
                                       p signif
`T cell CD8+ central memory_XCELL` 0.079      ·
Age                                0.000    ***
Rsquare = 0.063 (max possible = 9.97e-01 )
Likelihood ratio test p = 5.56e-05 
Wald test p = 5.6e-05 
Score (logrank) test p = 4.85e-05 

T cell CD8+ central memory_XCELL in PAAD (n=179):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
175 patients with 93 dying ( 4 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -3.588 0.028    2.782   0.000   6.460 -1.289
Age                                 0.024 1.024    0.010   1.003   1.045  2.279
Stage2                              0.825 2.282    0.399   1.043   4.991  2.066
Stage3                              0.292 1.339    1.085   0.160  11.236  0.269
Stage4                              0.317 1.373    0.809   0.281   6.703  0.392
                                       p signif
`T cell CD8+ central memory_XCELL` 0.197       
Age                                0.023      *
Stage2                             0.039      *
Stage3                             0.788       
Stage4                             0.695       
Rsquare = 0.075 (max possible = 9.91e-01 )
Likelihood ratio test p = 1.76e-02 
Wald test p = 3.42e-02 
Score (logrank) test p = 3.01e-02 

T cell CD8+ central memory_XCELL in PCPG (n=181):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age 
181 patients with 7 dying ( 0 missing obs. )
                                    coef      HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ central memory_XCELL` 6.608 740.841   81.710   0.000 2.640943e+72
Age                                0.023   1.023    0.024   0.976 1.073000e+00
                                       z     p signif
`T cell CD8+ central memory_XCELL` 0.081 0.936       
Age                                0.953 0.341       
Rsquare = 0.005 (max possible = 2.89e-01 )
Likelihood ratio test p = 6.33e-01 
Wald test p = 6.35e-01 
Score (logrank) test p = 6.3e-01 

T cell CD8+ central memory_XCELL in PRAD (n=498):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age 
496 patients with 10 dying ( 2 missing obs. )
                                     coef    HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ central memory_XCELL` -4.541 0.011   12.571   0.000 534797634.50
Age                                 0.050 1.052    0.050   0.954         1.16
                                        z     p signif
`T cell CD8+ central memory_XCELL` -0.361 0.718       
Age                                 1.014 0.311       
Rsquare = 0.003 (max possible = 1.68e-01 )
Likelihood ratio test p = 5.29e-01 
Wald test p = 5.41e-01 
Score (logrank) test p = 5.36e-01 

T cell CD8+ central memory_XCELL in READ (n=166):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
82 patients with 14 dying ( 84 missing obs. )
                                     coef    HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ central memory_XCELL` -6.827 0.001   17.359   0.000 6.468426e+11
Age                                 0.126 1.134    0.045   1.038 1.240000e+00
Stage2                             -1.348 0.260    1.259   0.022 3.065000e+00
Stage3                              0.201 1.222    0.846   0.233 6.417000e+00
Stage4                              0.223 1.249    0.935   0.200 7.807000e+00
                                        z     p signif
`T cell CD8+ central memory_XCELL` -0.393 0.694       
Age                                 2.780 0.005     **
Stage2                             -1.070 0.284       
Stage3                              0.237 0.813       
Stage4                              0.238 0.812       
Rsquare = 0.227 (max possible = 7.04e-01 )
Likelihood ratio test p = 7.75e-04 
Wald test p = 3.61e-02 
Score (logrank) test p = 1.53e-03 

T cell CD8+ central memory_XCELL in SARC (n=260):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age 
257 patients with 99 dying ( 3 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -2.084 0.124    1.252   0.011   1.447 -1.665
Age                                 0.022 1.023    0.008   1.007   1.039  2.822
                                       p signif
`T cell CD8+ central memory_XCELL` 0.096      ·
Age                                0.005     **
Rsquare = 0.041 (max possible = 9.77e-01 )
Likelihood ratio test p = 4.66e-03 
Wald test p = 6.18e-03 
Score (logrank) test p = 5.85e-03 

T cell CD8+ central memory_XCELL in SKCM (n=471):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
407 patients with 192 dying ( 64 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -3.002 0.050    0.719   0.012   0.203 -4.177
Age                                 0.018 1.018    0.005   1.008   1.029  3.502
Stage2                              0.146 1.157    0.217   0.757   1.770  0.674
Stage3                              0.585 1.794    0.200   1.213   2.654  2.926
Stage4                              1.265 3.544    0.350   1.786   7.034  3.617
                                       p signif
`T cell CD8+ central memory_XCELL` 0.000    ***
Age                                0.000    ***
Stage2                             0.500       
Stage3                             0.003     **
Stage4                             0.000    ***
Rsquare = 0.127 (max possible = 9.92e-01 )
Likelihood ratio test p = 1.22e-10 
Wald test p = 1.8e-09 
Score (logrank) test p = 7.09e-10 

T cell CD8+ central memory_XCELL in SKCM-Primary (n=103):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
95 patients with 26 dying ( 8 missing obs. )
                                     coef           HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ central memory_XCELL` -1.752 1.730000e-01    2.792   0.001  41.260
Age                                 0.005 1.005000e+00    0.014   0.977   1.034
Stage2                             17.291 3.232052e+07 6208.202   0.000     Inf
Stage3                             17.985 6.466484e+07 6208.202   0.000     Inf
Stage4                             19.642 3.393322e+08 6208.202   0.000     Inf
                                        z     p signif
`T cell CD8+ central memory_XCELL` -0.627 0.530       
Age                                 0.361 0.718       
Stage2                              0.003 0.998       
Stage3                              0.003 0.998       
Stage4                              0.003 0.997       
Rsquare = 0.114 (max possible = 8.67e-01 )
Likelihood ratio test p = 4.15e-02 
Wald test p = 3.63e-02 
Score (logrank) test p = 3.3e-03 

T cell CD8+ central memory_XCELL in SKCM-Metastasis (n=368):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
312 patients with 166 dying ( 56 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -2.876 0.056    0.750   0.013   0.245 -3.835
Age                                 0.021 1.021    0.006   1.010   1.032  3.672
Stage2                              0.038 1.038    0.228   0.665   1.622  0.165
Stage3                              0.518 1.678    0.204   1.124   2.505  2.534
Stage4                              1.045 2.842    0.397   1.305   6.188  2.631
                                       p signif
`T cell CD8+ central memory_XCELL` 0.000    ***
Age                                0.000    ***
Stage2                             0.869       
Stage3                             0.011      *
Stage4                             0.009     **
Rsquare = 0.142 (max possible = 9.95e-01 )
Likelihood ratio test p = 4.16e-09 
Wald test p = 4.74e-08 
Score (logrank) test p = 2.43e-08 

T cell CD8+ central memory_XCELL in STAD (n=415):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
368 patients with 148 dying ( 47 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -0.690 0.502    1.205   0.047   5.324 -0.573
Age                                 0.029 1.029    0.009   1.012   1.046  3.338
Stage2                              0.462 1.588    0.337   0.821   3.073  1.373
Stage3                              0.945 2.573    0.315   1.386   4.774  2.995
Stage4                              1.632 5.116    0.366   2.498  10.475  4.464
                                       p signif
`T cell CD8+ central memory_XCELL` 0.567       
Age                                0.001     **
Stage2                             0.170       
Stage3                             0.003     **
Stage4                             0.000    ***
Rsquare = 0.086 (max possible = 9.85e-01 )
Likelihood ratio test p = 3.58e-06 
Wald test p = 5.1e-06 
Score (logrank) test p = 2.42e-06 

T cell CD8+ central memory_XCELL in TGCT (n=150):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
81 patients with 2 dying ( 69 missing obs. )
                                     coef           HR  se(coef) 95%CI_l
`T cell CD8+ central memory_XCELL`  2.104 8.201000e+00    28.418   0.000
Age                                -0.212 8.090000e-01     0.193   0.554
Stage2                             18.695 1.315659e+08 33839.929   0.000
Stage3                             41.476 1.029898e+18 85551.278   0.000
                                        95%CI_u      z     p signif
`T cell CD8+ central memory_XCELL` 1.268529e+25  0.074 0.941       
Age                                1.181000e+00 -1.100 0.271       
Stage2                                      Inf  0.001 1.000   <NA>
Stage3                                      Inf  0.000 1.000   <NA>
Rsquare = 0.084 (max possible = 1.32e-01 )
Likelihood ratio test p = 1.33e-01 
Wald test p = 8.68e-01 
Score (logrank) test p = 1.42e-01 

T cell CD8+ central memory_XCELL in THCA (n=509):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
506 patients with 16 dying ( 3 missing obs. )
                                      coef    HR se(coef) 95%CI_l  95%CI_u
`T cell CD8+ central memory_XCELL` -11.912 0.000    9.998   0.000 2175.024
Age                                  0.159 1.173    0.031   1.104    1.245
Stage2                               0.243 1.276    1.019   0.173    9.400
Stage3                               0.200 1.222    0.811   0.249    5.991
Stage4                               0.739 2.094    0.854   0.393   11.160
                                        z     p signif
`T cell CD8+ central memory_XCELL` -1.191 0.234       
Age                                 5.197 0.000    ***
Stage2                              0.239 0.811       
Stage3                              0.247 0.805       
Stage4                              0.866 0.387       
Rsquare = 0.112 (max possible = 2.9e-01 )
Likelihood ratio test p = 1.14e-11 
Wald test p = 2.76e-05 
Score (logrank) test p = 1.66e-11 

T cell CD8+ central memory_XCELL in THYM (n=120):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age 
119 patients with 9 dying ( 1 missing obs. )
                                    coef      HR se(coef) 95%CI_l     95%CI_u
`T cell CD8+ central memory_XCELL` 6.379 589.334    4.134   0.178 1947480.018
Age                                0.067   1.069    0.031   1.006       1.135
                                       z     p signif
`T cell CD8+ central memory_XCELL` 1.543 0.123       
Age                                2.165 0.030      *
Rsquare = 0.053 (max possible = 4.39e-01 )
Likelihood ratio test p = 3.83e-02 
Wald test p = 4.27e-02 
Score (logrank) test p = 3.35e-02 

T cell CD8+ central memory_XCELL in UCEC (n=545):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age 
173 patients with 32 dying ( 372 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ central memory_XCELL` -3.275 0.038    3.672   0.000  50.482 -0.892
Age                                 0.014 1.014    0.016   0.983   1.047  0.880
                                       p signif
`T cell CD8+ central memory_XCELL` 0.372       
Age                                0.379       
Rsquare = 0.011 (max possible = 7.9e-01 )
Likelihood ratio test p = 3.88e-01 
Wald test p = 4.26e-01 
Score (logrank) test p = 4.22e-01 

T cell CD8+ central memory_XCELL in UCS (n=57):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age 
55 patients with 34 dying ( 2 missing obs. )
                                     coef    HR se(coef) 95%CI_l  95%CI_u
`T cell CD8+ central memory_XCELL` -2.969 0.051    5.911   0.000 5518.506
Age                                 0.046 1.047    0.023   1.001    1.095
                                        z     p signif
`T cell CD8+ central memory_XCELL` -0.502 0.615       
Age                                 2.024 0.043      *
Rsquare = 0.075 (max possible = 9.83e-01 )
Likelihood ratio test p = 1.17e-01 
Wald test p = 1.19e-01 
Score (logrank) test p = 1.16e-01 

T cell CD8+ central memory_XCELL in UVM (n=80):
Model: Surv(OS, EVENT) ~ `T cell CD8+ central memory_XCELL` + Age + Stage 
79 patients with 22 dying ( 1 missing obs. )
                                    coef      HR se(coef) 95%CI_l   95%CI_u
`T cell CD8+ central memory_XCELL` 5.717 303.908    2.116   4.808 19208.682
Age                                0.043   1.044    0.020   1.003     1.087
Stage3                             0.162   1.176    0.473   0.466     2.971
Stage4                             3.774  43.537    1.217   4.011   472.534
                                       z     p signif
`T cell CD8+ central memory_XCELL` 2.702 0.007     **
Age                                2.117 0.034      *
Stage3                             0.343 0.732       
Stage4                             3.102 0.002     **
Rsquare = 0.264 (max possible = 8.67e-01 )
Likelihood ratio test p = 7.2e-05 
Wald test p = 1.51e-04 
Score (logrank) test p = 1.36e-11 

T cell CD8+ effector memory_XCELL in ACC (n=79):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age 
79 patients with 28 dying ( 0 missing obs. )
                                      coef           HR se(coef) 95%CI_l
`T cell CD8+ effector memory_XCELL` 18.084 71438354.616   22.568   0.000
Age                                  0.011        1.012    0.013   0.987
                                         95%CI_u     z     p signif
`T cell CD8+ effector memory_XCELL` 1.159126e+27 0.801 0.423       
Age                                 1.037000e+00 0.918 0.359       
Rsquare = 0.017 (max possible = 9.35e-01 )
Likelihood ratio test p = 5.11e-01 
Wald test p = 5.02e-01 
Score (logrank) test p = 4.98e-01 

T cell CD8+ effector memory_XCELL in BLCA (n=408):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
401 patients with 176 dying ( 7 missing obs. )
                                      coef          HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -7.471       0.001    4.149   0.000   1.936
Age                                  0.031       1.031    0.008   1.016   1.047
Stage2                              14.653 2310774.677 1914.962   0.000     Inf
Stage3                              15.102 3618643.562 1914.962   0.000     Inf
Stage4                              15.596 5932577.891 1914.962   0.000     Inf
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -1.801 0.072      ·
Age                                  3.921 0.000    ***
Stage2                               0.008 0.994       
Stage3                               0.008 0.994       
Stage4                               0.008 0.994       
Rsquare = 0.121 (max possible = 9.91e-01 )
Likelihood ratio test p = 5.88e-10 
Wald test p = 5.68e-09 
Score (logrank) test p = 1.15e-09 

T cell CD8+ effector memory_XCELL in BRCA (n=1100):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
1057 patients with 143 dying ( 43 missing obs. )
                                       coef     HR se(coef) 95%CI_l  95%CI_u
`T cell CD8+ effector memory_XCELL` -10.629  0.000    9.361   0.000 2251.256
Age                                   0.033  1.034    0.007   1.020    1.048
Stage2                                0.570  1.768    0.279   1.023    3.057
Stage3                                1.210  3.354    0.294   1.884    5.971
Stage4                                2.396 10.975    0.362   5.402   22.301
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -1.135 0.256       
Age                                  4.872 0.000    ***
Stage2                               2.042 0.041      *
Stage3                               4.113 0.000    ***
Stage4                               6.623 0.000    ***
Rsquare = 0.069 (max possible = 7.87e-01 )
Likelihood ratio test p = 9.13e-15 
Wald test p = 1.05e-17 
Score (logrank) test p = 9.35e-23 

T cell CD8+ effector memory_XCELL in BRCA-Basal (n=191):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
185 patients with 26 dying ( 6 missing obs. )
                                      coef           HR se(coef) 95%CI_l
`T cell CD8+ effector memory_XCELL` -9.835 0.000000e+00   10.662   0.000
Age                                  0.014 1.014000e+00    0.016   0.982
Stage2                              18.906 1.625338e+08 6233.489   0.000
Stage3                              20.291 6.493498e+08 6233.489   0.000
Stage4                              21.377 1.922258e+09 6233.489   0.000
                                      95%CI_u      z     p signif
`T cell CD8+ effector memory_XCELL` 63666.971 -0.922 0.356       
Age                                     1.047  0.862 0.389       
Stage2                                    Inf  0.003 0.998       
Stage3                                    Inf  0.003 0.997       
Stage4                                    Inf  0.003 0.997       
Rsquare = 0.137 (max possible = 7.08e-01 )
Likelihood ratio test p = 4.9e-05 
Wald test p = 1.54e-03 
Score (logrank) test p = 4.52e-07 

T cell CD8+ effector memory_XCELL in BRCA-Her2 (n=82):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
75 patients with 16 dying ( 7 missing obs. )
                                          coef     HR    se(coef) 95%CI_l
`T cell CD8+ effector memory_XCELL` -64357.378  0.000 2659621.820   0.000
Age                                      0.081  1.084       0.023   1.036
Stage2                                  -1.136  0.321       0.618   0.096
Stage3                                   0.148  1.159       0.551   0.394
Stage4                                   2.770 15.960       0.711   3.965
                                    95%CI_u      z     p signif
`T cell CD8+ effector memory_XCELL`     Inf -0.024 0.981       
Age                                   1.134  3.522 0.000    ***
Stage2                                1.079 -1.837 0.066      ·
Stage3                                3.410  0.268 0.789       
Stage4                               64.249  3.898 0.000    ***
Rsquare = 0.307 (max possible = 7.59e-01 )
Likelihood ratio test p = 4.46e-05 
Wald test p = 1e+00 
Score (logrank) test p = 6.85e-08 

T cell CD8+ effector memory_XCELL in BRCA-LumA (n=568):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
547 patients with 62 dying ( 21 missing obs. )
                                     coef    HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ effector memory_XCELL` 0.834 2.302   15.240   0.000 2.157819e+13
Age                                 0.045 1.046    0.011   1.024 1.069000e+00
Stage2                              0.469 1.599    0.359   0.790 3.233000e+00
Stage3                              0.895 2.446    0.393   1.133 5.280000e+00
Stage4                              2.026 7.587    0.544   2.613 2.203000e+01
                                        z     p signif
`T cell CD8+ effector memory_XCELL` 0.055 0.956       
Age                                 4.105 0.000    ***
Stage2                              1.306 0.192       
Stage3                              2.279 0.023      *
Stage4                              3.726 0.000    ***
Rsquare = 0.052 (max possible = 6.7e-01 )
Likelihood ratio test p = 2.2e-05 
Wald test p = 4.6e-06 
Score (logrank) test p = 3.59e-07 

T cell CD8+ effector memory_XCELL in BRCA-LumB (n=219):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
211 patients with 32 dying ( 8 missing obs. )
                                       coef    HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ effector memory_XCELL` -38.758 0.000   38.756   0.000 1.434687e+16
Age                                   0.030 1.030    0.015   1.000 1.061000e+00
Stage2                                0.747 2.110    0.776   0.461 9.652000e+00
Stage3                                1.259 3.523    0.786   0.755 1.644700e+01
Stage4                                1.947 7.007    0.908   1.181 4.156900e+01
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -1.000 0.317       
Age                                  1.960 0.050      ·
Stage2                               0.963 0.336       
Stage3                               1.602 0.109       
Stage4                               2.143 0.032      *
Rsquare = 0.068 (max possible = 7e-01 )
Likelihood ratio test p = 1.15e-02 
Wald test p = 1.68e-02 
Score (logrank) test p = 6.89e-03 

T cell CD8+ effector memory_XCELL in CESC (n=306):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age 
293 patients with 73 dying ( 13 missing obs. )
                                       coef    HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -17.682 0.000    5.928   0.000   0.002
Age                                   0.014 1.014    0.009   0.997   1.031
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -2.983 0.003     **
Age                                  1.651 0.099      ·
Rsquare = 0.062 (max possible = 9.11e-01 )
Likelihood ratio test p = 8.83e-05 
Wald test p = 3e-03 
Score (logrank) test p = 1.25e-03 

T cell CD8+ effector memory_XCELL in CHOL (n=36):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
36 patients with 18 dying ( 0 missing obs. )
                                       coef           HR se(coef)      95%CI_l
`T cell CD8+ effector memory_XCELL`  69.998 2.510208e+30   27.144 19706869.224
Age                                   0.024 1.024000e+00    0.019        0.986
Stage2                                1.204 3.334000e+00    0.652        0.930
Stage3                              -26.613 0.000000e+00 8515.507        0.000
Stage4                                1.280 3.595000e+00    0.653        1.000
                                         95%CI_u      z     p signif
`T cell CD8+ effector memory_XCELL` 3.197435e+53  2.579 0.010      *
Age                                 1.063000e+00  1.238 0.216       
Stage2                              1.195300e+01  1.848 0.065      ·
Stage3                                       Inf -0.003 0.998       
Stage4                              1.292200e+01  1.960 0.050      ·
Rsquare = 0.227 (max possible = 9.46e-01 )
Likelihood ratio test p = 9.8e-02 
Wald test p = 1.43e-01 
Score (logrank) test p = 4.43e-02 

T cell CD8+ effector memory_XCELL in COAD (n=458):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
267 patients with 62 dying ( 191 missing obs. )
                                     coef      HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ effector memory_XCELL` 4.620 101.445   15.258   0.000 9.867893e+14
Age                                 0.036   1.037    0.012   1.013 1.061000e+00
Stage2                              0.720   2.055    0.624   0.605 6.986000e+00
Stage3                              1.350   3.859    0.622   1.140 1.305700e+01
Stage4                              2.516  12.382    0.631   3.594 4.266300e+01
                                        z     p signif
`T cell CD8+ effector memory_XCELL` 0.303 0.762       
Age                                 3.080 0.002     **
Stage2                              1.154 0.248       
Stage3                              2.171 0.030      *
Stage4                              3.987 0.000    ***
Rsquare = 0.123 (max possible = 8.92e-01 )
Likelihood ratio test p = 1.42e-06 
Wald test p = 1.43e-06 
Score (logrank) test p = 1.15e-07 

T cell CD8+ effector memory_XCELL in DLBC (n=48):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age 
47 patients with 9 dying ( 1 missing obs. )
                                      coef     HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ effector memory_XCELL`  2.627 13.828   14.333   0.000 2.191799e+13
Age                                 -0.011  0.989    0.026   0.941 1.040000e+00
                                         z     p signif
`T cell CD8+ effector memory_XCELL`  0.183 0.855       
Age                                 -0.428 0.669       
Rsquare = 0.004 (max possible = 6.72e-01 )
Likelihood ratio test p = 9.02e-01 
Wald test p = 9e-01 
Score (logrank) test p = 9e-01 

T cell CD8+ effector memory_XCELL in ESCA (n=185):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
160 patients with 63 dying ( 25 missing obs. )
                                     coef     HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ effector memory_XCELL` 0.800  2.225    7.889   0.000 11536476.449
Age                                 0.005  1.005    0.011   0.984        1.027
Stage2                              0.776  2.173    0.553   0.735        6.420
Stage3                              1.708  5.517    0.567   1.817       16.750
Stage4                              2.483 11.980    0.645   3.384       42.408
                                        z     p signif
`T cell CD8+ effector memory_XCELL` 0.101 0.919       
Age                                 0.444 0.657       
Stage2                              1.404 0.160       
Stage3                              3.014 0.003     **
Stage4                              3.850 0.000    ***
Rsquare = 0.145 (max possible = 9.61e-01 )
Likelihood ratio test p = 1.37e-04 
Wald test p = 1.47e-04 
Score (logrank) test p = 2.06e-05 

T cell CD8+ effector memory_XCELL in GBM (n=153):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age 
150 patients with 120 dying ( 3 missing obs. )
                                      coef           HR se(coef) 95%CI_l
`T cell CD8+ effector memory_XCELL` 65.366 2.444046e+28   54.968   0.000
Age                                  0.029 1.029000e+00    0.008   1.014
                                         95%CI_u     z     p signif
`T cell CD8+ effector memory_XCELL` 1.501773e+75 1.189 0.234       
Age                                 1.045000e+00 3.799 0.000    ***
Rsquare = 0.105 (max possible = 9.98e-01 )
Likelihood ratio test p = 2.44e-04 
Wald test p = 4.82e-04 
Score (logrank) test p = 4.28e-04 

T cell CD8+ effector memory_XCELL in HNSC (n=522):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
446 patients with 191 dying ( 76 missing obs. )
                                      coef    HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -7.754 0.000    3.678   0.000   0.579
Age                                  0.024 1.025    0.007   1.011   1.039
Stage2                               0.758 2.133    0.538   0.743   6.124
Stage3                               0.857 2.355    0.535   0.825   6.723
Stage4                               1.340 3.819    0.508   1.410  10.340
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -2.108 0.035      *
Age                                  3.452 0.001     **
Stage2                               1.408 0.159       
Stage3                               1.601 0.109       
Stage4                               2.636 0.008     **
Rsquare = 0.075 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.72e-06 
Wald test p = 1.3e-05 
Score (logrank) test p = 8.08e-06 

T cell CD8+ effector memory_XCELL in HNSC-HPV+ (n=98):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
67 patients with 24 dying ( 31 missing obs. )
                                       coef          HR se(coef) 95%CI_l
`T cell CD8+ effector memory_XCELL` -45.230        0.00   20.919    0.00
Age                                  -0.010        0.99    0.021    0.95
Stage2                               17.054 25501661.53 5357.973    0.00
Stage3                               17.187 29121827.50 5357.973    0.00
Stage4                               17.388 35593343.80 5357.973    0.00
                                    95%CI_u      z     p signif
`T cell CD8+ effector memory_XCELL`   0.015 -2.162 0.031      *
Age                                   1.033 -0.452 0.651       
Stage2                                  Inf  0.003 0.997       
Stage3                                  Inf  0.003 0.997       
Stage4                                  Inf  0.003 0.997       
Rsquare = 0.202 (max possible = 9.24e-01 )
Likelihood ratio test p = 9.79e-03 
Wald test p = 3.78e-01 
Score (logrank) test p = 1.41e-01 

T cell CD8+ effector memory_XCELL in HNSC-HPV- (n=422):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
379 patients with 167 dying ( 43 missing obs. )
                                      coef    HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -3.651 0.026    3.920   0.000  56.389
Age                                  0.028 1.028    0.008   1.013   1.044
Stage2                               0.507 1.660    0.545   0.570   4.834
Stage3                               0.715 2.045    0.538   0.712   5.869
Stage4                               1.227 3.413    0.509   1.257   9.262
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -0.931 0.352       
Age                                  3.573 0.000    ***
Stage2                               0.929 0.353       
Stage3                               1.330 0.184       
Stage4                               2.409 0.016      *
Rsquare = 0.076 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.39e-05 
Wald test p = 6.54e-05 
Score (logrank) test p = 4.62e-05 

T cell CD8+ effector memory_XCELL in KICH (n=66):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
65 patients with 9 dying ( 1 missing obs. )
                                          coef           HR    se(coef)
`T cell CD8+ effector memory_XCELL` -55695.459         0.00 1780761.532
Age                                      0.040         1.04       0.029
Stage2                                  15.798   7259091.80       0.844
Stage3                                  16.468  14196091.46       0.781
Stage4                                  19.282 236630618.53       0.895
                                         95%CI_l      95%CI_u      z     p
`T cell CD8+ effector memory_XCELL`        0.000          Inf -0.031 0.975
Age                                        0.983 1.101000e+00  1.376 0.169
Stage2                               1388518.948 3.795009e+07 18.720 0.000
Stage3                               3074313.828 6.555252e+07 21.098 0.000
Stage4                              40985215.455 1.366201e+09 21.555 0.000
                                    signif
`T cell CD8+ effector memory_XCELL`       
Age                                       
Stage2                                 ***
Stage3                                 ***
Stage4                                 ***
Rsquare = 0.337 (max possible = 6.61e-01 )
Likelihood ratio test p = 6.55e-05 
Wald test p = 1e+00 
Score (logrank) test p = 6.02e-11 

T cell CD8+ effector memory_XCELL in KIRC (n=533):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
526 patients with 172 dying ( 7 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u     z
`T cell CD8+ effector memory_XCELL` 1.436 4.203    1.467   0.237  74.526 0.979
Age                                 0.034 1.035    0.007   1.020   1.050 4.578
Stage2                              0.271 1.311    0.317   0.704   2.442 0.852
Stage3                              0.924 2.520    0.210   1.668   3.807 4.392
Stage4                              1.914 6.781    0.201   4.577  10.046 9.543
                                        p signif
`T cell CD8+ effector memory_XCELL` 0.328       
Age                                 0.000    ***
Stage2                              0.394       
Stage3                              0.000    ***
Stage4                              0.000    ***
Rsquare = 0.21 (max possible = 9.75e-01 )
Likelihood ratio test p = 5.18e-25 
Wald test p = 1.26e-24 
Score (logrank) test p = 1.1e-30 

T cell CD8+ effector memory_XCELL in KIRP (n=290):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
255 patients with 39 dying ( 35 missing obs. )
                                      coef        HR se(coef) 95%CI_l
`T cell CD8+ effector memory_XCELL`  9.332 11289.936    4.257   2.689
Age                                  0.008     1.008    0.014   0.980
Stage2                              -0.056     0.946    0.768   0.210
Stage3                               1.554     4.733    0.384   2.228
Stage4                               2.847    17.231    0.454   7.076
                                         95%CI_u      z     p signif
`T cell CD8+ effector memory_XCELL` 47407254.283  2.192 0.028      *
Age                                        1.037  0.542 0.588       
Stage2                                     4.259 -0.073 0.942       
Stage3                                    10.054  4.043 0.000    ***
Stage4                                    41.958  6.269 0.000    ***
Rsquare = 0.15 (max possible = 7.61e-01 )
Likelihood ratio test p = 8.01e-08 
Wald test p = 1.34e-08 
Score (logrank) test p = 1.31e-13 

T cell CD8+ effector memory_XCELL in LGG (n=516):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age 
511 patients with 125 dying ( 5 missing obs. )
                                     coef    HR se(coef) 95%CI_l 95%CI_u     z
`T cell CD8+ effector memory_XCELL`    NA    NA    0.000      NA      NA    NA
Age                                 0.057 1.058    0.007   1.043   1.074 7.796
                                     p signif
`T cell CD8+ effector memory_XCELL` NA   <NA>
Age                                  0    ***
Rsquare = 0.112 (max possible = 9.13e-01 )
Likelihood ratio test p = 7.67e-15 
Wald test p = 6.38e-15 
Score (logrank) test p = 9.23e-16 

T cell CD8+ effector memory_XCELL in LIHC (n=371):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
340 patients with 116 dying ( 31 missing obs. )
                                      coef    HR se(coef) 95%CI_l    95%CI_u
`T cell CD8+ effector memory_XCELL` -4.065 0.017    8.417   0.000 250747.355
Age                                  0.012 1.012    0.007   0.998      1.027
Stage2                               0.317 1.373    0.251   0.840      2.245
Stage3                               0.991 2.693    0.215   1.765      4.107
Stage4                               1.677 5.352    0.600   1.651     17.353
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -0.483 0.629       
Age                                  1.629 0.103       
Stage2                               1.264 0.206       
Stage3                               4.597 0.000    ***
Stage4                               2.795 0.005     **
Rsquare = 0.076 (max possible = 9.69e-01 )
Likelihood ratio test p = 6.55e-05 
Wald test p = 2.9e-05 
Score (logrank) test p = 9.35e-06 

T cell CD8+ effector memory_XCELL in LUAD (n=515):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
484 patients with 177 dying ( 31 missing obs. )
                                      coef    HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -5.114 0.006    4.194   0.000  22.357
Age                                  0.009 1.009    0.008   0.994   1.024
Stage2                               0.841 2.319    0.188   1.605   3.350
Stage3                               1.181 3.256    0.196   2.216   4.784
Stage4                               1.287 3.621    0.282   2.081   6.299
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -1.219 0.223       
Age                                  1.148 0.251       
Stage2                               4.482 0.000    ***
Stage3                               6.015 0.000    ***
Stage4                               4.555 0.000    ***
Rsquare = 0.099 (max possible = 9.79e-01 )
Likelihood ratio test p = 1.25e-09 
Wald test p = 1.64e-09 
Score (logrank) test p = 1.88e-10 

T cell CD8+ effector memory_XCELL in LUSC (n=501):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
484 patients with 209 dying ( 17 missing obs. )
                                      coef    HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -0.279 0.757    3.420   0.001 617.165
Age                                  0.018 1.018    0.009   1.001   1.036
Stage2                               0.165 1.179    0.164   0.855   1.626
Stage3                               0.469 1.599    0.184   1.115   2.292
Stage4                               1.186 3.275    0.462   1.323   8.106
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -0.081 0.935       
Age                                  2.083 0.037      *
Stage2                               1.005 0.315       
Stage3                               2.553 0.011      *
Stage4                               2.566 0.010      *
Rsquare = 0.028 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.89e-02 
Wald test p = 1.12e-02 
Score (logrank) test p = 8.5e-03 

T cell CD8+ effector memory_XCELL in MESO (n=87):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
86 patients with 73 dying ( 1 missing obs. )
                                      coef    HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -0.168 0.846    3.583   0.001 948.954
Age                                  0.019 1.019    0.015   0.990   1.049
Stage2                              -0.404 0.668    0.448   0.278   1.605
Stage3                              -0.235 0.790    0.383   0.373   1.673
Stage4                              -0.302 0.739    0.444   0.309   1.765
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -0.047 0.963       
Age                                  1.285 0.199       
Stage2                              -0.903 0.367       
Stage3                              -0.616 0.538       
Stage4                              -0.681 0.496       
Rsquare = 0.032 (max possible = 9.98e-01 )
Likelihood ratio test p = 7.31e-01 
Wald test p = 7.23e-01 
Score (logrank) test p = 7.21e-01 

T cell CD8+ effector memory_XCELL in OV (n=303):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age 
302 patients with 183 dying ( 1 missing obs. )
                                      coef    HR se(coef) 95%CI_l   95%CI_u
`T cell CD8+ effector memory_XCELL` -6.849 0.001    8.943   0.000 43400.486
Age                                  0.029 1.030    0.007   1.015     1.045
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -0.766 0.444       
Age                                  4.050 0.000    ***
Rsquare = 0.054 (max possible = 9.97e-01 )
Likelihood ratio test p = 2.31e-04 
Wald test p = 2.02e-04 
Score (logrank) test p = 1.83e-04 

T cell CD8+ effector memory_XCELL in PAAD (n=179):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
175 patients with 93 dying ( 4 missing obs. )
                                      coef    HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ effector memory_XCELL` -3.247 0.039   13.804   0.000 2.186975e+10
Age                                  0.024 1.024    0.010   1.004 1.045000e+00
Stage2                               0.782 2.186    0.398   1.002 4.772000e+00
Stage3                               0.077 1.080    1.074   0.132 8.862000e+00
Stage4                               0.355 1.426    0.809   0.292 6.957000e+00
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -0.235 0.814       
Age                                  2.297 0.022      *
Stage2                               1.964 0.049      *
Stage3                               0.072 0.943       
Stage4                               0.439 0.661       
Rsquare = 0.065 (max possible = 9.91e-01 )
Likelihood ratio test p = 3.72e-02 
Wald test p = 6.42e-02 
Score (logrank) test p = 5.73e-02 

T cell CD8+ effector memory_XCELL in PCPG (n=181):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age 
181 patients with 7 dying ( 0 missing obs. )
                                          coef    HR     se(coef) 95%CI_l
`T cell CD8+ effector memory_XCELL` -67254.004 0.000 41916869.578   0.000
Age                                      0.022 1.022        0.024   0.975
                                    95%CI_u      z     p signif
`T cell CD8+ effector memory_XCELL`     Inf -0.002 0.999       
Age                                   1.072  0.912 0.362       
Rsquare = 0.006 (max possible = 2.89e-01 )
Likelihood ratio test p = 5.84e-01 
Wald test p = 1e+00 
Score (logrank) test p = 6.29e-01 

T cell CD8+ effector memory_XCELL in PRAD (n=498):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age 
496 patients with 10 dying ( 2 missing obs. )
                                          coef    HR   se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -33914.030 0.000 4415133.66   0.000     Inf
Age                                      0.053 1.055       0.05   0.957   1.163
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -0.008 0.994       
Age                                  1.070 0.284       
Rsquare = 0.003 (max possible = 1.68e-01 )
Likelihood ratio test p = 4.7e-01 
Wald test p = 1e+00 
Score (logrank) test p = 5.45e-01 

T cell CD8+ effector memory_XCELL in READ (n=166):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
82 patients with 14 dying ( 84 missing obs. )
                                       coef    HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ effector memory_XCELL` -64.857 0.000   67.291   0.000 1.292748e+29
Age                                   0.142 1.152    0.052   1.041 1.275000e+00
Stage2                               -1.156 0.315    1.247   0.027 3.629000e+00
Stage3                                0.524 1.689    0.841   0.325 8.772000e+00
Stage4                                0.325 1.384    0.928   0.224 8.532000e+00
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -0.964 0.335       
Age                                  2.731 0.006     **
Stage2                              -0.927 0.354       
Stage3                               0.623 0.533       
Stage4                               0.350 0.726       
Rsquare = 0.236 (max possible = 7.04e-01 )
Likelihood ratio test p = 5.18e-04 
Wald test p = 4.92e-02 
Score (logrank) test p = 1.52e-03 

T cell CD8+ effector memory_XCELL in SARC (n=260):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age 
257 patients with 99 dying ( 3 missing obs. )
                                      coef    HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -7.802 0.000    4.864   0.000   5.641
Age                                  0.022 1.022    0.008   1.007   1.038
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -1.604 0.109       
Age                                  2.791 0.005     **
Rsquare = 0.042 (max possible = 9.77e-01 )
Likelihood ratio test p = 4.27e-03 
Wald test p = 6.46e-03 
Score (logrank) test p = 6.14e-03 

T cell CD8+ effector memory_XCELL in SKCM (n=471):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
407 patients with 192 dying ( 64 missing obs. )
                                      coef    HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -7.531 0.001    2.632   0.000   0.093
Age                                  0.019 1.019    0.005   1.009   1.030
Stage2                               0.228 1.256    0.216   0.823   1.918
Stage3                               0.631 1.880    0.199   1.271   2.778
Stage4                               1.286 3.618    0.349   1.826   7.170
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -2.861 0.004     **
Age                                  3.777 0.000    ***
Stage2                               1.057 0.291       
Stage3                               3.164 0.002     **
Stage4                               3.686 0.000    ***
Rsquare = 0.104 (max possible = 9.92e-01 )
Likelihood ratio test p = 1.79e-08 
Wald test p = 8.97e-08 
Score (logrank) test p = 4.14e-08 

T cell CD8+ effector memory_XCELL in SKCM-Primary (n=103):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
95 patients with 26 dying ( 8 missing obs. )
                                      coef           HR se(coef) 95%CI_l
`T cell CD8+ effector memory_XCELL`  2.074 7.954000e+00    9.737   0.000
Age                                  0.005 1.005000e+00    0.014   0.977
Stage2                              17.635 4.558191e+07 6192.471   0.000
Stage3                              18.242 8.362414e+07 6192.471   0.000
Stage4                              20.011 4.904369e+08 6192.471   0.000
                                         95%CI_u     z     p signif
`T cell CD8+ effector memory_XCELL` 1.543428e+09 0.213 0.831       
Age                                 1.033000e+00 0.325 0.745       
Stage2                                       Inf 0.003 0.998       
Stage3                                       Inf 0.003 0.998       
Stage4                                       Inf 0.003 0.997       
Rsquare = 0.111 (max possible = 8.67e-01 )
Likelihood ratio test p = 4.81e-02 
Wald test p = 4.1e-02 
Score (logrank) test p = 3.89e-03 

T cell CD8+ effector memory_XCELL in SKCM-Metastasis (n=368):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
312 patients with 166 dying ( 56 missing obs. )
                                      coef    HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -7.565 0.001    2.787   0.000   0.122
Age                                  0.022 1.022    0.006   1.011   1.033
Stage2                               0.112 1.119    0.227   0.717   1.746
Stage3                               0.562 1.754    0.204   1.176   2.616
Stage4                               1.061 2.890    0.396   1.329   6.282
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -2.715 0.007     **
Age                                  3.930 0.000    ***
Stage2                               0.496 0.620       
Stage3                               2.753 0.006     **
Stage4                               2.679 0.007     **
Rsquare = 0.119 (max possible = 9.95e-01 )
Likelihood ratio test p = 1.84e-07 
Wald test p = 9.46e-07 
Score (logrank) test p = 5.43e-07 

T cell CD8+ effector memory_XCELL in STAD (n=415):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
368 patients with 148 dying ( 47 missing obs. )
                                      coef    HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -4.288 0.014    4.761   0.000 154.992
Age                                  0.029 1.029    0.009   1.012   1.047
Stage2                               0.459 1.583    0.335   0.822   3.050
Stage3                               0.955 2.599    0.315   1.403   4.815
Stage4                               1.631 5.107    0.365   2.498  10.441
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -0.901 0.368       
Age                                  3.388 0.001     **
Stage2                               1.372 0.170       
Stage3                               3.036 0.002     **
Stage4                               4.469 0.000    ***
Rsquare = 0.087 (max possible = 9.85e-01 )
Likelihood ratio test p = 2.78e-06 
Wald test p = 3.92e-06 
Score (logrank) test p = 1.83e-06 

T cell CD8+ effector memory_XCELL in TGCT (n=150):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
81 patients with 2 dying ( 69 missing obs. )
                                         coef           HR   se(coef) 95%CI_l
`T cell CD8+ effector memory_XCELL` -3110.276 0.000000e+00 817467.323       0
Age                                    -5.120 6.000000e-03   1221.321       0
Stage2                                -64.105 0.000000e+00  94780.846       0
Stage3                                 48.803 1.566001e+21  24675.884       0
                                    95%CI_u      z     p signif
`T cell CD8+ effector memory_XCELL`     Inf -0.004 0.997       
Age                                     Inf -0.004 0.997       
Stage2                                  Inf -0.001 0.999       
Stage3                                  Inf  0.002 0.998       
Rsquare = 0.132 (max possible = 1.32e-01 )
Likelihood ratio test p = 2.16e-02 
Wald test p = 1e+00 
Score (logrank) test p = 1.42e-01 

T cell CD8+ effector memory_XCELL in THCA (n=509):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
506 patients with 16 dying ( 3 missing obs. )
                                         coef    HR   se(coef) 95%CI_l 95%CI_u
`T cell CD8+ effector memory_XCELL` -7037.146 0.000 852878.891   0.000     Inf
Age                                     0.159 1.172      0.028   1.109   1.238
Stage2                                  0.822 2.276      0.758   0.515  10.063
Stage3                                  0.166 1.181      0.506   0.438   3.181
Stage4                                  0.827 2.287      0.544   0.787   6.644
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -0.008 0.993       
Age                                  5.615 0.000    ***
Stage2                               1.084 0.278       
Stage3                               0.329 0.742       
Stage4                               1.521 0.128       
Rsquare = 0.115 (max possible = 2.9e-01 )
Likelihood ratio test p = 4.84e-12 
Wald test p = 1e+00 
Score (logrank) test p = 1.77e-11 

T cell CD8+ effector memory_XCELL in THYM (n=120):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age 
119 patients with 9 dying ( 1 missing obs. )
                                      coef          HR se(coef) 95%CI_l
`T cell CD8+ effector memory_XCELL` 15.059 3469159.895    7.698   0.972
Age                                  0.055       1.056    0.031   0.993
                                         95%CI_u     z     p signif
`T cell CD8+ effector memory_XCELL` 1.238579e+13 1.956 0.050      ·
Age                                 1.123000e+00 1.746 0.081      ·
Rsquare = 0.056 (max possible = 4.39e-01 )
Likelihood ratio test p = 3.23e-02 
Wald test p = 2.69e-02 
Score (logrank) test p = 1.1e-02 

T cell CD8+ effector memory_XCELL in UCEC (n=545):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age 
173 patients with 32 dying ( 372 missing obs. )
                                      coef    HR se(coef) 95%CI_l   95%CI_u
`T cell CD8+ effector memory_XCELL` -1.842 0.158    6.099   0.000 24642.441
Age                                  0.015 1.015    0.016   0.983     1.048
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -0.302 0.763       
Age                                  0.938 0.348       
Rsquare = 0.006 (max possible = 7.9e-01 )
Likelihood ratio test p = 6e-01 
Wald test p = 6.05e-01 
Score (logrank) test p = 6.04e-01 

T cell CD8+ effector memory_XCELL in UCS (n=57):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age 
55 patients with 34 dying ( 2 missing obs. )
                                       coef    HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ effector memory_XCELL` -16.364 0.000   25.257   0.000 2.464318e+14
Age                                   0.046 1.047    0.023   1.002 1.094000e+00
                                         z     p signif
`T cell CD8+ effector memory_XCELL` -0.648 0.517       
Age                                  2.031 0.042      *
Rsquare = 0.085 (max possible = 9.83e-01 )
Likelihood ratio test p = 8.78e-02 
Wald test p = 1.07e-01 
Score (logrank) test p = 9.58e-02 

T cell CD8+ effector memory_XCELL in UVM (n=80):
Model: Surv(OS, EVENT) ~ `T cell CD8+ effector memory_XCELL` + Age + Stage 
79 patients with 22 dying ( 1 missing obs. )
                                      coef           HR se(coef) 95%CI_l
`T cell CD8+ effector memory_XCELL` 19.090 1.952414e+08    9.652   1.188
Age                                  0.040 1.041000e+00    0.020   1.002
Stage3                               0.104 1.110000e+00    0.479   0.434
Stage4                               3.882 4.853500e+01    1.204   4.580
                                         95%CI_u     z     p signif
`T cell CD8+ effector memory_XCELL` 3.207585e+16 1.978 0.048      *
Age                                 1.082000e+00 2.047 0.041      *
Stage3                              2.838000e+00 0.217 0.828       
Stage4                              5.143640e+02 3.223 0.001     **
Rsquare = 0.239 (max possible = 8.67e-01 )
Likelihood ratio test p = 2.49e-04 
Wald test p = 4.91e-04 
Score (logrank) test p = 9.81e-11 

T cell CD8+ naive_XCELL in ACC (n=79):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age 
79 patients with 28 dying ( 0 missing obs. )
                              coef    HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+ naive_XCELL` -183.941 0.000  205.718   0.000 1.671772e+95 -0.894
Age                          0.009 1.009    0.013   0.984 1.034000e+00  0.689
                              p signif
`T cell CD8+ naive_XCELL` 0.371       
Age                       0.491       
Rsquare = 0.025 (max possible = 9.35e-01 )
Likelihood ratio test p = 3.69e-01 
Wald test p = 5.04e-01 
Score (logrank) test p = 4.84e-01 

T cell CD8+ naive_XCELL in BLCA (n=408):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
401 patients with 176 dying ( 7 missing obs. )
                             coef          HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ naive_XCELL` -14.531       0.000   20.135   0.000 6.729815e+10
Age                         0.031       1.031    0.008   1.015 1.047000e+00
Stage2                     14.606 2205180.377 1905.920   0.000          Inf
Stage3                     15.033 3380288.974 1905.920   0.000          Inf
Stage4                     15.578 5829680.032 1905.920   0.000          Inf
                               z     p signif
`T cell CD8+ naive_XCELL` -0.722 0.470       
Age                        3.870 0.000    ***
Stage2                     0.008 0.994       
Stage3                     0.008 0.994       
Stage4                     0.008 0.993       
Rsquare = 0.114 (max possible = 9.91e-01 )
Likelihood ratio test p = 2.95e-09 
Wald test p = 1.88e-08 
Score (logrank) test p = 4.01e-09 

T cell CD8+ naive_XCELL in BRCA (n=1100):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
1057 patients with 143 dying ( 43 missing obs. )
                             coef     HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+ naive_XCELL` -19.171  0.000   10.916   0.000   9.241 -1.756 0.079
Age                         0.033  1.034    0.007   1.020   1.048  4.771 0.000
Stage2                      0.588  1.800    0.279   1.041   3.111  2.105 0.035
Stage3                      1.235  3.439    0.294   1.933   6.120  4.201 0.000
Stage4                      2.362 10.616    0.363   5.211  21.625  6.507 0.000
                          signif
`T cell CD8+ naive_XCELL`      ·
Age                          ***
Stage2                         *
Stage3                       ***
Stage4                       ***
Rsquare = 0.07 (max possible = 7.87e-01 )
Likelihood ratio test p = 4.28e-15 
Wald test p = 3.75e-18 
Score (logrank) test p = 3.39e-23 

T cell CD8+ naive_XCELL in BRCA-Basal (n=191):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
185 patients with 26 dying ( 6 missing obs. )
                             coef           HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ naive_XCELL` -16.534 0.000000e+00   19.294    0.00 1.748582e+09
Age                         0.012 1.012000e+00    0.016    0.98 1.045000e+00
Stage2                     18.942 1.684807e+08 6220.917    0.00          Inf
Stage3                     20.378 7.076864e+08 6220.917    0.00          Inf
Stage4                     21.724 2.720872e+09 6220.917    0.00          Inf
                               z     p signif
`T cell CD8+ naive_XCELL` -0.857 0.391       
Age                        0.705 0.481       
Stage2                     0.003 0.998       
Stage3                     0.003 0.997       
Stage4                     0.003 0.997       
Rsquare = 0.136 (max possible = 7.08e-01 )
Likelihood ratio test p = 5.64e-05 
Wald test p = 1.49e-03 
Score (logrank) test p = 3.85e-07 

T cell CD8+ naive_XCELL in BRCA-Her2 (n=82):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
75 patients with 16 dying ( 7 missing obs. )
                             coef     HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+ naive_XCELL` -26.015  0.000   52.994   0.000 6.455998e+33 -0.491
Age                         0.078  1.082    0.028   1.024 1.142000e+00  2.827
Stage2                     -0.755  0.470    1.152   0.049 4.494000e+00 -0.656
Stage3                      0.555  1.742    1.142   0.186 1.634200e+01  0.486
Stage4                      3.353 28.586    1.241   2.509 3.256890e+02  2.701
                              p signif
`T cell CD8+ naive_XCELL` 0.623       
Age                       0.005     **
Stage2                    0.512       
Stage3                    0.627       
Stage4                    0.007     **
Rsquare = 0.289 (max possible = 7.59e-01 )
Likelihood ratio test p = 1.1e-04 
Wald test p = 3.61e-04 
Score (logrank) test p = 9.09e-08 

T cell CD8+ naive_XCELL in BRCA-LumA (n=568):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
547 patients with 62 dying ( 21 missing obs. )
                            coef    HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+ naive_XCELL` -5.050 0.006   18.463   0.000 3.328764e+13 -0.274
Age                        0.044 1.045    0.011   1.023 1.068000e+00  3.988
Stage2                     0.476 1.609    0.360   0.795 3.258000e+00  1.322
Stage3                     0.895 2.448    0.393   1.134 5.284000e+00  2.279
Stage4                     2.007 7.440    0.548   2.541 2.178300e+01  3.662
                              p signif
`T cell CD8+ naive_XCELL` 0.784       
Age                       0.000    ***
Stage2                    0.186       
Stage3                    0.023      *
Stage4                    0.000    ***
Rsquare = 0.052 (max possible = 6.7e-01 )
Likelihood ratio test p = 2.12e-05 
Wald test p = 4.35e-06 
Score (logrank) test p = 3.44e-07 

T cell CD8+ naive_XCELL in BRCA-LumB (n=219):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
211 patients with 32 dying ( 8 missing obs. )
                             coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+ naive_XCELL` -63.409 0.000   25.018   0.000   0.000 -2.534 0.011
Age                         0.036 1.036    0.016   1.004   1.070  2.185 0.029
Stage2                      0.736 2.087    0.764   0.467   9.322  0.964 0.335
Stage3                      1.198 3.313    0.777   0.723  15.180  1.542 0.123
Stage4                      1.484 4.409    0.918   0.729  26.658  1.616 0.106
                          signif
`T cell CD8+ naive_XCELL`      *
Age                            *
Stage2                          
Stage3                          
Stage4                          
Rsquare = 0.095 (max possible = 7e-01 )
Likelihood ratio test p = 8.23e-04 
Wald test p = 2.17e-03 
Score (logrank) test p = 6.74e-04 

T cell CD8+ naive_XCELL in CESC (n=306):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age 
293 patients with 73 dying ( 13 missing obs. )
                             coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+ naive_XCELL` -38.941 0.000   21.138   0.000  12.035 -1.842 0.065
Age                         0.015 1.015    0.009   0.998   1.033  1.722 0.085
                          signif
`T cell CD8+ naive_XCELL`      ·
Age                            ·
Rsquare = 0.023 (max possible = 9.11e-01 )
Likelihood ratio test p = 3.53e-02 
Wald test p = 3.96e-02 
Score (logrank) test p = 3.86e-02 

T cell CD8+ naive_XCELL in CHOL (n=36):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
36 patients with 18 dying ( 0 missing obs. )
                             coef    HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+ naive_XCELL` -47.590 0.000   83.546   0.000 2.793605e+50 -0.570
Age                         0.024 1.025    0.020   0.984 1.067000e+00  1.187
Stage2                      0.917 2.502    0.612   0.754 8.297000e+00  1.499
Stage3                    -15.172 0.000 6580.442   0.000          Inf -0.002
Stage4                      0.928 2.530    0.610   0.765 8.362000e+00  1.521
                              p signif
`T cell CD8+ naive_XCELL` 0.569       
Age                       0.235       
Stage2                    0.134       
Stage3                    0.998       
Stage4                    0.128       
Rsquare = 0.139 (max possible = 9.46e-01 )
Likelihood ratio test p = 3.68e-01 
Wald test p = 5.53e-01 
Score (logrank) test p = 4.14e-01 

T cell CD8+ naive_XCELL in COAD (n=458):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
267 patients with 62 dying ( 191 missing obs. )
                            coef           HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ naive_XCELL` 22.226 4.492273e+09   37.712   0.000 5.657721e+41
Age                        0.037 1.038000e+00    0.012   1.014 1.062000e+00
Stage2                     0.711 2.036000e+00    0.624   0.599 6.922000e+00
Stage3                     1.333 3.794000e+00    0.623   1.120 1.285300e+01
Stage4                     2.516 1.237600e+01    0.630   3.598 4.256800e+01
                              z     p signif
`T cell CD8+ naive_XCELL` 0.589 0.556       
Age                       3.170 0.002     **
Stage2                    1.139 0.255       
Stage3                    2.142 0.032      *
Stage4                    3.991 0.000    ***
Rsquare = 0.124 (max possible = 8.92e-01 )
Likelihood ratio test p = 1.26e-06 
Wald test p = 1.26e-06 
Score (logrank) test p = 9.93e-08 

T cell CD8+ naive_XCELL in DLBC (n=48):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age 
47 patients with 9 dying ( 1 missing obs. )
                                coef    HR    se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+ naive_XCELL` -64017.039 0.000 1.41629e+07   0.000     Inf -0.005
Age                           -0.016 0.984 2.60000e-02   0.935   1.036 -0.598
                              p signif
`T cell CD8+ naive_XCELL` 0.996       
Age                       0.550       
Rsquare = 0.106 (max possible = 6.72e-01 )
Likelihood ratio test p = 7.12e-02 
Wald test p = 1e+00 
Score (logrank) test p = 4.4e-01 

T cell CD8+ naive_XCELL in ESCA (n=185):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
160 patients with 63 dying ( 25 missing obs. )
                            coef           HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ naive_XCELL` 36.662 8.356131e+15   22.298   0.001 7.980206e+34
Age                        0.006 1.006000e+00    0.011   0.984 1.028000e+00
Stage2                     0.768 2.155000e+00    0.552   0.730 6.365000e+00
Stage3                     1.648 5.197000e+00    0.567   1.711 1.578800e+01
Stage4                     2.401 1.103100e+01    0.645   3.115 3.906200e+01
                              z     p signif
`T cell CD8+ naive_XCELL` 1.644 0.100       
Age                       0.526 0.599       
Stage2                    1.390 0.165       
Stage3                    2.907 0.004     **
Stage4                    3.721 0.000    ***
Rsquare = 0.157 (max possible = 9.61e-01 )
Likelihood ratio test p = 4.8e-05 
Wald test p = 4.07e-05 
Score (logrank) test p = 5.1e-06 

T cell CD8+ naive_XCELL in GBM (n=153):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age 
150 patients with 120 dying ( 3 missing obs. )
                             coef    HR se(coef) 95%CI_l 95%CI_u      z    p
`T cell CD8+ naive_XCELL` -38.607 0.000   18.825   0.000   0.181 -2.051 0.04
Age                         0.027 1.027    0.008   1.012   1.043  3.577 0.00
                          signif
`T cell CD8+ naive_XCELL`      *
Age                          ***
Rsquare = 0.126 (max possible = 9.98e-01 )
Likelihood ratio test p = 4.1e-05 
Wald test p = 1.05e-04 
Score (logrank) test p = 8.71e-05 

T cell CD8+ naive_XCELL in HNSC (n=522):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
446 patients with 191 dying ( 76 missing obs. )
                            coef        HR se(coef) 95%CI_l      95%CI_u     z
`T cell CD8+ naive_XCELL` 11.378 87341.666   10.772   0.000 1.289754e+14 1.056
Age                        0.024     1.024    0.007   1.010 1.038000e+00 3.352
Stage2                     0.763     2.144    0.539   0.746 6.162000e+00 1.416
Stage3                     0.836     2.307    0.535   0.808 6.587000e+00 1.562
Stage4                     1.378     3.965    0.509   1.463 1.074600e+01 2.708
                              p signif
`T cell CD8+ naive_XCELL` 0.291       
Age                       0.001     **
Stage2                    0.157       
Stage3                    0.118       
Stage4                    0.007     **
Rsquare = 0.066 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.24e-05 
Wald test p = 7.85e-05 
Score (logrank) test p = 5.16e-05 

T cell CD8+ naive_XCELL in HNSC-HPV+ (n=98):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
67 patients with 24 dying ( 31 missing obs. )
                             coef           HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ naive_XCELL` -47.417        0.000   32.505   0.000 11904913.528
Age                         0.001        1.001    0.022   0.959        1.045
Stage2                     17.113 27053640.709 5364.631   0.000          Inf
Stage3                     16.566 15655029.869 5364.631   0.000          Inf
Stage4                     17.401 36077046.633 5364.631   0.000          Inf
                               z     p signif
`T cell CD8+ naive_XCELL` -1.459 0.145       
Age                        0.045 0.964       
Stage2                     0.003 0.997       
Stage3                     0.003 0.998       
Stage4                     0.003 0.997       
Rsquare = 0.09 (max possible = 9.24e-01 )
Likelihood ratio test p = 2.74e-01 
Wald test p = 6.1e-01 
Score (logrank) test p = 4.33e-01 

T cell CD8+ naive_XCELL in HNSC-HPV- (n=422):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
379 patients with 167 dying ( 43 missing obs. )
                            coef           HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ naive_XCELL` 26.505 3.243876e+11   11.908  23.695 4.440845e+21
Age                        0.028 1.028000e+00    0.008   1.013 1.044000e+00
Stage2                     0.576 1.780000e+00    0.546   0.610 5.193000e+00
Stage3                     0.754 2.125000e+00    0.538   0.740 6.104000e+00
Stage4                     1.325 3.762000e+00    0.511   1.382 1.024300e+01
                              z     p signif
`T cell CD8+ naive_XCELL` 2.226 0.026      *
Age                       3.595 0.000    ***
Stage2                    1.055 0.292       
Stage3                    1.401 0.161       
Stage4                    2.593 0.010      *
Rsquare = 0.085 (max possible = 9.9e-01 )
Likelihood ratio test p = 2.56e-06 
Wald test p = 1.83e-05 
Score (logrank) test p = 1.2e-05 

T cell CD8+ naive_XCELL in KICH (n=66):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
65 patients with 9 dying ( 1 missing obs. )
                            coef           HR se(coef)      95%CI_l
`T cell CD8+ naive_XCELL`  5.383 2.176660e+02  206.653        0.000
Age                        0.042 1.043000e+00    0.028        0.987
Stage2                    15.684 6.478138e+06    0.845  1235464.582
Stage3                    16.628 1.665882e+07    0.779  3617436.158
Stage4                    19.460 2.827882e+08    0.896 48821672.929
                                95%CI_u      z     p signif
`T cell CD8+ naive_XCELL` 1.743638e+178  0.026 0.979       
Age                        1.102000e+00  1.487 0.137       
Stage2                     3.396801e+07 18.552 0.000    ***
Stage3                     7.671632e+07 21.341 0.000    ***
Stage4                     1.637985e+09 21.714 0.000    ***
Rsquare = 0.322 (max possible = 6.61e-01 )
Likelihood ratio test p = 1.24e-04 
Wald test p = 3.86e-273 
Score (logrank) test p = 5.52e-11 

T cell CD8+ naive_XCELL in KIRC (n=533):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
526 patients with 172 dying ( 7 missing obs. )
                            coef        HR se(coef) 95%CI_l      95%CI_u     z
`T cell CD8+ naive_XCELL` 10.919 55192.859    8.935   0.001 2.223872e+12 1.222
Age                        0.033     1.034    0.007   1.019 1.049000e+00 4.487
Stage2                     0.293     1.341    0.317   0.720 2.495000e+00 0.925
Stage3                     0.954     2.597    0.209   1.723 3.914000e+00 4.559
Stage4                     1.934     6.914    0.197   4.697 1.017700e+01 9.803
                              p signif
`T cell CD8+ naive_XCELL` 0.222       
Age                       0.000    ***
Stage2                    0.355       
Stage3                    0.000    ***
Stage4                    0.000    ***
Rsquare = 0.21 (max possible = 9.75e-01 )
Likelihood ratio test p = 4.05e-25 
Wald test p = 6.1e-25 
Score (logrank) test p = 5.39e-31 

T cell CD8+ naive_XCELL in KIRP (n=290):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
255 patients with 39 dying ( 35 missing obs. )
                            coef          HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ naive_XCELL` 56.671 4.09134e+24   33.752   0.000 2.195688e+53
Age                        0.009 1.00900e+00    0.015   0.981 1.039000e+00
Stage2                    -0.067 9.35000e-01    0.773   0.206 4.251000e+00
Stage3                     1.580 4.85600e+00    0.382   2.295 1.027400e+01
Stage4                     2.891 1.80040e+01    0.455   7.381 4.391600e+01
                               z     p signif
`T cell CD8+ naive_XCELL`  1.679 0.093      ·
Age                        0.635 0.525       
Stage2                    -0.087 0.931       
Stage3                     4.132 0.000    ***
Stage4                     6.353 0.000    ***
Rsquare = 0.148 (max possible = 7.61e-01 )
Likelihood ratio test p = 9.68e-08 
Wald test p = 1.27e-08 
Score (logrank) test p = 2.35e-13 

T cell CD8+ naive_XCELL in LGG (n=516):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age 
511 patients with 125 dying ( 5 missing obs. )
                             coef   HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+ naive_XCELL` -94.437 0.00   65.452   0.000 5.006494e+14 -1.443
Age                         0.058 1.06    0.007   1.044 1.075000e+00  7.887
                              p signif
`T cell CD8+ naive_XCELL` 0.149       
Age                       0.000    ***
Rsquare = 0.116 (max possible = 9.13e-01 )
Likelihood ratio test p = 2.14e-14 
Wald test p = 2.35e-14 
Score (logrank) test p = 2.93e-15 

T cell CD8+ naive_XCELL in LIHC (n=371):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
340 patients with 116 dying ( 31 missing obs. )
                             coef    HR se(coef) 95%CI_l   95%CI_u      z     p
`T cell CD8+ naive_XCELL` -31.231 0.000   21.504   0.000 55034.392 -1.452 0.146
Age                         0.012 1.012    0.007   0.998     1.027  1.691 0.091
Stage2                      0.300 1.350    0.251   0.825     2.209  1.194 0.232
Stage3                      0.995 2.705    0.215   1.773     4.126  4.619 0.000
Stage4                      1.688 5.408    0.600   1.668    17.530  2.813 0.005
                          signif
`T cell CD8+ naive_XCELL`       
Age                            ·
Stage2                          
Stage3                       ***
Stage4                        **
Rsquare = 0.081 (max possible = 9.69e-01 )
Likelihood ratio test p = 2.62e-05 
Wald test p = 1.14e-05 
Score (logrank) test p = 3.49e-06 

T cell CD8+ naive_XCELL in LUAD (n=515):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
484 patients with 177 dying ( 31 missing obs. )
                           coef    HR se(coef) 95%CI_l      95%CI_u     z     p
`T cell CD8+ naive_XCELL` 1.690 5.418   18.434   0.000 2.657927e+16 0.092 0.927
Age                       0.009 1.009    0.008   0.993 1.024000e+00 1.114 0.265
Stage2                    0.827 2.285    0.188   1.582 3.302000e+00 4.401 0.000
Stage3                    1.183 3.265    0.197   2.221 4.800000e+00 6.016 0.000
Stage4                    1.304 3.686    0.282   2.120 6.409000e+00 4.622 0.000
                          signif
`T cell CD8+ naive_XCELL`       
Age                             
Stage2                       ***
Stage3                       ***
Stage4                       ***
Rsquare = 0.095 (max possible = 9.79e-01 )
Likelihood ratio test p = 2.73e-09 
Wald test p = 3.32e-09 
Score (logrank) test p = 3.88e-10 

T cell CD8+ naive_XCELL in LUSC (n=501):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
484 patients with 209 dying ( 17 missing obs. )
                             coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+ naive_XCELL` -29.608 0.000   15.443   0.000   1.934 -1.917 0.055
Age                         0.016 1.016    0.009   0.999   1.034  1.846 0.065
Stage2                      0.175 1.191    0.164   0.863   1.643  1.065 0.287
Stage3                      0.477 1.611    0.184   1.124   2.310  2.597 0.009
Stage4                      1.215 3.369    0.462   1.363   8.326  2.631 0.009
                          signif
`T cell CD8+ naive_XCELL`      ·
Age                            ·
Stage2                          
Stage3                        **
Stage4                        **
Rsquare = 0.036 (max possible = 9.9e-01 )
Likelihood ratio test p = 3.6e-03 
Wald test p = 2.32e-03 
Score (logrank) test p = 1.73e-03 

T cell CD8+ naive_XCELL in MESO (n=87):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
86 patients with 73 dying ( 1 missing obs. )
                            coef         HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ naive_XCELL` 12.791 358794.275   39.736   0.000 2.388531e+39
Age                        0.019      1.019    0.015   0.990 1.049000e+00
Stage2                    -0.389      0.678    0.450   0.281 1.638000e+00
Stage3                    -0.241      0.786    0.383   0.371 1.665000e+00
Stage4                    -0.279      0.757    0.450   0.313 1.827000e+00
                               z     p signif
`T cell CD8+ naive_XCELL`  0.322 0.748       
Age                        1.297 0.195       
Stage2                    -0.864 0.388       
Stage3                    -0.628 0.530       
Stage4                    -0.620 0.535       
Rsquare = 0.033 (max possible = 9.98e-01 )
Likelihood ratio test p = 7.16e-01 
Wald test p = 7.06e-01 
Score (logrank) test p = 7.04e-01 

T cell CD8+ naive_XCELL in OV (n=303):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age 
302 patients with 183 dying ( 1 missing obs. )
                           coef    HR se(coef) 95%CI_l      95%CI_u     z     p
`T cell CD8+ naive_XCELL` 2.169 8.746   18.618   0.000 6.152912e+16 0.116 0.907
Age                       0.029 1.030    0.007   1.015 1.045000e+00 3.924 0.000
                          signif
`T cell CD8+ naive_XCELL`       
Age                          ***
Rsquare = 0.052 (max possible = 9.97e-01 )
Likelihood ratio test p = 3.18e-04 
Wald test p = 2.86e-04 
Score (logrank) test p = 2.63e-04 

T cell CD8+ naive_XCELL in PAAD (n=179):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
175 patients with 93 dying ( 4 missing obs. )
                             coef    HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+ naive_XCELL` -27.494 0.000   42.013   0.000 6.626747e+23 -0.654
Age                         0.024 1.024    0.010   1.003 1.045000e+00  2.272
Stage2                      0.774 2.168    0.398   0.993 4.734000e+00  1.942
Stage3                      0.203 1.225    1.090   0.144 1.037900e+01  0.186
Stage4                      0.330 1.390    0.810   0.284 6.797000e+00  0.407
                              p signif
`T cell CD8+ naive_XCELL` 0.513       
Age                       0.023      *
Stage2                    0.052      ·
Stage3                    0.853       
Stage4                    0.684       
Rsquare = 0.068 (max possible = 9.91e-01 )
Likelihood ratio test p = 3.17e-02 
Wald test p = 5.4e-02 
Score (logrank) test p = 4.77e-02 

T cell CD8+ naive_XCELL in PCPG (n=181):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age 
181 patients with 7 dying ( 0 missing obs. )
                             coef    HR se(coef) 95%CI_l       95%CI_u      z
`T cell CD8+ naive_XCELL` -90.944 0.000  204.536   0.000 4.022901e+134 -0.445
Age                         0.023 1.023    0.024   0.977  1.072000e+00  0.962
                              p signif
`T cell CD8+ naive_XCELL` 0.657       
Age                       0.336       
Rsquare = 0.006 (max possible = 2.89e-01 )
Likelihood ratio test p = 5.55e-01 
Wald test p = 5.71e-01 
Score (logrank) test p = 5.62e-01 

T cell CD8+ naive_XCELL in PRAD (n=498):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age 
496 patients with 10 dying ( 2 missing obs. )
                             coef           HR se(coef) 95%CI_l       95%CI_u
`T cell CD8+ naive_XCELL` 214.837 2.007851e+93  115.999   0.000 1.098785e+192
Age                         0.054 1.056000e+00    0.051   0.955  1.166000e+00
                              z     p signif
`T cell CD8+ naive_XCELL` 1.852 0.064      ·
Age                       1.063 0.288       
Rsquare = 0.007 (max possible = 1.68e-01 )
Likelihood ratio test p = 1.63e-01 
Wald test p = 1.07e-01 
Score (logrank) test p = 8.32e-02 

T cell CD8+ naive_XCELL in READ (n=166):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
82 patients with 14 dying ( 84 missing obs. )
                              coef    HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+ naive_XCELL` -193.604 0.000  177.163   0.000 5.256046e+66 -1.093
Age                          0.142 1.153    0.051   1.043 1.273000e+00  2.799
Stage2                      -1.087 0.337    1.256   0.029 3.955000e+00 -0.865
Stage3                       0.573 1.773    0.849   0.336 9.367000e+00  0.675
Stage4                       0.537 1.710    0.949   0.266 1.098700e+01  0.565
                              p signif
`T cell CD8+ naive_XCELL` 0.274       
Age                       0.005     **
Stage2                    0.387       
Stage3                    0.500       
Stage4                    0.572       
Rsquare = 0.237 (max possible = 7.04e-01 )
Likelihood ratio test p = 4.77e-04 
Wald test p = 3.86e-02 
Score (logrank) test p = 1.45e-03 

T cell CD8+ naive_XCELL in SARC (n=260):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age 
257 patients with 99 dying ( 3 missing obs. )
                            coef           HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ naive_XCELL` 27.121 6.005929e+11   16.184   0.010 3.582838e+25
Age                        0.020 1.020000e+00    0.008   1.005 1.036000e+00
                              z     p signif
`T cell CD8+ naive_XCELL` 1.676 0.094      ·
Age                       2.532 0.011      *
Rsquare = 0.038 (max possible = 9.77e-01 )
Likelihood ratio test p = 6.58e-03 
Wald test p = 5.96e-03 
Score (logrank) test p = 5.65e-03 

T cell CD8+ naive_XCELL in SKCM (n=471):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
407 patients with 192 dying ( 64 missing obs. )
                             coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+ naive_XCELL` -32.601 0.000   13.301   0.000   0.001 -2.451 0.014
Age                         0.019 1.020    0.005   1.009   1.030  3.809 0.000
Stage2                      0.179 1.196    0.215   0.784   1.824  0.831 0.406
Stage3                      0.540 1.715    0.201   1.158   2.542  2.689 0.007
Stage4                      1.117 3.056    0.349   1.541   6.058  3.199 0.001
                          signif
`T cell CD8+ naive_XCELL`      *
Age                          ***
Stage2                          
Stage3                        **
Stage4                        **
Rsquare = 0.095 (max possible = 9.92e-01 )
Likelihood ratio test p = 1.12e-07 
Wald test p = 2.61e-07 
Score (logrank) test p = 1.58e-07 

T cell CD8+ naive_XCELL in SKCM-Primary (n=103):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
95 patients with 26 dying ( 8 missing obs. )
                             coef           HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+ naive_XCELL` -13.286 0.000000e+00   33.884   0.000 1.180811e+23
Age                         0.003 1.003000e+00    0.015   0.973 1.033000e+00
Stage2                     17.396 3.590736e+07 6217.409   0.000          Inf
Stage3                     18.023 6.716660e+07 6217.409   0.000          Inf
Stage4                     19.797 3.958531e+08 6217.409   0.000          Inf
                               z     p signif
`T cell CD8+ naive_XCELL` -0.392 0.695       
Age                        0.177 0.860       
Stage2                     0.003 0.998       
Stage3                     0.003 0.998       
Stage4                     0.003 0.997       
Rsquare = 0.112 (max possible = 8.67e-01 )
Likelihood ratio test p = 4.6e-02 
Wald test p = 3.8e-02 
Score (logrank) test p = 3.56e-03 

T cell CD8+ naive_XCELL in SKCM-Metastasis (n=368):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
312 patients with 166 dying ( 56 missing obs. )
                             coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+ naive_XCELL` -38.050 0.000   14.552   0.000   0.000 -2.615 0.009
Age                         0.022 1.022    0.006   1.011   1.034  4.007 0.000
Stage2                      0.047 1.048    0.226   0.673   1.632  0.207 0.836
Stage3                      0.460 1.584    0.205   1.059   2.368  2.241 0.025
Stage4                      0.857 2.357    0.396   1.084   5.123  2.165 0.030
                          signif
`T cell CD8+ naive_XCELL`     **
Age                          ***
Stage2                          
Stage3                         *
Stage4                         *
Rsquare = 0.114 (max possible = 9.95e-01 )
Likelihood ratio test p = 4.11e-07 
Wald test p = 1.42e-06 
Score (logrank) test p = 9.99e-07 

T cell CD8+ naive_XCELL in STAD (n=415):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
368 patients with 148 dying ( 47 missing obs. )
                           coef     HR se(coef) 95%CI_l      95%CI_u     z
`T cell CD8+ naive_XCELL` 4.324 75.480   15.786   0.000 2.063375e+15 0.274
Age                       0.029  1.030    0.009   1.013 1.047000e+00 3.410
Stage2                    0.437  1.547    0.334   0.804 2.977000e+00 1.308
Stage3                    0.920  2.510    0.313   1.360 4.633000e+00 2.943
Stage4                    1.621  5.056    0.365   2.472 1.034200e+01 4.439
                              p signif
`T cell CD8+ naive_XCELL` 0.784       
Age                       0.001     **
Stage2                    0.191       
Stage3                    0.003     **
Stage4                    0.000    ***
Rsquare = 0.085 (max possible = 9.85e-01 )
Likelihood ratio test p = 4.04e-06 
Wald test p = 6.23e-06 
Score (logrank) test p = 2.93e-06 

T cell CD8+ naive_XCELL in TGCT (n=150):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
81 patients with 2 dying ( 69 missing obs. )
                               coef           HR    se(coef) 95%CI_l 95%CI_u
`T cell CD8+ naive_XCELL` -4234.339 0.000000e+00 3088634.452       0     Inf
Age                          -2.184 1.130000e-01    2154.813       0     Inf
Stage2                      -35.374 0.000000e+00   41915.957       0     Inf
Stage3                       19.227 2.238872e+08   89238.458       0     Inf
                               z     p signif
`T cell CD8+ naive_XCELL` -0.001 0.999       
Age                       -0.001 0.999       
Stage2                    -0.001 0.999       
Stage3                     0.000 1.000   <NA>
Rsquare = 0.132 (max possible = 1.32e-01 )
Likelihood ratio test p = 2.16e-02 
Wald test p = 1e+00 
Score (logrank) test p = 7.53e-02 

T cell CD8+ naive_XCELL in THCA (n=509):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
506 patients with 16 dying ( 3 missing obs. )
                            coef          HR se(coef) 95%CI_l       95%CI_u
`T cell CD8+ naive_XCELL` 15.209 4030467.133  125.125   0.000 1.292848e+113
Age                        0.150       1.161    0.028   1.100  1.227000e+00
Stage2                     0.192       1.212    1.016   0.166  8.874000e+00
Stage3                     0.225       1.253    0.815   0.253  6.189000e+00
Stage4                     0.880       2.410    0.860   0.447  1.299100e+01
                              z     p signif
`T cell CD8+ naive_XCELL` 0.122 0.903       
Age                       5.361 0.000    ***
Stage2                    0.190 0.850       
Stage3                    0.276 0.782       
Stage4                    1.023 0.306       
Rsquare = 0.109 (max possible = 2.9e-01 )
Likelihood ratio test p = 2.78e-11 
Wald test p = 9.8e-06 
Score (logrank) test p = 1.21e-11 

T cell CD8+ naive_XCELL in THYM (n=120):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age 
119 patients with 9 dying ( 1 missing obs. )
                              coef    HR se(coef) 95%CI_l     95%CI_u      z
`T cell CD8+ naive_XCELL` -112.081 0.000   65.362   0.000 9114232.220 -1.715
Age                          0.023 1.023    0.034   0.958       1.092  0.677
                              p signif
`T cell CD8+ naive_XCELL` 0.086      ·
Age                       0.498       
Rsquare = 0.062 (max possible = 4.39e-01 )
Likelihood ratio test p = 2.25e-02 
Wald test p = 4.43e-02 
Score (logrank) test p = 2.23e-02 

T cell CD8+ naive_XCELL in UCEC (n=545):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age 
173 patients with 32 dying ( 372 missing obs. )
                             coef    HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+ naive_XCELL` -47.027 0.000   35.501   0.000 6.235019e+09 -1.325
Age                         0.017 1.018    0.016   0.985 1.051000e+00  1.064
                              p signif
`T cell CD8+ naive_XCELL` 0.185       
Age                       0.287       
Rsquare = 0.018 (max possible = 7.9e-01 )
Likelihood ratio test p = 2.1e-01 
Wald test p = 2.46e-01 
Score (logrank) test p = 2.44e-01 

T cell CD8+ naive_XCELL in UCS (n=57):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age 
55 patients with 34 dying ( 2 missing obs. )
                           coef      HR se(coef) 95%CI_l     95%CI_u     z
`T cell CD8+ naive_XCELL` 5.610 273.032   31.264       0 1.11735e+29 0.179
Age                       0.047   1.048    0.024       1 1.09900e+00 1.946
                              p signif
`T cell CD8+ naive_XCELL` 0.858       
Age                       0.052      ·
Rsquare = 0.071 (max possible = 9.83e-01 )
Likelihood ratio test p = 1.34e-01 
Wald test p = 1.31e-01 
Score (logrank) test p = 1.28e-01 

T cell CD8+ naive_XCELL in UVM (n=80):
Model: Surv(OS, EVENT) ~ `T cell CD8+ naive_XCELL` + Age + Stage 
79 patients with 22 dying ( 1 missing obs. )
                            coef         HR se(coef) 95%CI_l       95%CI_u
`T cell CD8+ naive_XCELL` 97.410 2.0161e+42   79.632   0.000 1.222214e+110
Age                        0.041 1.0420e+00    0.020   1.003  1.083000e+00
Stage3                     0.319 1.3750e+00    0.478   0.539  3.511000e+00
Stage4                     3.889 4.8871e+01    1.216   4.511  5.294050e+02
                              z     p signif
`T cell CD8+ naive_XCELL` 1.223 0.221       
Age                       2.122 0.034      *
Stage3                    0.667 0.505       
Stage4                    3.199 0.001     **
Rsquare = 0.224 (max possible = 8.67e-01 )
Likelihood ratio test p = 4.87e-04 
Wald test p = 1.28e-03 
Score (logrank) test p = 3.24e-10 

T cell CD8+_CIBERSORT in ACC (n=79):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age 
79 patients with 28 dying ( 0 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -2.067 0.127    3.056   0.000  50.534 -0.676 0.499
Age                      0.011 1.011    0.013   0.987   1.036  0.887 0.375
                        signif
`T cell CD8+_CIBERSORT`       
Age                           
Rsquare = 0.016 (max possible = 9.35e-01 )
Likelihood ratio test p = 5.28e-01 
Wald test p = 5.46e-01 
Score (logrank) test p = 5.44e-01 

T cell CD8+_CIBERSORT in BLCA (n=408):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
401 patients with 176 dying ( 7 missing obs. )
                          coef          HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+_CIBERSORT` -2.522       0.080    1.107   0.009   0.702 -2.279
Age                      0.030       1.031    0.008   1.015   1.047  3.828
Stage2                  14.774 2608651.546 1921.030   0.000     Inf  0.008
Stage3                  15.192 3962716.023 1921.030   0.000     Inf  0.008
Stage4                  15.707 6628214.382 1921.030   0.000     Inf  0.008
                            p signif
`T cell CD8+_CIBERSORT` 0.023      *
Age                     0.000    ***
Stage2                  0.994       
Stage3                  0.994       
Stage4                  0.993       
Rsquare = 0.124 (max possible = 9.91e-01 )
Likelihood ratio test p = 2.95e-10 
Wald test p = 1.83e-09 
Score (logrank) test p = 3.69e-10 

T cell CD8+_CIBERSORT in BRCA (n=1100):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
1057 patients with 143 dying ( 43 missing obs. )
                          coef     HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -4.349  0.013    1.585   0.001   0.289 -2.743 0.006
Age                      0.035  1.035    0.007   1.021   1.049  4.987 0.000
Stage2                   0.591  1.805    0.279   1.044   3.122  2.114 0.035
Stage3                   1.338  3.812    0.298   2.128   6.830  4.497 0.000
Stage4                   2.444 11.521    0.361   5.681  23.367  6.775 0.000
                        signif
`T cell CD8+_CIBERSORT`     **
Age                        ***
Stage2                       *
Stage3                     ***
Stage4                     ***
Rsquare = 0.074 (max possible = 7.87e-01 )
Likelihood ratio test p = 4.5e-16 
Wald test p = 8.17e-19 
Score (logrank) test p = 8.41e-24 

T cell CD8+_CIBERSORT in BRCA-Basal (n=191):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
185 patients with 26 dying ( 6 missing obs. )
                          coef           HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+_CIBERSORT` -3.464 3.100000e-02    3.184   0.000  16.053 -1.088
Age                      0.013 1.013000e+00    0.017   0.981   1.047  0.804
Stage2                  18.915 1.639431e+08 6211.095   0.000     Inf  0.003
Stage3                  20.374 7.053199e+08 6211.095   0.000     Inf  0.003
Stage4                  21.614 2.436026e+09 6211.095   0.000     Inf  0.003
                            p signif
`T cell CD8+_CIBERSORT` 0.277       
Age                     0.422       
Stage2                  0.998       
Stage3                  0.997       
Stage4                  0.997       
Rsquare = 0.138 (max possible = 7.08e-01 )
Likelihood ratio test p = 4.74e-05 
Wald test p = 1.44e-03 
Score (logrank) test p = 4.22e-07 

T cell CD8+_CIBERSORT in BRCA-Her2 (n=82):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
75 patients with 16 dying ( 7 missing obs. )
                          coef         HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+_CIBERSORT` 11.921 150441.053    7.644   0.047 4.828162e+11  1.560
Age                      0.077      1.080    0.027   1.024 1.140000e+00  2.816
Stage2                  -0.666      0.514    1.158   0.053 4.969000e+00 -0.576
Stage3                   0.734      2.084    1.143   0.222 1.957600e+01  0.642
Stage4                   4.009     55.104    1.358   3.851 7.885560e+02  2.953
                            p signif
`T cell CD8+_CIBERSORT` 0.119       
Age                     0.005     **
Stage2                  0.565       
Stage3                  0.521       
Stage4                  0.003     **
Rsquare = 0.312 (max possible = 7.59e-01 )
Likelihood ratio test p = 3.59e-05 
Wald test p = 2.82e-04 
Score (logrank) test p = 3.75e-08 

T cell CD8+_CIBERSORT in BRCA-LumA (n=568):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
547 patients with 62 dying ( 21 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -5.012 0.007    2.601   0.000   1.090 -1.927 0.054
Age                      0.046 1.047    0.011   1.024   1.069  4.155 0.000
Stage2                   0.509 1.664    0.361   0.820   3.377  1.411 0.158
Stage3                   1.083 2.952    0.408   1.328   6.563  2.656 0.008
Stage4                   1.935 6.926    0.546   2.374  20.205  3.543 0.000
                        signif
`T cell CD8+_CIBERSORT`      ·
Age                        ***
Stage2                        
Stage3                      **
Stage4                     ***
Rsquare = 0.059 (max possible = 6.7e-01 )
Likelihood ratio test p = 3.52e-06 
Wald test p = 1.04e-06 
Score (logrank) test p = 8.53e-08 

T cell CD8+_CIBERSORT in BRCA-LumB (n=219):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
211 patients with 32 dying ( 8 missing obs. )
                          coef     HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -9.294  0.000    4.018   0.000   0.242 -2.313 0.021
Age                      0.033  1.033    0.016   1.002   1.065  2.068 0.039
Stage2                   0.752  2.121    0.761   0.477   9.420  0.988 0.323
Stage3                   1.474  4.365    0.775   0.956  19.930  1.902 0.057
Stage4                   2.396 10.981    0.897   1.891  63.760  2.670 0.008
                        signif
`T cell CD8+_CIBERSORT`      *
Age                          *
Stage2                        
Stage3                       ·
Stage4                      **
Rsquare = 0.086 (max possible = 7e-01 )
Likelihood ratio test p = 1.89e-03 
Wald test p = 3.4e-03 
Score (logrank) test p = 1.43e-03 

T cell CD8+_CIBERSORT in CESC (n=306):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age 
293 patients with 73 dying ( 13 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -5.130 0.006    1.430   0.000   0.098 -3.587 0.000
Age                      0.013 1.013    0.009   0.996   1.031  1.516 0.129
                        signif
`T cell CD8+_CIBERSORT`    ***
Age                           
Rsquare = 0.055 (max possible = 9.11e-01 )
Likelihood ratio test p = 2.38e-04 
Wald test p = 4.08e-04 
Score (logrank) test p = 3.2e-04 

T cell CD8+_CIBERSORT in CHOL (n=36):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
36 patients with 18 dying ( 0 missing obs. )
                           coef      HR se(coef) 95%CI_l    95%CI_u      z
`T cell CD8+_CIBERSORT`   5.860 350.715    3.390   0.456 269449.698  1.729
Age                       0.024   1.025    0.020   0.985      1.066  1.224
Stage2                    1.062   2.893    0.625   0.849      9.858  1.699
Stage3                  -17.509   0.000 6723.217   0.000        Inf -0.003
Stage4                    1.227   3.410    0.667   0.924     12.594  1.841
                            p signif
`T cell CD8+_CIBERSORT` 0.084      ·
Age                     0.221       
Stage2                  0.089      ·
Stage3                  0.998       
Stage4                  0.066      ·
Rsquare = 0.201 (max possible = 9.46e-01 )
Likelihood ratio test p = 1.52e-01 
Wald test p = 3.4e-01 
Score (logrank) test p = 2.14e-01 

T cell CD8+_CIBERSORT in COAD (n=458):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
267 patients with 62 dying ( 191 missing obs. )
                         coef     HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_CIBERSORT` 1.501  4.485    1.602   0.194 103.509 0.937 0.349
Age                     0.035  1.035    0.012   1.012   1.060 2.957 0.003
Stage2                  0.759  2.136    0.626   0.626   7.286 1.212 0.225
Stage3                  1.353  3.870    0.621   1.145  13.083 2.177 0.029
Stage4                  2.558 12.913    0.633   3.737  44.615 4.044 0.000
                        signif
`T cell CD8+_CIBERSORT`       
Age                         **
Stage2                        
Stage3                       *
Stage4                     ***
Rsquare = 0.126 (max possible = 8.92e-01 )
Likelihood ratio test p = 1e-06 
Wald test p = 9.25e-07 
Score (logrank) test p = 6.73e-08 

T cell CD8+_CIBERSORT in DLBC (n=48):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age 
47 patients with 9 dying ( 1 missing obs. )
                           coef   HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -16.408 0.00    7.361   0.000   0.138 -2.229 0.026
Age                      -0.010 0.99    0.025   0.942   1.040 -0.393 0.694
                        signif
`T cell CD8+_CIBERSORT`      *
Age                           
Rsquare = 0.11 (max possible = 6.72e-01 )
Likelihood ratio test p = 6.44e-02 
Wald test p = 8.11e-02 
Score (logrank) test p = 5.85e-02 

T cell CD8+_CIBERSORT in ESCA (n=185):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
160 patients with 63 dying ( 25 missing obs. )
                          coef     HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -1.590  0.204    2.355   0.002  20.589 -0.675 0.499
Age                      0.006  1.006    0.011   0.984   1.027  0.506 0.613
Stage2                   0.822  2.275    0.558   0.762   6.794  1.472 0.141
Stage3                   1.788  5.975    0.579   1.919  18.603  3.085 0.002
Stage4                   2.506 12.259    0.649   3.437  43.723  3.863 0.000
                        signif
`T cell CD8+_CIBERSORT`       
Age                           
Stage2                        
Stage3                      **
Stage4                     ***
Rsquare = 0.147 (max possible = 9.61e-01 )
Likelihood ratio test p = 1.12e-04 
Wald test p = 1.34e-04 
Score (logrank) test p = 1.8e-05 

T cell CD8+_CIBERSORT in GBM (n=153):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age 
150 patients with 120 dying ( 3 missing obs. )
                         coef     HR se(coef) 95%CI_l   95%CI_u     z     p
`T cell CD8+_CIBERSORT` 4.019 55.651    3.284   0.089 34771.666 1.224 0.221
Age                     0.029  1.030    0.008   1.014     1.045 3.828 0.000
                        signif
`T cell CD8+_CIBERSORT`       
Age                        ***
Rsquare = 0.107 (max possible = 9.98e-01 )
Likelihood ratio test p = 2.03e-04 
Wald test p = 4.71e-04 
Score (logrank) test p = 4.51e-04 

T cell CD8+_CIBERSORT in HNSC (n=522):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
446 patients with 191 dying ( 76 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -2.846 0.058    1.095   0.007   0.497 -2.599 0.009
Age                      0.024 1.024    0.007   1.010   1.038  3.443 0.001
Stage2                   0.698 2.010    0.538   0.700   5.775  1.297 0.195
Stage3                   0.776 2.174    0.536   0.761   6.210  1.450 0.147
Stage4                   1.296 3.653    0.508   1.349   9.894  2.548 0.011
                        signif
`T cell CD8+_CIBERSORT`     **
Age                         **
Stage2                        
Stage3                        
Stage4                       *
Rsquare = 0.079 (max possible = 9.9e-01 )
Likelihood ratio test p = 6.85e-07 
Wald test p = 3.72e-06 
Score (logrank) test p = 2.31e-06 

T cell CD8+_CIBERSORT in HNSC-HPV+ (n=98):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
67 patients with 24 dying ( 31 missing obs. )
                          coef           HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+_CIBERSORT` -9.939        0.000    3.213   0.000   0.026 -3.093
Age                     -0.011        0.989    0.023   0.946   1.034 -0.472
Stage2                  16.512 14833413.515 5321.951   0.000     Inf  0.003
Stage3                  16.687 17663033.218 5321.951   0.000     Inf  0.003
Stage4                  17.014 24504304.067 5321.951   0.000     Inf  0.003
                            p signif
`T cell CD8+_CIBERSORT` 0.002     **
Age                     0.637       
Stage2                  0.998       
Stage3                  0.997       
Stage4                  0.997       
Rsquare = 0.224 (max possible = 9.24e-01 )
Likelihood ratio test p = 4.54e-03 
Wald test p = 4.92e-02 
Score (logrank) test p = 2.17e-02 

T cell CD8+_CIBERSORT in HNSC-HPV- (n=422):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
379 patients with 167 dying ( 43 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -1.485 0.226    1.213   0.021   2.439 -1.225 0.221
Age                      0.028 1.028    0.008   1.013   1.044  3.621 0.000
Stage2                   0.478 1.613    0.546   0.553   4.704  0.876 0.381
Stage3                   0.675 1.965    0.539   0.683   5.651  1.253 0.210
Stage4                   1.208 3.345    0.510   1.231   9.089  2.368 0.018
                        signif
`T cell CD8+_CIBERSORT`       
Age                        ***
Stage2                        
Stage3                        
Stage4                       *
Rsquare = 0.078 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.04e-05 
Wald test p = 4.25e-05 
Score (logrank) test p = 2.95e-05 

T cell CD8+_CIBERSORT in KICH (n=66):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
65 patients with 9 dying ( 1 missing obs. )
                          coef           HR se(coef)      95%CI_l      95%CI_u
`T cell CD8+_CIBERSORT` -6.473 2.000000e-03   12.337        0.000 4.905286e+07
Age                      0.043 1.044000e+00    0.028        0.989 1.102000e+00
Stage2                  15.612 6.030558e+06    0.846  1148029.516 3.167831e+07
Stage3                  16.572 1.575008e+07    0.780  3414696.339 7.264628e+07
Stage4                  19.415 2.702869e+08    0.902 46174443.988 1.582152e+09
                             z     p signif
`T cell CD8+_CIBERSORT` -0.525 0.600       
Age                      1.543 0.123       
Stage2                  18.447 0.000    ***
Stage3                  21.247 0.000    ***
Stage4                  21.534 0.000    ***
Rsquare = 0.325 (max possible = 6.61e-01 )
Likelihood ratio test p = 1.09e-04 
Wald test p = 7.6e-270 
Score (logrank) test p = 4.77e-11 

T cell CD8+_CIBERSORT in KIRC (n=533):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
526 patients with 172 dying ( 7 missing obs. )
                         coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_CIBERSORT` 0.092 1.096    0.660   0.301   3.995 0.139 0.889       
Age                     0.034 1.034    0.007   1.019   1.049 4.554 0.000    ***
Stage2                  0.285 1.330    0.318   0.714   2.479 0.899 0.369       
Stage3                  0.943 2.567    0.210   1.700   3.877 4.481 0.000    ***
Stage4                  1.946 6.999    0.199   4.742  10.331 9.794 0.000    ***
Rsquare = 0.208 (max possible = 9.75e-01 )
Likelihood ratio test p = 8.08e-25 
Wald test p = 1.93e-24 
Score (logrank) test p = 1.79e-30 

T cell CD8+_CIBERSORT in KIRP (n=290):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
255 patients with 39 dying ( 35 missing obs. )
                          coef     HR se(coef) 95%CI_l  95%CI_u      z     p
`T cell CD8+_CIBERSORT`  4.479 88.141    1.806   2.559 3035.566  2.480 0.013
Age                      0.009  1.009    0.015   0.980    1.039  0.594 0.553
Stage2                  -0.196  0.822    0.783   0.177    3.812 -0.251 0.802
Stage3                   1.334  3.796    0.398   1.740    8.280  3.352 0.001
Stage4                   2.790 16.279    0.449   6.756   39.223  6.218 0.000
                        signif
`T cell CD8+_CIBERSORT`      *
Age                           
Stage2                        
Stage3                      **
Stage4                     ***
Rsquare = 0.157 (max possible = 7.61e-01 )
Likelihood ratio test p = 2.69e-08 
Wald test p = 2.7e-09 
Score (logrank) test p = 2.85e-14 

T cell CD8+_CIBERSORT in LGG (n=516):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age 
511 patients with 125 dying ( 5 missing obs. )
                         coef    HR se(coef) 95%CI_l 95%CI_u     z    p signif
`T cell CD8+_CIBERSORT` 1.458 4.297    1.931   0.098 189.155 0.755 0.45       
Age                     0.056 1.057    0.007   1.042   1.073 7.488 0.00    ***
Rsquare = 0.112 (max possible = 9.13e-01 )
Likelihood ratio test p = 5.89e-14 
Wald test p = 3.69e-14 
Score (logrank) test p = 4.39e-15 

T cell CD8+_CIBERSORT in LIHC (n=371):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
340 patients with 116 dying ( 31 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -2.737 0.065    1.078   0.008   0.536 -2.539 0.011
Age                      0.013 1.013    0.007   0.999   1.027  1.803 0.071
Stage2                   0.283 1.327    0.252   0.810   2.174  1.123 0.261
Stage3                   1.000 2.720    0.215   1.783   4.148  4.643 0.000
Stage4                   1.777 5.914    0.601   1.819  19.223  2.955 0.003
                        signif
`T cell CD8+_CIBERSORT`      *
Age                          ·
Stage2                        
Stage3                     ***
Stage4                      **
Rsquare = 0.094 (max possible = 9.69e-01 )
Likelihood ratio test p = 3.03e-06 
Wald test p = 1.19e-06 
Score (logrank) test p = 3.49e-07 

T cell CD8+_CIBERSORT in LUAD (n=515):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
484 patients with 177 dying ( 31 missing obs. )
                         coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_CIBERSORT` 0.277 1.319    1.318   0.100  17.458 0.210 0.833       
Age                     0.009 1.009    0.008   0.993   1.024 1.121 0.262       
Stage2                  0.828 2.288    0.188   1.584   3.305 4.412 0.000    ***
Stage3                  1.187 3.278    0.198   2.225   4.829 6.004 0.000    ***
Stage4                  1.308 3.698    0.283   2.125   6.437 4.625 0.000    ***
Rsquare = 0.096 (max possible = 9.79e-01 )
Likelihood ratio test p = 2.69e-09 
Wald test p = 3.28e-09 
Score (logrank) test p = 3.82e-10 

T cell CD8+_CIBERSORT in LUSC (n=501):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
484 patients with 209 dying ( 17 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -1.533 0.216    1.161   0.022   2.101 -1.321 0.187
Age                      0.017 1.018    0.009   1.000   1.035  1.993 0.046
Stage2                   0.149 1.161    0.164   0.841   1.602  0.909 0.363
Stage3                   0.463 1.589    0.184   1.109   2.278  2.521 0.012
Stage4                   1.131 3.100    0.463   1.250   7.688  2.442 0.015
                        signif
`T cell CD8+_CIBERSORT`       
Age                          *
Stage2                        
Stage3                       *
Stage4                       *
Rsquare = 0.031 (max possible = 9.9e-01 )
Likelihood ratio test p = 9.04e-03 
Wald test p = 5.53e-03 
Score (logrank) test p = 4.14e-03 

T cell CD8+_CIBERSORT in MESO (n=87):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
86 patients with 73 dying ( 1 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT`  1.839 6.290    1.398   0.406  97.343  1.316 0.188
Age                      0.023 1.023    0.015   0.993   1.053  1.509 0.131
Stage2                  -0.328 0.720    0.451   0.298   1.744 -0.727 0.467
Stage3                  -0.248 0.781    0.382   0.369   1.652 -0.647 0.517
Stage4                  -0.227 0.797    0.448   0.331   1.919 -0.506 0.613
                        signif
`T cell CD8+_CIBERSORT`       
Age                           
Stage2                        
Stage3                        
Stage4                        
Rsquare = 0.05 (max possible = 9.98e-01 )
Likelihood ratio test p = 4.9e-01 
Wald test p = 4.7e-01 
Score (logrank) test p = 4.64e-01 

T cell CD8+_CIBERSORT in OV (n=303):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age 
302 patients with 183 dying ( 1 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -0.303 0.739    1.467   0.042  13.095 -0.206 0.837
Age                      0.029 1.030    0.007   1.015   1.045  4.008 0.000
                        signif
`T cell CD8+_CIBERSORT`       
Age                        ***
Rsquare = 0.052 (max possible = 9.97e-01 )
Likelihood ratio test p = 3.13e-04 
Wald test p = 2.85e-04 
Score (logrank) test p = 2.61e-04 

T cell CD8+_CIBERSORT in PAAD (n=179):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
175 patients with 93 dying ( 4 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -1.384 0.251    2.311   0.003  23.237 -0.599 0.549
Age                      0.024 1.024    0.010   1.004   1.046  2.308 0.021
Stage2                   0.772 2.165    0.398   0.991   4.727  1.938 0.053
Stage3                   0.113 1.119    1.076   0.136   9.217  0.105 0.917
Stage4                   0.349 1.417    0.809   0.290   6.915  0.431 0.666
                        signif
`T cell CD8+_CIBERSORT`       
Age                          *
Stage2                       ·
Stage3                        
Stage4                        
Rsquare = 0.067 (max possible = 9.91e-01 )
Likelihood ratio test p = 3.3e-02 
Wald test p = 5.74e-02 
Score (logrank) test p = 5.07e-02 

T cell CD8+_CIBERSORT in PCPG (n=181):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age 
181 patients with 7 dying ( 0 missing obs. )
                         coef    HR se(coef) 95%CI_l     95%CI_u     z     p
`T cell CD8+_CIBERSORT` 1.332 3.789    7.430   0.000 7999406.018 0.179 0.858
Age                     0.023 1.023    0.024   0.975       1.073 0.928 0.353
                        signif
`T cell CD8+_CIBERSORT`       
Age                           
Rsquare = 0.005 (max possible = 2.89e-01 )
Likelihood ratio test p = 6.25e-01 
Wald test p = 6.28e-01 
Score (logrank) test p = 6.24e-01 

T cell CD8+_CIBERSORT in PRAD (n=498):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age 
496 patients with 10 dying ( 2 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -5.821 0.003    5.927   0.000 328.603 -0.982 0.326
Age                      0.051 1.052    0.049   0.956   1.158  1.036 0.300
                        signif
`T cell CD8+_CIBERSORT`       
Age                           
Rsquare = 0.005 (max possible = 1.68e-01 )
Likelihood ratio test p = 3.24e-01 
Wald test p = 3.49e-01 
Score (logrank) test p = 3.37e-01 

T cell CD8+_CIBERSORT in READ (n=166):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
82 patients with 14 dying ( 84 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -17.902 0.000    8.371   0.000   0.224 -2.138 0.032
Age                       0.147 1.159    0.051   1.048   1.281  2.887 0.004
Stage2                   -1.303 0.272    1.230   0.024   3.026 -1.060 0.289
Stage3                    0.336 1.400    0.815   0.283   6.911  0.413 0.680
Stage4                    0.456 1.578    0.946   0.247  10.070  0.483 0.629
                        signif
`T cell CD8+_CIBERSORT`      *
Age                         **
Stage2                        
Stage3                        
Stage4                        
Rsquare = 0.268 (max possible = 7.04e-01 )
Likelihood ratio test p = 1.05e-04 
Wald test p = 1.42e-02 
Score (logrank) test p = 5.08e-04 

T cell CD8+_CIBERSORT in SARC (n=260):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age 
257 patients with 99 dying ( 3 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -0.341 0.711    1.306   0.055   9.193 -0.261 0.794
Age                      0.021 1.022    0.008   1.006   1.038  2.689 0.007
                        signif
`T cell CD8+_CIBERSORT`       
Age                         **
Rsquare = 0.029 (max possible = 9.77e-01 )
Likelihood ratio test p = 2.28e-02 
Wald test p = 2.69e-02 
Score (logrank) test p = 2.69e-02 

T cell CD8+_CIBERSORT in SKCM (n=471):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
407 patients with 192 dying ( 64 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -2.891 0.056    0.701   0.014   0.219 -4.123 0.000
Age                      0.020 1.020    0.005   1.010   1.031  3.934 0.000
Stage2                   0.163 1.177    0.216   0.770   1.798  0.753 0.452
Stage3                   0.559 1.749    0.200   1.183   2.587  2.803 0.005
Stage4                   1.112 3.040    0.348   1.536   6.018  3.191 0.001
                        signif
`T cell CD8+_CIBERSORT`    ***
Age                        ***
Stage2                        
Stage3                      **
Stage4                      **
Rsquare = 0.12 (max possible = 9.92e-01 )
Likelihood ratio test p = 5.36e-10 
Wald test p = 1.66e-09 
Score (logrank) test p = 6.78e-10 

T cell CD8+_CIBERSORT in SKCM-Primary (n=103):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
95 patients with 26 dying ( 8 missing obs. )
                          coef           HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+_CIBERSORT` -2.916 5.400000e-02    1.925   0.001   2.356 -1.515
Age                      0.009 1.009000e+00    0.014   0.981   1.037  0.612
Stage2                  17.024 2.475067e+07 6200.545   0.000     Inf  0.003
Stage3                  17.740 5.060953e+07 6200.545   0.000     Inf  0.003
Stage4                  19.055 1.885953e+08 6200.545   0.000     Inf  0.003
                            p signif
`T cell CD8+_CIBERSORT` 0.130       
Age                     0.541       
Stage2                  0.998       
Stage3                  0.998       
Stage4                  0.998       
Rsquare = 0.133 (max possible = 8.67e-01 )
Likelihood ratio test p = 1.87e-02 
Wald test p = 2.05e-02 
Score (logrank) test p = 1.57e-03 

T cell CD8+_CIBERSORT in SKCM-Metastasis (n=368):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
312 patients with 166 dying ( 56 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -2.833 0.059    0.756   0.013   0.259 -3.748 0.000
Age                      0.023 1.023    0.006   1.012   1.034  4.059 0.000
Stage2                   0.039 1.039    0.228   0.665   1.624  0.170 0.865
Stage3                   0.489 1.631    0.204   1.093   2.435  2.396 0.017
Stage4                   0.894 2.445    0.395   1.127   5.304  2.263 0.024
                        signif
`T cell CD8+_CIBERSORT`    ***
Age                        ***
Stage2                        
Stage3                       *
Stage4                       *
Rsquare = 0.134 (max possible = 9.95e-01 )
Likelihood ratio test p = 1.53e-08 
Wald test p = 4.63e-08 
Score (logrank) test p = 2.53e-08 

T cell CD8+_CIBERSORT in STAD (n=415):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
368 patients with 148 dying ( 47 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -0.027 0.974    1.056   0.123   7.709 -0.025 0.980
Age                      0.029 1.029    0.009   1.012   1.047  3.389 0.001
Stage2                   0.437 1.548    0.334   0.804   2.979  1.308 0.191
Stage3                   0.921 2.512    0.313   1.360   4.639  2.943 0.003
Stage4                   1.618 5.043    0.365   2.467  10.310  4.434 0.000
                        signif
`T cell CD8+_CIBERSORT`       
Age                         **
Stage2                        
Stage3                      **
Stage4                     ***
Rsquare = 0.085 (max possible = 9.85e-01 )
Likelihood ratio test p = 4.17e-06 
Wald test p = 6.22e-06 
Score (logrank) test p = 2.95e-06 

T cell CD8+_CIBERSORT in TGCT (n=150):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
81 patients with 2 dying ( 69 missing obs. )
                           coef           HR  se(coef) 95%CI_l      95%CI_u
`T cell CD8+_CIBERSORT` -14.802 0.000000e+00    24.719   0.000 4.096496e+14
Age                      -0.344 7.090000e-01     0.443   0.297 1.690000e+00
Stage2                   16.214 1.101058e+07 35880.610   0.000          Inf
Stage3                   41.167 7.563519e+17 76986.471   0.000          Inf
                             z     p signif
`T cell CD8+_CIBERSORT` -0.599 0.549       
Age                     -0.777 0.437       
Stage2                   0.000 1.000   <NA>
Stage3                   0.001 1.000   <NA>
Rsquare = 0.089 (max possible = 1.32e-01 )
Likelihood ratio test p = 1.09e-01 
Wald test p = 9.62e-01 
Score (logrank) test p = 1.41e-01 

T cell CD8+_CIBERSORT in THCA (n=509):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
506 patients with 16 dying ( 3 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -1.326 0.266    4.175   0.000 950.901 -0.318 0.751
Age                      0.151 1.163    0.028   1.100   1.229  5.336 0.000
Stage2                   0.295 1.343    1.048   0.172  10.480  0.282 0.778
Stage3                   0.185 1.203    0.826   0.238   6.074  0.224 0.823
Stage4                   0.849 2.337    0.860   0.433  12.603  0.987 0.324
                        signif
`T cell CD8+_CIBERSORT`       
Age                        ***
Stage2                        
Stage3                        
Stage4                        
Rsquare = 0.109 (max possible = 2.9e-01 )
Likelihood ratio test p = 2.66e-11 
Wald test p = 1.12e-05 
Score (logrank) test p = 1.87e-11 

T cell CD8+_CIBERSORT in THYM (n=120):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age 
119 patients with 9 dying ( 1 missing obs. )
                          coef        HR se(coef) 95%CI_l      95%CI_u     z
`T cell CD8+_CIBERSORT` 11.631 112568.74    4.849   8.401 1.508335e+09 2.399
Age                      0.068      1.07    0.032   1.005 1.139000e+00 2.117
                            p signif
`T cell CD8+_CIBERSORT` 0.016      *
Age                     0.034      *
Rsquare = 0.094 (max possible = 4.39e-01 )
Likelihood ratio test p = 2.85e-03 
Wald test p = 8.4e-03 
Score (logrank) test p = 3.7e-03 

T cell CD8+_CIBERSORT in UCEC (n=545):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age 
173 patients with 32 dying ( 372 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT` -3.199 0.041    2.241   0.001   3.297 -1.428 0.153
Age                      0.011 1.011    0.016   0.979   1.044  0.683 0.495
                        signif
`T cell CD8+_CIBERSORT`       
Age                           
Rsquare = 0.018 (max possible = 7.9e-01 )
Likelihood ratio test p = 2.08e-01 
Wald test p = 2.3e-01 
Score (logrank) test p = 2.24e-01 

T cell CD8+_CIBERSORT in UCS (n=57):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age 
55 patients with 34 dying ( 2 missing obs. )
                         coef    HR se(coef) 95%CI_l  95%CI_u     z     p
`T cell CD8+_CIBERSORT` 1.201 3.323    3.166   0.007 1647.021 0.379 0.704
Age                     0.046 1.047    0.023   1.001    1.094 2.011 0.044
                        signif
`T cell CD8+_CIBERSORT`       
Age                          *
Rsquare = 0.072 (max possible = 9.83e-01 )
Likelihood ratio test p = 1.27e-01 
Wald test p = 1.21e-01 
Score (logrank) test p = 1.17e-01 

T cell CD8+_CIBERSORT in UVM (n=80):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT` + Age + Stage 
79 patients with 22 dying ( 1 missing obs. )
                         coef     HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_CIBERSORT` 3.869 47.889    1.419   2.969 772.310 2.727 0.006
Age                     0.043  1.044    0.020   1.003   1.087 2.114 0.035
Stage3                  0.217  1.243    0.472   0.493   3.131 0.460 0.645
Stage4                  4.065 58.289    1.218   5.353 634.690 3.337 0.001
                        signif
`T cell CD8+_CIBERSORT`     **
Age                          *
Stage3                        
Stage4                      **
Rsquare = 0.274 (max possible = 8.67e-01 )
Likelihood ratio test p = 4.48e-05 
Wald test p = 1.84e-04 
Score (logrank) test p = 2.28e-11 

T cell CD8+_CIBERSORT-ABS in ACC (n=79):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age 
79 patients with 28 dying ( 0 missing obs. )
                             coef      HR se(coef) 95%CI_l     95%CI_u     z
`T cell CD8+_CIBERSORT-ABS` 4.884 132.125    5.500   0.003 6347335.857 0.888
Age                         0.010   1.010    0.012   0.986       1.035 0.811
                                p signif
`T cell CD8+_CIBERSORT-ABS` 0.375       
Age                         0.417       
Rsquare = 0.018 (max possible = 9.35e-01 )
Likelihood ratio test p = 4.79e-01 
Wald test p = 4.54e-01 
Score (logrank) test p = 4.48e-01 

T cell CD8+_CIBERSORT-ABS in BLCA (n=408):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
401 patients with 176 dying ( 7 missing obs. )
                              coef          HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+_CIBERSORT-ABS` -2.028       0.132    1.376   0.009   1.953 -1.474
Age                          0.030       1.031    0.008   1.015   1.047  3.858
Stage2                      14.673 2357881.287 1913.076   0.000     Inf  0.008
Stage3                      15.122 3693919.798 1913.076   0.000     Inf  0.008
Stage4                      15.625 6104423.979 1913.076   0.000     Inf  0.008
                                p signif
`T cell CD8+_CIBERSORT-ABS` 0.141       
Age                         0.000    ***
Stage2                      0.994       
Stage3                      0.994       
Stage4                      0.993       
Rsquare = 0.118 (max possible = 9.91e-01 )
Likelihood ratio test p = 1.24e-09 
Wald test p = 7.18e-09 
Score (logrank) test p = 1.49e-09 

T cell CD8+_CIBERSORT-ABS in BRCA (n=1100):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
1057 patients with 143 dying ( 43 missing obs. )
                              coef     HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -3.103  0.045    1.917   0.001   1.924 -1.619 0.106
Age                          0.033  1.034    0.007   1.020   1.048  4.804 0.000
Stage2                       0.562  1.755    0.279   1.015   3.033  2.014 0.044
Stage3                       1.237  3.444    0.294   1.935   6.130  4.205 0.000
Stage4                       2.398 10.996    0.361   5.415  22.331  6.633 0.000
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                            ***
Stage2                           *
Stage3                         ***
Stage4                         ***
Rsquare = 0.07 (max possible = 7.87e-01 )
Likelihood ratio test p = 5.26e-15 
Wald test p = 6.03e-18 
Score (logrank) test p = 5.17e-23 

T cell CD8+_CIBERSORT-ABS in BRCA-Basal (n=191):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
185 patients with 26 dying ( 6 missing obs. )
                              coef           HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+_CIBERSORT-ABS` -4.924 7.000000e-03    3.963   0.000  17.179 -1.242
Age                          0.011 1.011000e+00    0.017   0.979   1.045  0.671
Stage2                      18.895 1.606680e+08 6249.518   0.000     Inf  0.003
Stage3                      20.312 6.628243e+08 6249.518   0.000     Inf  0.003
Stage4                      21.872 3.153184e+09 6249.518   0.000     Inf  0.003
                                p signif
`T cell CD8+_CIBERSORT-ABS` 0.214       
Age                         0.502       
Stage2                      0.998       
Stage3                      0.997       
Stage4                      0.997       
Rsquare = 0.142 (max possible = 7.08e-01 )
Likelihood ratio test p = 3.06e-05 
Wald test p = 9.46e-04 
Score (logrank) test p = 1.8e-07 

T cell CD8+_CIBERSORT-ABS in BRCA-Her2 (n=82):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
75 patients with 16 dying ( 7 missing obs. )
                              coef     HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+_CIBERSORT-ABS`  3.732 41.743    9.092   0.000 2.291058e+09  0.410
Age                          0.084  1.088    0.028   1.029 1.149000e+00  2.992
Stage2                      -0.657  0.518    1.195   0.050 5.391000e+00 -0.550
Stage3                       0.690  1.993    1.179   0.198 2.009400e+01  0.585
Stage4                       3.500 33.116    1.379   2.219 4.941910e+02  2.538
                                p signif
`T cell CD8+_CIBERSORT-ABS` 0.682       
Age                         0.003     **
Stage2                      0.582       
Stage3                      0.559       
Stage4                      0.011      *
Rsquare = 0.288 (max possible = 7.59e-01 )
Likelihood ratio test p = 1.14e-04 
Wald test p = 4.69e-04 
Score (logrank) test p = 1.09e-07 

T cell CD8+_CIBERSORT-ABS in BRCA-LumA (n=568):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
547 patients with 62 dying ( 21 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -0.722 0.486    2.791   0.002 115.377 -0.259 0.796
Age                          0.045 1.046    0.011   1.024   1.069  4.091 0.000
Stage2                       0.473 1.604    0.360   0.793   3.247  1.314 0.189
Stage3                       0.903 2.467    0.394   1.139   5.343  2.290 0.022
Stage4                       2.016 7.511    0.545   2.582  21.854  3.701 0.000
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                            ***
Stage2                            
Stage3                           *
Stage4                         ***
Rsquare = 0.052 (max possible = 6.7e-01 )
Likelihood ratio test p = 2.13e-05 
Wald test p = 4.54e-06 
Score (logrank) test p = 3.54e-07 

T cell CD8+_CIBERSORT-ABS in BRCA-LumB (n=219):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
211 patients with 32 dying ( 8 missing obs. )
                               coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -10.168 0.000    5.754   0.000   3.033 -1.767 0.077
Age                           0.031 1.031    0.016   1.000   1.063  1.938 0.053
Stage2                        0.661 1.937    0.765   0.432   8.682  0.864 0.388
Stage3                        1.308 3.699    0.774   0.811  16.866  1.690 0.091
Stage4                        1.954 7.059    0.896   1.218  40.898  2.180 0.029
                            signif
`T cell CD8+_CIBERSORT-ABS`      ·
Age                              ·
Stage2                            
Stage3                           ·
Stage4                           *
Rsquare = 0.077 (max possible = 7e-01 )
Likelihood ratio test p = 4.49e-03 
Wald test p = 8.59e-03 
Score (logrank) test p = 3.23e-03 

T cell CD8+_CIBERSORT-ABS in CESC (n=306):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age 
293 patients with 73 dying ( 13 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -7.087 0.001    2.336   0.000   0.081 -3.034 0.002
Age                          0.014 1.014    0.009   0.997   1.031  1.565 0.118
                            signif
`T cell CD8+_CIBERSORT-ABS`     **
Age                               
Rsquare = 0.051 (max possible = 9.11e-01 )
Likelihood ratio test p = 4.66e-04 
Wald test p = 2.65e-03 
Score (logrank) test p = 3.56e-03 

T cell CD8+_CIBERSORT-ABS in CHOL (n=36):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
36 patients with 18 dying ( 0 missing obs. )
                               coef      HR se(coef) 95%CI_l    95%CI_u      z
`T cell CD8+_CIBERSORT-ABS`   5.074 159.801    3.709   0.111 229641.260  1.368
Age                           0.018   1.019    0.019   0.981      1.058  0.955
Stage2                        1.007   2.736    0.623   0.807      9.279  1.615
Stage3                      -17.941   0.000 6664.728   0.000        Inf -0.003
Stage4                        1.222   3.394    0.657   0.937     12.299  1.860
                                p signif
`T cell CD8+_CIBERSORT-ABS` 0.171       
Age                         0.340       
Stage2                      0.106       
Stage3                      0.998       
Stage4                      0.063      ·
Rsquare = 0.171 (max possible = 9.46e-01 )
Likelihood ratio test p = 2.4e-01 
Wald test p = 4.18e-01 
Score (logrank) test p = 2.9e-01 

T cell CD8+_CIBERSORT-ABS in COAD (n=458):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
267 patients with 62 dying ( 191 missing obs. )
                             coef     HR se(coef) 95%CI_l  95%CI_u     z     p
`T cell CD8+_CIBERSORT-ABS` 2.560 12.938    2.220   0.167 1003.279 1.153 0.249
Age                         0.035  1.036    0.012   1.012    1.060 3.008 0.003
Stage2                      0.739  2.095    0.624   0.617    7.116 1.185 0.236
Stage3                      1.357  3.885    0.622   1.149   13.143 2.183 0.029
Stage4                      2.560 12.935    0.633   3.744   44.686 4.047 0.000
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                             **
Stage2                            
Stage3                           *
Stage4                         ***
Rsquare = 0.127 (max possible = 8.92e-01 )
Likelihood ratio test p = 8.99e-07 
Wald test p = 9.84e-07 
Score (logrank) test p = 6.83e-08 

T cell CD8+_CIBERSORT-ABS in DLBC (n=48):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age 
47 patients with 9 dying ( 1 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -3.134 0.044    2.764   0.000   9.810 -1.134 0.257
Age                         -0.015 0.985    0.026   0.937   1.036 -0.583 0.560
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                               
Rsquare = 0.036 (max possible = 6.72e-01 )
Likelihood ratio test p = 4.2e-01 
Wald test p = 4.61e-01 
Score (logrank) test p = 4.49e-01 

T cell CD8+_CIBERSORT-ABS in ESCA (n=185):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
160 patients with 63 dying ( 25 missing obs. )
                              coef     HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -1.467  0.231    3.775   0.000 376.902 -0.389 0.698
Age                          0.006  1.006    0.011   0.984   1.028  0.522 0.602
Stage2                       0.817  2.263    0.562   0.752   6.811  1.453 0.146
Stage3                       1.760  5.813    0.579   1.867  18.094  3.038 0.002
Stage4                       2.506 12.258    0.649   3.436  43.734  3.862 0.000
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                               
Stage2                            
Stage3                          **
Stage4                         ***
Rsquare = 0.146 (max possible = 9.61e-01 )
Likelihood ratio test p = 1.28e-04 
Wald test p = 1.4e-04 
Score (logrank) test p = 1.93e-05 

T cell CD8+_CIBERSORT-ABS in GBM (n=153):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age 
150 patients with 120 dying ( 3 missing obs. )
                              coef           HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+_CIBERSORT-ABS` 21.237 1.671332e+09    9.015  35.406 7.889488e+16
Age                          0.030 1.030000e+00    0.008   1.015 1.046000e+00
                                z     p signif
`T cell CD8+_CIBERSORT-ABS` 2.356 0.018      *
Age                         3.838 0.000    ***
Rsquare = 0.126 (max possible = 9.98e-01 )
Likelihood ratio test p = 4.06e-05 
Wald test p = 7.5e-05 
Score (logrank) test p = 7.29e-05 

T cell CD8+_CIBERSORT-ABS in HNSC (n=522):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
446 patients with 191 dying ( 76 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -3.773 0.023    1.399   0.001   0.356 -2.697 0.007
Age                          0.023 1.024    0.007   1.010   1.038  3.357 0.001
Stage2                       0.723 2.060    0.538   0.717   5.915  1.343 0.179
Stage3                       0.801 2.229    0.535   0.781   6.362  1.497 0.134
Stage4                       1.314 3.721    0.508   1.374  10.076  2.586 0.010
                            signif
`T cell CD8+_CIBERSORT-ABS`     **
Age                             **
Stage2                            
Stage3                            
Stage4                           *
Rsquare = 0.081 (max possible = 9.9e-01 )
Likelihood ratio test p = 4.1e-07 
Wald test p = 3.84e-06 
Score (logrank) test p = 2.76e-06 

T cell CD8+_CIBERSORT-ABS in HNSC-HPV+ (n=98):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
67 patients with 24 dying ( 31 missing obs. )
                               coef           HR se(coef) 95%CI_l 95%CI_u
`T cell CD8+_CIBERSORT-ABS` -12.587        0.000    4.306    0.00   0.016
Age                          -0.018        0.982    0.022    0.94   1.026
Stage2                       16.611 16367641.820 5113.709    0.00     Inf
Stage3                       16.873 21279988.406 5113.709    0.00     Inf
Stage4                       16.893 21699678.948 5113.709    0.00     Inf
                                 z     p signif
`T cell CD8+_CIBERSORT-ABS` -2.923 0.003     **
Age                         -0.803 0.422       
Stage2                       0.003 0.997       
Stage3                       0.003 0.997       
Stage4                       0.003 0.997       
Rsquare = 0.233 (max possible = 9.24e-01 )
Likelihood ratio test p = 3.25e-03 
Wald test p = 8.83e-02 
Score (logrank) test p = 3.67e-02 

T cell CD8+_CIBERSORT-ABS in HNSC-HPV- (n=422):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
379 patients with 167 dying ( 43 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -2.130 0.119    1.544   0.006   2.450 -1.380 0.168
Age                          0.028 1.028    0.008   1.013   1.044  3.641 0.000
Stage2                       0.488 1.629    0.546   0.559   4.746  0.895 0.371
Stage3                       0.681 1.976    0.538   0.688   5.677  1.264 0.206
Stage4                       1.220 3.386    0.509   1.248   9.190  2.394 0.017
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                            ***
Stage2                            
Stage3                            
Stage4                           *
Rsquare = 0.079 (max possible = 9.9e-01 )
Likelihood ratio test p = 8.31e-06 
Wald test p = 3.7e-05 
Score (logrank) test p = 2.66e-05 

T cell CD8+_CIBERSORT-ABS in KICH (n=66):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
65 patients with 9 dying ( 1 missing obs. )
                               coef           HR se(coef)      95%CI_l
`T cell CD8+_CIBERSORT-ABS` -13.136 0.000000e+00   45.304        0.000
Age                           0.041 1.042000e+00    0.028        0.986
Stage2                       15.643 6.216978e+06    0.846  1185273.050
Stage3                       16.551 1.541395e+07    0.780  3342161.519
Stage4                       19.401 2.666073e+08    0.899 45791593.196
                                 95%CI_u      z     p signif
`T cell CD8+_CIBERSORT-ABS` 7.210029e+32 -0.290 0.772       
Age                         1.101000e+00  1.456 0.145       
Stage2                      3.260920e+07 18.499 0.000    ***
Stage3                      7.108866e+07 21.221 0.000    ***
Stage4                      1.552238e+09 21.585 0.000    ***
Rsquare = 0.323 (max possible = 6.61e-01 )
Likelihood ratio test p = 1.19e-04 
Wald test p = 2.13e-270 
Score (logrank) test p = 5.21e-11 

T cell CD8+_CIBERSORT-ABS in KIRC (n=533):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
526 patients with 172 dying ( 7 missing obs. )
                             coef    HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_CIBERSORT-ABS` 0.123 1.131    0.794   0.238   5.369 0.155 0.877
Age                         0.034 1.034    0.007   1.019   1.050 4.549 0.000
Stage2                      0.285 1.330    0.317   0.714   2.479 0.899 0.368
Stage3                      0.942 2.565    0.211   1.697   3.876 4.472 0.000
Stage4                      1.945 6.996    0.199   4.739  10.327 9.790 0.000
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                            ***
Stage2                            
Stage3                         ***
Stage4                         ***
Rsquare = 0.208 (max possible = 9.75e-01 )
Likelihood ratio test p = 8.06e-25 
Wald test p = 1.93e-24 
Score (logrank) test p = 1.79e-30 

T cell CD8+_CIBERSORT-ABS in KIRP (n=290):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
255 patients with 39 dying ( 35 missing obs. )
                              coef       HR se(coef) 95%CI_l    95%CI_u      z
`T cell CD8+_CIBERSORT-ABS`  7.493 1794.751    2.346  18.089 178069.982  3.194
Age                          0.011    1.011    0.015   0.983      1.041  0.768
Stage2                      -0.230    0.795    0.780   0.172      3.668 -0.295
Stage3                       1.421    4.142    0.386   1.945      8.820  3.685
Stage4                       2.781   16.133    0.449   6.687     38.924  6.188
                                p signif
`T cell CD8+_CIBERSORT-ABS` 0.001     **
Age                         0.442       
Stage2                      0.768       
Stage3                      0.000    ***
Stage4                      0.000    ***
Rsquare = 0.166 (max possible = 7.61e-01 )
Likelihood ratio test p = 8.43e-09 
Wald test p = 3.23e-10 
Score (logrank) test p = 1.41e-15 

T cell CD8+_CIBERSORT-ABS in LGG (n=516):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age 
511 patients with 125 dying ( 5 missing obs. )
                              coef         HR se(coef)      95%CI_l
`T cell CD8+_CIBERSORT-ABS` 51.183 1.6923e+22   10.098 4.294501e+13
Age                          0.051 1.0530e+00    0.007 1.037000e+00
                                 95%CI_u     z p signif
`T cell CD8+_CIBERSORT-ABS` 6.668717e+30 5.069 0    ***
Age                         1.068000e+00 6.880 0    ***
Rsquare = 0.144 (max possible = 9.13e-01 )
Likelihood ratio test p = 6.31e-18 
Wald test p = 1.16e-20 
Score (logrank) test p = 5.37e-23 

T cell CD8+_CIBERSORT-ABS in LIHC (n=371):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
340 patients with 116 dying ( 31 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -1.279 0.278    1.362   0.019   4.016 -0.939 0.348
Age                          0.012 1.012    0.007   0.997   1.026  1.584 0.113
Stage2                       0.324 1.383    0.251   0.846   2.262  1.293 0.196
Stage3                       0.994 2.703    0.215   1.772   4.123  4.616 0.000
Stage4                       1.675 5.341    0.600   1.648  17.313  2.792 0.005
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                               
Stage2                            
Stage3                         ***
Stage4                          **
Rsquare = 0.077 (max possible = 9.69e-01 )
Likelihood ratio test p = 4.72e-05 
Wald test p = 2.14e-05 
Score (logrank) test p = 6.9e-06 

T cell CD8+_CIBERSORT-ABS in LUAD (n=515):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
484 patients with 177 dying ( 31 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -1.255 0.285    1.460   0.016   4.981 -0.860 0.390
Age                          0.009 1.009    0.008   0.994   1.025  1.144 0.253
Stage2                       0.820 2.271    0.187   1.573   3.278  4.377 0.000
Stage3                       1.163 3.199    0.197   2.172   4.710  5.890 0.000
Stage4                       1.282 3.603    0.283   2.068   6.277  4.525 0.000
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                               
Stage2                         ***
Stage3                         ***
Stage4                         ***
Rsquare = 0.097 (max possible = 9.79e-01 )
Likelihood ratio test p = 1.91e-09 
Wald test p = 2.38e-09 
Score (logrank) test p = 2.77e-10 

T cell CD8+_CIBERSORT-ABS in LUSC (n=501):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
484 patients with 209 dying ( 17 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -0.637 0.529    1.426   0.032   8.648 -0.447 0.655
Age                          0.018 1.018    0.009   1.001   1.036  2.089 0.037
Stage2                       0.162 1.176    0.164   0.853   1.622  0.990 0.322
Stage3                       0.472 1.604    0.184   1.119   2.300  2.570 0.010
Stage4                       1.172 3.230    0.463   1.303   8.003  2.532 0.011
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                              *
Stage2                            
Stage3                           *
Stage4                           *
Rsquare = 0.028 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.74e-02 
Wald test p = 1.03e-02 
Score (logrank) test p = 7.83e-03 

T cell CD8+_CIBERSORT-ABS in MESO (n=87):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
86 patients with 73 dying ( 1 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS`  0.626 1.871    1.263   0.158  22.220  0.496 0.620
Age                          0.020 1.020    0.015   0.991   1.050  1.333 0.183
Stage2                      -0.388 0.678    0.448   0.282   1.634 -0.865 0.387
Stage3                      -0.244 0.784    0.383   0.370   1.661 -0.636 0.525
Stage4                      -0.284 0.753    0.445   0.314   1.802 -0.638 0.523
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                               
Stage2                            
Stage3                            
Stage4                            
Rsquare = 0.035 (max possible = 9.98e-01 )
Likelihood ratio test p = 6.96e-01 
Wald test p = 6.87e-01 
Score (logrank) test p = 6.85e-01 

T cell CD8+_CIBERSORT-ABS in OV (n=303):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age 
302 patients with 183 dying ( 1 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z   p
`T cell CD8+_CIBERSORT-ABS` -1.398 0.247    2.665   0.001  45.873 -0.524 0.6
Age                          0.030 1.030    0.007   1.015   1.045  4.046 0.0
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                            ***
Rsquare = 0.053 (max possible = 9.97e-01 )
Likelihood ratio test p = 2.78e-04 
Wald test p = 2.46e-04 
Score (logrank) test p = 2.25e-04 

T cell CD8+_CIBERSORT-ABS in PAAD (n=179):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
175 patients with 93 dying ( 4 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -1.527 0.217    2.396   0.002  23.790 -0.637 0.524
Age                          0.023 1.024    0.010   1.003   1.045  2.230 0.026
Stage2                       0.801 2.227    0.400   1.017   4.876  2.003 0.045
Stage3                       0.126 1.134    1.077   0.137   9.361  0.117 0.907
Stage4                       0.341 1.406    0.809   0.288   6.867  0.422 0.673
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                              *
Stage2                           *
Stage3                            
Stage4                            
Rsquare = 0.067 (max possible = 9.91e-01 )
Likelihood ratio test p = 3.23e-02 
Wald test p = 5.78e-02 
Score (logrank) test p = 5.12e-02 

T cell CD8+_CIBERSORT-ABS in PCPG (n=181):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age 
181 patients with 7 dying ( 0 missing obs. )
                             coef    HR se(coef) 95%CI_l      95%CI_u     z
`T cell CD8+_CIBERSORT-ABS` 0.735 2.085   27.435   0.000 4.699605e+23 0.027
Age                         0.023 1.023    0.024   0.976 1.073000e+00 0.943
                                p signif
`T cell CD8+_CIBERSORT-ABS` 0.979       
Age                         0.346       
Rsquare = 0.005 (max possible = 2.89e-01 )
Likelihood ratio test p = 6.35e-01 
Wald test p = 6.35e-01 
Score (logrank) test p = 6.31e-01 

T cell CD8+_CIBERSORT-ABS in PRAD (n=498):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age 
496 patients with 10 dying ( 2 missing obs. )
                              coef    HR se(coef) 95%CI_l     95%CI_u      z
`T cell CD8+_CIBERSORT-ABS` -4.770 0.008   13.439   0.000 2.33057e+09 -0.355
Age                          0.051 1.052    0.049   0.955 1.15900e+00  1.031
                                p signif
`T cell CD8+_CIBERSORT-ABS` 0.723       
Age                         0.302       
Rsquare = 0.003 (max possible = 1.68e-01 )
Likelihood ratio test p = 5.34e-01 
Wald test p = 5.4e-01 
Score (logrank) test p = 5.36e-01 

T cell CD8+_CIBERSORT-ABS in READ (n=166):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
82 patients with 14 dying ( 84 missing obs. )
                              coef    HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+_CIBERSORT-ABS` -5.472 0.004   11.320   0.000 18169418.199 -0.483
Age                          0.125 1.133    0.046   1.036        1.239  2.742
Stage2                      -1.348 0.260    1.248   0.023        3.001 -1.080
Stage3                       0.181 1.199    0.843   0.230        6.254  0.215
Stage4                       0.221 1.247    0.934   0.200        7.782  0.236
                                p signif
`T cell CD8+_CIBERSORT-ABS` 0.629       
Age                         0.006     **
Stage2                      0.280       
Stage3                      0.830       
Stage4                      0.813       
Rsquare = 0.228 (max possible = 7.04e-01 )
Likelihood ratio test p = 7.46e-04 
Wald test p = 3.57e-02 
Score (logrank) test p = 1.44e-03 

T cell CD8+_CIBERSORT-ABS in SARC (n=260):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age 
257 patients with 99 dying ( 3 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -1.995 0.136    1.723   0.005   3.986 -1.157 0.247
Age                          0.022 1.022    0.008   1.007   1.039  2.790 0.005
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                             **
Rsquare = 0.034 (max possible = 9.77e-01 )
Likelihood ratio test p = 1.12e-02 
Wald test p = 1.37e-02 
Score (logrank) test p = 1.36e-02 

T cell CD8+_CIBERSORT-ABS in SKCM (n=471):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
407 patients with 192 dying ( 64 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -3.074 0.046    0.750   0.011   0.201 -4.101 0.000
Age                          0.019 1.020    0.005   1.010   1.030  3.807 0.000
Stage2                       0.134 1.143    0.217   0.748   1.748  0.617 0.537
Stage3                       0.562 1.754    0.200   1.186   2.595  2.812 0.005
Stage4                       1.229 3.417    0.349   1.724   6.769  3.522 0.000
                            signif
`T cell CD8+_CIBERSORT-ABS`    ***
Age                            ***
Stage2                            
Stage3                          **
Stage4                         ***
Rsquare = 0.126 (max possible = 9.92e-01 )
Likelihood ratio test p = 1.42e-10 
Wald test p = 1.96e-09 
Score (logrank) test p = 7.57e-10 

T cell CD8+_CIBERSORT-ABS in SKCM-Primary (n=103):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
95 patients with 26 dying ( 8 missing obs. )
                              coef           HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+_CIBERSORT-ABS` -1.272 2.800000e-01    3.060   0.001 112.871 -0.416
Age                          0.006 1.006000e+00    0.014   0.978   1.034  0.393
Stage2                      17.352 3.435529e+07 6207.471   0.000     Inf  0.003
Stage3                      17.994 6.527979e+07 6207.471   0.000     Inf  0.003
Stage4                      19.661 3.457732e+08 6207.471   0.000     Inf  0.003
                                p signif
`T cell CD8+_CIBERSORT-ABS` 0.678       
Age                         0.694       
Stage2                      0.998       
Stage3                      0.998       
Stage4                      0.997       
Rsquare = 0.112 (max possible = 8.67e-01 )
Likelihood ratio test p = 4.56e-02 
Wald test p = 3.92e-02 
Score (logrank) test p = 3.66e-03 

T cell CD8+_CIBERSORT-ABS in SKCM-Metastasis (n=368):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
312 patients with 166 dying ( 56 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -2.924 0.054    0.777   0.012   0.247 -3.762 0.000
Age                          0.022 1.022    0.006   1.011   1.033  3.960 0.000
Stage2                       0.023 1.023    0.228   0.655   1.598  0.101 0.920
Stage3                       0.500 1.648    0.204   1.104   2.460  2.445 0.014
Stage4                       1.009 2.744    0.396   1.263   5.961  2.550 0.011
                            signif
`T cell CD8+_CIBERSORT-ABS`    ***
Age                            ***
Stage2                            
Stage3                           *
Stage4                           *
Rsquare = 0.141 (max possible = 9.95e-01 )
Likelihood ratio test p = 4.78e-09 
Wald test p = 4.77e-08 
Score (logrank) test p = 2.31e-08 

T cell CD8+_CIBERSORT-ABS in STAD (n=415):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
368 patients with 148 dying ( 47 missing obs. )
                             coef    HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_CIBERSORT-ABS` 0.602 1.825    1.195   0.175  18.999 0.504 0.615
Age                         0.029 1.030    0.009   1.013   1.047 3.416 0.001
Stage2                      0.420 1.522    0.336   0.788   2.937 1.251 0.211
Stage3                      0.900 2.460    0.315   1.326   4.565 2.854 0.004
Stage4                      1.606 4.983    0.365   2.435  10.196 4.397 0.000
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                             **
Stage2                            
Stage3                          **
Stage4                         ***
Rsquare = 0.086 (max possible = 9.85e-01 )
Likelihood ratio test p = 3.73e-06 
Wald test p = 5.23e-06 
Score (logrank) test p = 2.44e-06 

T cell CD8+_CIBERSORT-ABS in TGCT (n=150):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
81 patients with 2 dying ( 69 missing obs. )
                              coef           HR  se(coef) 95%CI_l      95%CI_u
`T cell CD8+_CIBERSORT-ABS` -0.803 4.480000e-01    29.225   0.000 3.371877e+24
Age                         -0.210 8.100000e-01     0.194   0.555 1.184000e+00
Stage2                      18.541 1.127695e+08 33788.947   0.000          Inf
Stage3                      41.308 8.702773e+17 82962.370   0.000          Inf
                                 z     p signif
`T cell CD8+_CIBERSORT-ABS` -0.027 0.978       
Age                         -1.087 0.277       
Stage2                       0.001 1.000   <NA>
Stage3                       0.000 1.000   <NA>
Rsquare = 0.083 (max possible = 1.32e-01 )
Likelihood ratio test p = 1.33e-01 
Wald test p = 8.66e-01 
Score (logrank) test p = 1.38e-01 

T cell CD8+_CIBERSORT-ABS in THCA (n=509):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
506 patients with 16 dying ( 3 missing obs. )
                              coef    HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+_CIBERSORT-ABS` -3.757 0.023   10.717   0.000 30965565.111 -0.351
Age                          0.151 1.163    0.028   1.100        1.230  5.315
Stage2                       0.227 1.254    1.018   0.171        9.221  0.223
Stage3                       0.225 1.253    0.811   0.256        6.140  0.278
Stage4                       0.846 2.331    0.857   0.435       12.496  0.987
                                p signif
`T cell CD8+_CIBERSORT-ABS` 0.726       
Age                         0.000    ***
Stage2                      0.824       
Stage3                      0.781       
Stage4                      0.323       
Rsquare = 0.109 (max possible = 2.9e-01 )
Likelihood ratio test p = 2.63e-11 
Wald test p = 1.42e-05 
Score (logrank) test p = 1.85e-11 

T cell CD8+_CIBERSORT-ABS in THYM (n=120):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age 
119 patients with 9 dying ( 1 missing obs. )
                             coef      HR se(coef) 95%CI_l   95%CI_u     z
`T cell CD8+_CIBERSORT-ABS` 6.085 439.238    2.623   2.572 75007.757 2.320
Age                         0.062   1.064    0.030   1.004     1.128 2.107
                                p signif
`T cell CD8+_CIBERSORT-ABS` 0.020      *
Age                         0.035      *
Rsquare = 0.072 (max possible = 4.39e-01 )
Likelihood ratio test p = 1.15e-02 
Wald test p = 1.35e-02 
Score (logrank) test p = 8.76e-03 

T cell CD8+_CIBERSORT-ABS in UCEC (n=545):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age 
173 patients with 32 dying ( 372 missing obs. )
                              coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_CIBERSORT-ABS` -4.933 0.007    4.838    0.00  94.572 -1.020 0.308
Age                          0.012 1.012    0.016    0.98   1.045  0.738 0.461
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                               
Rsquare = 0.012 (max possible = 7.9e-01 )
Likelihood ratio test p = 3.46e-01 
Wald test p = 3.78e-01 
Score (logrank) test p = 3.74e-01 

T cell CD8+_CIBERSORT-ABS in UCS (n=57):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age 
55 patients with 34 dying ( 2 missing obs. )
                             coef    HR se(coef) 95%CI_l    95%CI_u     z     p
`T cell CD8+_CIBERSORT-ABS` 0.045 1.046    6.877       0 746537.080 0.007 0.995
Age                         0.046 1.047    0.023       1      1.096 1.963 0.050
                            signif
`T cell CD8+_CIBERSORT-ABS`       
Age                              ·
Rsquare = 0.07 (max possible = 9.83e-01 )
Likelihood ratio test p = 1.36e-01 
Wald test p = 1.32e-01 
Score (logrank) test p = 1.27e-01 

T cell CD8+_CIBERSORT-ABS in UVM (n=80):
Model: Surv(OS, EVENT) ~ `T cell CD8+_CIBERSORT-ABS` + Age + Stage 
79 patients with 22 dying ( 1 missing obs. )
                             coef     HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_CIBERSORT-ABS` 3.662 38.948    1.562   1.823 832.013 2.344 0.019
Age                         0.043  1.044    0.020   1.003   1.086 2.113 0.035
Stage3                      0.045  1.046    0.486   0.404   2.709 0.092 0.927
Stage4                      3.773 43.529    1.215   4.022 471.134 3.105 0.002
                            signif
`T cell CD8+_CIBERSORT-ABS`      *
Age                              *
Stage3                            
Stage4                          **
Rsquare = 0.252 (max possible = 8.67e-01 )
Likelihood ratio test p = 1.28e-04 
Wald test p = 3e-04 
Score (logrank) test p = 4.2e-11 

T cell CD8+_EPIC in ACC (n=79):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age 
79 patients with 28 dying ( 0 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -41.565 0.000   23.119   0.000  42.374 -1.798 0.072      ·
Age                  0.011 1.011    0.012   0.987   1.036  0.911 0.362       
Rsquare = 0.052 (max possible = 9.35e-01 )
Likelihood ratio test p = 1.21e-01 
Wald test p = 1.37e-01 
Score (logrank) test p = 1.42e-01 

T cell CD8+_EPIC in BLCA (n=408):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
401 patients with 176 dying ( 7 missing obs. )
                     coef          HR se(coef) 95%CI_l  95%CI_u     z     p
`T cell CD8+_EPIC`  5.235     187.732    1.899   4.540 7762.403 2.757 0.006
Age                 0.029       1.029    0.008   1.013    1.046 3.608 0.000
Stage2             14.604 2199102.864 1932.458   0.000      Inf 0.008 0.994
Stage3             15.038 3396402.112 1932.458   0.000      Inf 0.008 0.994
Stage4             15.594 5918777.842 1932.458   0.000      Inf 0.008 0.994
                   signif
`T cell CD8+_EPIC`     **
Age                   ***
Stage2                   
Stage3                   
Stage4                   
Rsquare = 0.126 (max possible = 9.91e-01 )
Likelihood ratio test p = 1.96e-10 
Wald test p = 8.37e-10 
Score (logrank) test p = 1.23e-10 

T cell CD8+_EPIC in BRCA (n=1100):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
1057 patients with 143 dying ( 43 missing obs. )
                    coef     HR se(coef) 95%CI_l    95%CI_u     z    p signif
`T cell CD8+_EPIC` 1.708  5.517    5.829   0.000 505188.630 0.293 0.77       
Age                0.034  1.034    0.007   1.020      1.048 4.893 0.00    ***
Stage2             0.572  1.772    0.279   1.025      3.063 2.050 0.04      *
Stage3             1.221  3.392    0.295   1.904      6.042 4.146 0.00    ***
Stage4             2.433 11.392    0.361   5.613     23.124 6.736 0.00    ***
Rsquare = 0.067 (max possible = 7.87e-01 )
Likelihood ratio test p = 2.11e-14 
Wald test p = 1.56e-17 
Score (logrank) test p = 1.66e-22 

T cell CD8+_EPIC in BRCA-Basal (n=191):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
185 patients with 26 dying ( 6 missing obs. )
                      coef           HR se(coef) 95%CI_l  95%CI_u      z     p
`T cell CD8+_EPIC` -16.812 0.000000e+00   13.070   0.000 6662.032 -1.286 0.198
Age                  0.009 1.009000e+00    0.016   0.978    1.042  0.578 0.564
Stage2              18.920 1.647900e+08 6287.683   0.000      Inf  0.003 0.998
Stage3              20.349 6.878917e+08 6287.683   0.000      Inf  0.003 0.997
Stage4              21.744 2.774999e+09 6287.683   0.000      Inf  0.003 0.997
                   signif
`T cell CD8+_EPIC`       
Age                      
Stage2                   
Stage3                   
Stage4                   
Rsquare = 0.142 (max possible = 7.08e-01 )
Likelihood ratio test p = 3.23e-05 
Wald test p = 1.12e-03 
Score (logrank) test p = 2.18e-07 

T cell CD8+_EPIC in BRCA-Her2 (n=82):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
75 patients with 16 dying ( 7 missing obs. )
                     coef           HR se(coef) 95%CI_l     95%CI_u      z
`T cell CD8+_EPIC` 29.994 1.062536e+13   17.523   0.013 8.75331e+27  1.712
Age                 0.079 1.082000e+00    0.028   1.025 1.14200e+00  2.842
Stage2             -0.509 6.010000e-01    1.157   0.062 5.80100e+00 -0.440
Stage3              0.938 2.555000e+00    1.185   0.250 2.60610e+01  0.791
Stage4              3.833 4.621000e+01    1.325   3.440 6.20715e+02  2.892
                       p signif
`T cell CD8+_EPIC` 0.087      ·
Age                0.004     **
Stage2             0.660       
Stage3             0.429       
Stage4             0.004     **
Rsquare = 0.306 (max possible = 7.59e-01 )
Likelihood ratio test p = 4.69e-05 
Wald test p = 3.61e-04 
Score (logrank) test p = 5.01e-08 

T cell CD8+_EPIC in BRCA-LumA (n=568):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
547 patients with 62 dying ( 21 missing obs. )
                     coef          HR se(coef) 95%CI_l      95%CI_u     z     p
`T cell CD8+_EPIC` 14.908 2981413.867    8.418   0.204 4.359297e+13 1.771 0.077
Age                 0.043       1.044    0.011   1.022 1.067000e+00 3.919 0.000
Stage2              0.429       1.536    0.360   0.758 3.110000e+00 1.191 0.234
Stage3              0.812       2.252    0.396   1.037 4.890000e+00 2.051 0.040
Stage4              2.047       7.743    0.544   2.667 2.248200e+01 3.764 0.000
                   signif
`T cell CD8+_EPIC`      ·
Age                   ***
Stage2                   
Stage3                  *
Stage4                ***
Rsquare = 0.056 (max possible = 6.7e-01 )
Likelihood ratio test p = 6.98e-06 
Wald test p = 1.5e-06 
Score (logrank) test p = 9.15e-08 

T cell CD8+_EPIC in BRCA-LumB (n=219):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
211 patients with 32 dying ( 8 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -34.607 0.000   19.745   0.000  59.956 -1.753 0.080      ·
Age                  0.034 1.035    0.016   1.003   1.067  2.155 0.031      *
Stage2               0.953 2.593    0.760   0.585  11.497  1.254 0.210       
Stage3               1.500 4.484    0.777   0.977  20.578  1.930 0.054      ·
Stage4               2.058 7.829    0.888   1.372  44.665  2.316 0.021      *
Rsquare = 0.077 (max possible = 7e-01 )
Likelihood ratio test p = 4.77e-03 
Wald test p = 8.39e-03 
Score (logrank) test p = 3.04e-03 

T cell CD8+_EPIC in CESC (n=306):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age 
293 patients with 73 dying ( 13 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -12.237 0.000    6.744   0.000   2.670 -1.814 0.070      ·
Age                  0.015 1.015    0.009   0.997   1.032  1.671 0.095      ·
Rsquare = 0.025 (max possible = 9.11e-01 )
Likelihood ratio test p = 2.38e-02 
Wald test p = 4.44e-02 
Score (logrank) test p = 4.47e-02 

T cell CD8+_EPIC in CHOL (n=36):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
36 patients with 18 dying ( 0 missing obs. )
                      coef           HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+_EPIC`  21.896 3.231515e+09   32.078   0.000 6.521953e+36  0.683
Age                  0.018 1.018000e+00    0.019   0.980 1.058000e+00  0.941
Stage2               0.876 2.402000e+00    0.605   0.734 7.859000e+00  1.449
Stage3             -17.086 0.000000e+00 6595.100   0.000          Inf -0.003
Stage4               0.998 2.713000e+00    0.612   0.817 9.007000e+00  1.630
                       p signif
`T cell CD8+_EPIC` 0.495       
Age                0.347       
Stage2             0.147       
Stage3             0.998       
Stage4             0.103       
Rsquare = 0.142 (max possible = 9.46e-01 )
Likelihood ratio test p = 3.57e-01 
Wald test p = 5.41e-01 
Score (logrank) test p = 3.99e-01 

T cell CD8+_EPIC in COAD (n=458):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
267 patients with 62 dying ( 191 missing obs. )
                     coef     HR se(coef) 95%CI_l      95%CI_u      z     p
`T cell CD8+_EPIC` -4.614  0.010   18.888   0.000 1.184075e+14 -0.244 0.807
Age                 0.037  1.037    0.012   1.014 1.062000e+00  3.139 0.002
Stage2              0.706  2.025    0.626   0.594 6.908000e+00  1.128 0.259
Stage3              1.342  3.826    0.623   1.128 1.297000e+01  2.154 0.031
Stage4              2.492 12.085    0.633   3.492 4.182800e+01  3.934 0.000
                   signif
`T cell CD8+_EPIC`       
Age                    **
Stage2                   
Stage3                  *
Stage4                ***
Rsquare = 0.123 (max possible = 8.92e-01 )
Likelihood ratio test p = 1.43e-06 
Wald test p = 1.4e-06 
Score (logrank) test p = 1.18e-07 

T cell CD8+_EPIC in DLBC (n=48):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age 
47 patients with 9 dying ( 1 missing obs. )
                     coef    HR se(coef) 95%CI_l      95%CI_u      z    p
`T cell CD8+_EPIC` -2.937 0.053   15.525   0.000 8.691876e+11 -0.189 0.85
Age                -0.011 0.989    0.025   0.941 1.040000e+00 -0.426 0.67
                   signif
`T cell CD8+_EPIC`       
Age                      
Rsquare = 0.005 (max possible = 6.72e-01 )
Likelihood ratio test p = 8.99e-01 
Wald test p = 8.99e-01 
Score (logrank) test p = 8.98e-01 

T cell CD8+_EPIC in ESCA (n=185):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
160 patients with 63 dying ( 25 missing obs. )
                      coef     HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -14.486  0.000   10.448   0.000 400.347 -1.386 0.166       
Age                  0.005  1.005    0.011   0.983   1.026  0.429 0.668       
Stage2               0.759  2.135    0.554   0.721   6.322  1.370 0.171       
Stage3               1.708  5.518    0.568   1.814  16.784  3.009 0.003     **
Stage4               2.442 11.492    0.648   3.227  40.933  3.767 0.000    ***
Rsquare = 0.156 (max possible = 9.61e-01 )
Likelihood ratio test p = 5.24e-05 
Wald test p = 8e-05 
Score (logrank) test p = 1.06e-05 

T cell CD8+_EPIC in GBM (n=153):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age 
150 patients with 120 dying ( 3 missing obs. )
                     coef       HR se(coef) 95%CI_l      95%CI_u     z     p
`T cell CD8+_EPIC` 10.893 53785.80   12.093   0.000 1.056617e+15 0.901 0.368
Age                 0.029     1.03    0.008   1.014 1.045000e+00 3.856 0.000
                   signif
`T cell CD8+_EPIC`       
Age                   ***
Rsquare = 0.103 (max possible = 9.98e-01 )
Likelihood ratio test p = 2.81e-04 
Wald test p = 5.14e-04 
Score (logrank) test p = 5.06e-04 

T cell CD8+_EPIC in HNSC (n=522):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
446 patients with 191 dying ( 76 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -7.497 0.001    5.590   0.000  31.786 -1.341 0.180       
Age                 0.023 1.023    0.007   1.009   1.038  3.284 0.001     **
Stage2              0.727 2.070    0.538   0.721   5.941  1.352 0.176       
Stage3              0.825 2.282    0.535   0.799   6.514  1.542 0.123       
Stage4              1.322 3.751    0.509   1.384  10.162  2.599 0.009     **
Rsquare = 0.067 (max possible = 9.9e-01 )
Likelihood ratio test p = 8.68e-06 
Wald test p = 4.94e-05 
Score (logrank) test p = 3.36e-05 

T cell CD8+_EPIC in HNSC-HPV+ (n=98):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
67 patients with 24 dying ( 31 missing obs. )
                      coef           HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_EPIC` -64.961        0.000   20.417   0.000   0.000 -3.182 0.001
Age                 -0.008        0.992    0.022   0.951   1.035 -0.368 0.713
Stage2              17.462 38341506.182 5165.809   0.000     Inf  0.003 0.997
Stage3              17.025 24768523.558 5165.809   0.000     Inf  0.003 0.997
Stage4              17.304 32726526.320 5165.809   0.000     Inf  0.003 0.997
                   signif
`T cell CD8+_EPIC`     **
Age                      
Stage2                   
Stage3                   
Stage4                   
Rsquare = 0.217 (max possible = 9.24e-01 )
Likelihood ratio test p = 5.74e-03 
Wald test p = 5.7e-02 
Score (logrank) test p = 4.29e-02 

T cell CD8+_EPIC in HNSC-HPV- (n=422):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
379 patients with 167 dying ( 43 missing obs. )
                     coef    HR se(coef) 95%CI_l   95%CI_u      z     p signif
`T cell CD8+_EPIC` -0.763 0.466    5.949   0.000 54005.007 -0.128 0.898       
Age                 0.027 1.027    0.008   1.012     1.043  3.456 0.001     **
Stage2              0.500 1.648    0.546   0.565     4.804  0.915 0.360       
Stage3              0.714 2.043    0.539   0.711     5.871  1.327 0.185       
Stage4              1.240 3.454    0.510   1.270     9.393  2.429 0.015      *
Rsquare = 0.074 (max possible = 9.9e-01 )
Likelihood ratio test p = 2.1e-05 
Wald test p = 1.01e-04 
Score (logrank) test p = 7.15e-05 

T cell CD8+_EPIC in KICH (n=66):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
65 patients with 9 dying ( 1 missing obs. )
                     coef           HR se(coef)      95%CI_l      95%CI_u
`T cell CD8+_EPIC`  1.965 7.133000e+00   34.664        0.000 2.287419e+30
Age                 0.042 1.043000e+00    0.028        0.987 1.102000e+00
Stage2             15.688 6.505096e+06    0.845  1240868.186 3.410215e+07
Stage3             16.608 1.632708e+07    0.779  3547766.832 7.513842e+07
Stage4             19.464 2.837387e+08    0.895 49091093.851 1.639965e+09
                        z     p signif
`T cell CD8+_EPIC`  0.057 0.955       
Age                 1.498 0.134       
Stage2             18.559 0.000    ***
Stage3             21.324 0.000    ***
Stage4             21.744 0.000    ***
Rsquare = 0.322 (max possible = 6.61e-01 )
Likelihood ratio test p = 1.24e-04 
Wald test p = 2.44e-273 
Score (logrank) test p = 6.06e-11 

T cell CD8+_EPIC in KIRC (n=533):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
526 patients with 172 dying ( 7 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -4.776 0.008    3.309   0.000   5.530 -1.443 0.149       
Age                 0.033 1.034    0.007   1.019   1.049  4.500 0.000    ***
Stage2              0.317 1.373    0.317   0.737   2.557  0.999 0.318       
Stage3              0.957 2.603    0.209   1.727   3.923  4.570 0.000    ***
Stage4              1.968 7.157    0.197   4.866  10.528  9.996 0.000    ***
Rsquare = 0.211 (max possible = 9.75e-01 )
Likelihood ratio test p = 2.77e-25 
Wald test p = 4.31e-25 
Score (logrank) test p = 4.12e-31 

T cell CD8+_EPIC in KIRP (n=290):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
255 patients with 39 dying ( 35 missing obs. )
                     coef     HR se(coef) 95%CI_l      95%CI_u      z     p
`T cell CD8+_EPIC` -0.031  0.969    9.621   0.000 1.499974e+08 -0.003 0.997
Age                 0.006  1.006    0.014   0.978 1.034000e+00  0.393 0.695
Stage2              0.022  1.022    0.772   0.225 4.639000e+00  0.028 0.977
Stage3              1.550  4.711    0.382   2.226 9.969000e+00  4.052 0.000
Stage4              2.786 16.216    0.449   6.724 3.910900e+01  6.203 0.000
                   signif
`T cell CD8+_EPIC`       
Age                      
Stage2                   
Stage3                ***
Stage4                ***
Rsquare = 0.141 (max possible = 7.61e-01 )
Likelihood ratio test p = 2.84e-07 
Wald test p = 3.39e-08 
Score (logrank) test p = 7.52e-13 

T cell CD8+_EPIC in LGG (n=516):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age 
511 patients with 125 dying ( 5 missing obs. )
                      coef   HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -20.686 0.00    9.568   0.000   0.145 -2.162 0.031      *
Age                  0.058 1.06    0.007   1.045   1.075  7.947 0.000    ***
Rsquare = 0.121 (max possible = 9.13e-01 )
Likelihood ratio test p = 5.44e-15 
Wald test p = 8.22e-15 
Score (logrank) test p = 1.13e-15 

T cell CD8+_EPIC in LIHC (n=371):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
340 patients with 116 dying ( 31 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -2.354 0.095    3.613   0.000 113.091 -0.651 0.515       
Age                 0.012 1.012    0.007   0.998   1.027  1.634 0.102       
Stage2              0.324 1.382    0.251   0.845   2.260  1.289 0.197       
Stage3              1.002 2.725    0.216   1.785   4.159  4.647 0.000    ***
Stage4              1.679 5.363    0.600   1.654  17.386  2.799 0.005     **
Rsquare = 0.076 (max possible = 9.69e-01 )
Likelihood ratio test p = 5.83e-05 
Wald test p = 2.48e-05 
Score (logrank) test p = 7.99e-06 

T cell CD8+_EPIC in LUAD (n=515):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
484 patients with 177 dying ( 31 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -10.947 0.000    6.811   0.000  11.048 -1.607 0.108       
Age                  0.010 1.010    0.008   0.995   1.026  1.266 0.206       
Stage2               0.789 2.202    0.188   1.522   3.185  4.192 0.000    ***
Stage3               1.151 3.163    0.197   2.149   4.656  5.836 0.000    ***
Stage4               1.388 4.007    0.287   2.282   7.036  4.831 0.000    ***
Rsquare = 0.1 (max possible = 9.79e-01 )
Likelihood ratio test p = 7.74e-10 
Wald test p = 9.89e-10 
Score (logrank) test p = 1.15e-10 

T cell CD8+_EPIC in LUSC (n=501):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
484 patients with 209 dying ( 17 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -0.166 0.847    3.027   0.002 319.829 -0.055 0.956       
Age                 0.018 1.018    0.009   1.001   1.036  2.090 0.037      *
Stage2              0.164 1.179    0.164   0.855   1.626  1.003 0.316       
Stage3              0.469 1.598    0.184   1.115   2.291  2.552 0.011      *
Stage4              1.191 3.292    0.464   1.325   8.181  2.565 0.010      *
Rsquare = 0.028 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.89e-02 
Wald test p = 1.12e-02 
Score (logrank) test p = 8.5e-03 

T cell CD8+_EPIC in MESO (n=87):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
86 patients with 73 dying ( 1 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -7.539 0.001    5.372   0.000  19.903 -1.403 0.161       
Age                 0.015 1.015    0.015   0.986   1.045  1.035 0.301       
Stage2             -0.404 0.668    0.450   0.277   1.612 -0.898 0.369       
Stage3             -0.350 0.705    0.395   0.325   1.528 -0.886 0.376       
Stage4             -0.417 0.659    0.453   0.272   1.601 -0.920 0.357       
Rsquare = 0.059 (max possible = 9.98e-01 )
Likelihood ratio test p = 3.85e-01 
Wald test p = 4.41e-01 
Score (logrank) test p = 4.37e-01 

T cell CD8+_EPIC in OV (n=303):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age 
302 patients with 183 dying ( 1 missing obs. )
                    coef      HR se(coef) 95%CI_l      95%CI_u     z     p
`T cell CD8+_EPIC` 6.849 943.037    6.967   0.001 8.033281e+08 0.983 0.326
Age                0.030   1.030    0.007   1.016 1.045000e+00 4.072 0.000
                   signif
`T cell CD8+_EPIC`       
Age                   ***
Rsquare = 0.055 (max possible = 9.97e-01 )
Likelihood ratio test p = 2.06e-04 
Wald test p = 2e-04 
Score (logrank) test p = 1.84e-04 

T cell CD8+_EPIC in PAAD (n=179):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
175 patients with 93 dying ( 4 missing obs. )
                     coef        HR se(coef) 95%CI_l      95%CI_u     z     p
`T cell CD8+_EPIC` 10.704 44524.024   10.238   0.000 2.308624e+13 1.045 0.296
Age                 0.024     1.024    0.010   1.004 1.046000e+00 2.297 0.022
Stage2              0.884     2.421    0.414   1.076 5.452000e+00 2.136 0.033
Stage3              0.176     1.192    1.080   0.144 9.891000e+00 0.163 0.871
Stage4              0.478     1.613    0.819   0.324 8.036000e+00 0.584 0.559
                   signif
`T cell CD8+_EPIC`       
Age                     *
Stage2                  *
Stage3                   
Stage4                   
Rsquare = 0.071 (max possible = 9.91e-01 )
Likelihood ratio test p = 2.51e-02 
Wald test p = 4.87e-02 
Score (logrank) test p = 4.41e-02 

T cell CD8+_EPIC in PCPG (n=181):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age 
181 patients with 7 dying ( 0 missing obs. )
                     coef           HR se(coef) 95%CI_l      95%CI_u     z
`T cell CD8+_EPIC` 20.666 9.443919e+08   38.675   0.000 7.857884e+41 0.534
Age                 0.023 1.024000e+00    0.024   0.977 1.072000e+00 0.984
                       p signif
`T cell CD8+_EPIC` 0.593       
Age                0.325       
Rsquare = 0.007 (max possible = 2.89e-01 )
Likelihood ratio test p = 5.49e-01 
Wald test p = 5.43e-01 
Score (logrank) test p = 5.4e-01 

T cell CD8+_EPIC in PRAD (n=498):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age 
496 patients with 10 dying ( 2 missing obs. )
                      coef    HR se(coef) 95%CI_l      95%CI_u      z     p
`T cell CD8+_EPIC` -18.938 0.000   41.445    0.00 1.131545e+27 -0.457 0.648
Age                  0.048 1.049    0.051    0.95 1.159000e+00  0.948 0.343
                   signif
`T cell CD8+_EPIC`       
Age                      
Rsquare = 0.003 (max possible = 1.68e-01 )
Likelihood ratio test p = 5.15e-01 
Wald test p = 5.3e-01 
Score (logrank) test p = 5.26e-01 

T cell CD8+_EPIC in READ (n=166):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
82 patients with 14 dying ( 84 missing obs. )
                      coef    HR se(coef) 95%CI_l      95%CI_u      z     p
`T cell CD8+_EPIC` -80.771 0.000   54.894   0.000 4.443952e+11 -1.471 0.141
Age                  0.133 1.143    0.047   1.042 1.253000e+00  2.835 0.005
Stage2              -1.249 0.287    1.252   0.025 3.336000e+00 -0.998 0.318
Stage3               0.472 1.603    0.825   0.318 8.073000e+00  0.572 0.567
Stage4               0.384 1.469    0.922   0.241 8.955000e+00  0.417 0.677
                   signif
`T cell CD8+_EPIC`       
Age                    **
Stage2                   
Stage3                   
Stage4                   
Rsquare = 0.246 (max possible = 7.04e-01 )
Likelihood ratio test p = 3.08e-04 
Wald test p = 2.2e-02 
Score (logrank) test p = 5.71e-04 

T cell CD8+_EPIC in SARC (n=260):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age 
257 patients with 99 dying ( 3 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -7.091 0.001    5.764   0.000  67.017 -1.230 0.219       
Age                 0.022 1.022    0.008   1.006   1.038  2.719 0.007     **
Rsquare = 0.035 (max possible = 9.77e-01 )
Likelihood ratio test p = 1.04e-02 
Wald test p = 1.34e-02 
Score (logrank) test p = 1.35e-02 

T cell CD8+_EPIC in SKCM (n=471):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
407 patients with 192 dying ( 64 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -8.101 0.000    3.624   0.000   0.368 -2.235 0.025      *
Age                 0.019 1.019    0.005   1.009   1.029  3.681 0.000    ***
Stage2              0.221 1.247    0.216   0.817   1.903  1.024 0.306       
Stage3              0.603 1.827    0.200   1.235   2.704  3.015 0.003     **
Stage4              1.163 3.199    0.349   1.615   6.337  3.334 0.001     **
Rsquare = 0.094 (max possible = 9.92e-01 )
Likelihood ratio test p = 1.48e-07 
Wald test p = 3.38e-07 
Score (logrank) test p = 1.76e-07 

T cell CD8+_EPIC in SKCM-Primary (n=103):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
95 patients with 26 dying ( 8 missing obs. )
                     coef           HR se(coef) 95%CI_l      95%CI_u     z
`T cell CD8+_EPIC`  6.042 4.209050e+02   15.411   0.000 5.518652e+15 0.392
Age                 0.005 1.005000e+00    0.014   0.977 1.033000e+00 0.321
Stage2             17.659 4.668786e+07 6196.394   0.000          Inf 0.003
Stage3             18.276 8.648973e+07 6196.394   0.000          Inf 0.003
Stage4             20.043 5.065840e+08 6196.394   0.000          Inf 0.003
                       p signif
`T cell CD8+_EPIC` 0.695       
Age                0.748       
Stage2             0.998       
Stage3             0.998       
Stage4             0.997       
Rsquare = 0.112 (max possible = 8.67e-01 )
Likelihood ratio test p = 4.62e-02 
Wald test p = 4e-02 
Score (logrank) test p = 3.75e-03 

T cell CD8+_EPIC in SKCM-Metastasis (n=368):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
312 patients with 166 dying ( 56 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -8.410 0.000    3.854   0.000   0.425 -2.182 0.029      *
Age                 0.021 1.022    0.006   1.011   1.033  3.855 0.000    ***
Stage2              0.099 1.104    0.227   0.708   1.722  0.437 0.662       
Stage3              0.533 1.704    0.205   1.141   2.544  2.604 0.009     **
Stage4              0.918 2.504    0.396   1.152   5.439  2.318 0.020      *
Rsquare = 0.108 (max possible = 9.95e-01 )
Likelihood ratio test p = 1.03e-06 
Wald test p = 2.81e-06 
Score (logrank) test p = 1.72e-06 

T cell CD8+_EPIC in STAD (n=415):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
368 patients with 148 dying ( 47 missing obs. )
                    coef    HR se(coef) 95%CI_l   95%CI_u     z     p signif
`T cell CD8+_EPIC` 1.732 5.652    4.905   0.000 84527.534 0.353 0.724       
Age                0.029 1.030    0.009   1.012     1.047 3.411 0.001     **
Stage2             0.449 1.566    0.336   0.811     3.025 1.336 0.181       
Stage3             0.930 2.535    0.314   1.370     4.693 2.962 0.003     **
Stage4             1.635 5.128    0.368   2.491    10.556 4.438 0.000    ***
Rsquare = 0.086 (max possible = 9.85e-01 )
Likelihood ratio test p = 3.95e-06 
Wald test p = 6.04e-06 
Score (logrank) test p = 2.84e-06 

T cell CD8+_EPIC in TGCT (n=150):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
81 patients with 2 dying ( 69 missing obs. )
                      coef           HR  se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+_EPIC` -20.739 0.000000e+00   104.189   0.000 4.776194e+79 -0.199
Age                 -0.212 8.090000e-01     0.187   0.561 1.167000e+00 -1.132
Stage2              18.474 1.054568e+08 34085.197   0.000          Inf  0.001
Stage3              41.435 9.880990e+17 83680.475   0.000          Inf  0.000
                       p signif
`T cell CD8+_EPIC` 0.842       
Age                0.257       
Stage2             1.000   <NA>
Stage3             1.000   <NA>
Rsquare = 0.084 (max possible = 1.32e-01 )
Likelihood ratio test p = 1.31e-01 
Wald test p = 8.62e-01 
Score (logrank) test p = 1.42e-01 

T cell CD8+_EPIC in THCA (n=509):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
506 patients with 16 dying ( 3 missing obs. )
                     coef        HR se(coef) 95%CI_l      95%CI_u     z     p
`T cell CD8+_EPIC` 10.688 43815.672    8.148   0.005 3.780038e+11 1.312 0.190
Age                 0.157     1.170    0.029   1.105 1.239000e+00 5.372 0.000
Stage2              0.072     1.075    1.022   0.145 7.967000e+00 0.071 0.943
Stage3              0.398     1.489    0.824   0.296 7.485000e+00 0.483 0.629
Stage4              1.135     3.110    0.878   0.556 1.739500e+01 1.292 0.196
                   signif
`T cell CD8+_EPIC`       
Age                   ***
Stage2                   
Stage3                   
Stage4                   
Rsquare = 0.111 (max possible = 2.9e-01 )
Likelihood ratio test p = 1.45e-11 
Wald test p = 1.3e-05 
Score (logrank) test p = 1.85e-11 

T cell CD8+_EPIC in THYM (n=120):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age 
119 patients with 9 dying ( 1 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -5.086 0.006    2.508   0.000   0.844 -2.028 0.043      *
Age                 0.012 1.012    0.033   0.949   1.079  0.376 0.707       
Rsquare = 0.085 (max possible = 4.39e-01 )
Likelihood ratio test p = 4.96e-03 
Wald test p = 4.31e-02 
Score (logrank) test p = 9.85e-03 

T cell CD8+_EPIC in UCEC (n=545):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age 
173 patients with 32 dying ( 372 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_EPIC` -36.835 0.000   17.597   0.000   0.096 -2.093 0.036      *
Age                  0.021 1.021    0.017   0.988   1.056  1.235 0.217       
Rsquare = 0.037 (max possible = 7.9e-01 )
Likelihood ratio test p = 3.89e-02 
Wald test p = 6.37e-02 
Score (logrank) test p = 6.48e-02 

T cell CD8+_EPIC in UCS (n=57):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age 
55 patients with 34 dying ( 2 missing obs. )
                      coef    HR se(coef) 95%CI_l     95%CI_u      z     p
`T cell CD8+_EPIC` -11.526 0.000   15.115   0.000 7.25478e+07 -0.763 0.446
Age                  0.047 1.048    0.022   1.003 1.09500e+00  2.075 0.038
                   signif
`T cell CD8+_EPIC`       
Age                     *
Rsquare = 0.081 (max possible = 9.83e-01 )
Likelihood ratio test p = 9.77e-02 
Wald test p = 9.43e-02 
Score (logrank) test p = 9.06e-02 

T cell CD8+_EPIC in UVM (n=80):
Model: Surv(OS, EVENT) ~ `T cell CD8+_EPIC` + Age + Stage 
79 patients with 22 dying ( 1 missing obs. )
                     coef           HR se(coef) 95%CI_l      95%CI_u     z
`T cell CD8+_EPIC` 34.153 6.800045e+14   23.013   0.000 2.638274e+34 1.484
Age                 0.039 1.040000e+00    0.019   1.002 1.079000e+00 2.074
Stage3              0.115 1.122000e+00    0.477   0.441 2.856000e+00 0.241
Stage4              3.900 4.941200e+01    1.200   4.700 5.194990e+02 3.249
                       p signif
`T cell CD8+_EPIC` 0.138       
Age                0.038      *
Stage3             0.809       
Stage4             0.001     **
Rsquare = 0.229 (max possible = 8.67e-01 )
Likelihood ratio test p = 3.88e-04 
Wald test p = 9.81e-04 
Score (logrank) test p = 2.78e-10 

T cell CD8+_MCPCOUNTER in ACC (n=79):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age 
79 patients with 28 dying ( 0 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_MCPCOUNTER` 0.006 1.006    0.007   0.992   1.021 0.850 0.396
Age                      0.010 1.010    0.013   0.986   1.035 0.813 0.416
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                            
Rsquare = 0.017 (max possible = 9.35e-01 )
Likelihood ratio test p = 4.98e-01 
Wald test p = 4.71e-01 
Score (logrank) test p = 4.63e-01 

T cell CD8+_MCPCOUNTER in BLCA (n=408):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
401 patients with 176 dying ( 7 missing obs. )
                           coef          HR se(coef) 95%CI_l 95%CI_u     z
`T cell CD8+_MCPCOUNTER`  0.000       1.000    0.000   1.000   1.001 0.990
Age                       0.030       1.031    0.008   1.015   1.047 3.829
Stage2                   14.561 2107807.815 1911.881   0.000     Inf 0.008
Stage3                   14.987 3227262.878 1911.881   0.000     Inf 0.008
Stage4                   15.551 5673753.451 1911.881   0.000     Inf 0.008
                             p signif
`T cell CD8+_MCPCOUNTER` 0.322       
Age                      0.000    ***
Stage2                   0.994       
Stage3                   0.994       
Stage4                   0.994       
Rsquare = 0.114 (max possible = 9.91e-01 )
Likelihood ratio test p = 2.61e-09 
Wald test p = 1.85e-08 
Score (logrank) test p = 3.45e-09 

T cell CD8+_MCPCOUNTER in BRCA (n=1100):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
1057 patients with 143 dying ( 43 missing obs. )
                           coef     HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.002  0.998    0.001   0.996   1.001 -1.358 0.174
Age                       0.033  1.034    0.007   1.020   1.048  4.779 0.000
Stage2                    0.566  1.761    0.279   1.019   3.043  2.027 0.043
Stage3                    1.238  3.448    0.294   1.937   6.138  4.207 0.000
Stage4                    2.402 11.045    0.361   5.438  22.430  6.645 0.000
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                         ***
Stage2                        *
Stage3                      ***
Stage4                      ***
Rsquare = 0.069 (max possible = 7.87e-01 )
Likelihood ratio test p = 7.74e-15 
Wald test p = 9.17e-18 
Score (logrank) test p = 8e-23 

T cell CD8+_MCPCOUNTER in BRCA-Basal (n=191):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
185 patients with 26 dying ( 6 missing obs. )
                           coef           HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+_MCPCOUNTER` -0.001 9.990000e-01    0.002   0.996   1.002 -0.826
Age                       0.010 1.011000e+00    0.016   0.979   1.044  0.640
Stage2                   18.940 1.681665e+08 6254.288   0.000     Inf  0.003
Stage3                   20.362 6.964797e+08 6254.288   0.000     Inf  0.003
Stage4                   21.661 2.553511e+09 6254.288   0.000     Inf  0.003
                             p signif
`T cell CD8+_MCPCOUNTER` 0.409       
Age                      0.522       
Stage2                   0.998       
Stage3                   0.997       
Stage4                   0.997       
Rsquare = 0.136 (max possible = 7.08e-01 )
Likelihood ratio test p = 5.87e-05 
Wald test p = 1.66e-03 
Score (logrank) test p = 4.34e-07 

T cell CD8+_MCPCOUNTER in BRCA-Her2 (n=82):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
75 patients with 16 dying ( 7 missing obs. )
                           coef     HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER`  0.001  1.001    0.006   0.990   1.013  0.183 0.855
Age                       0.083  1.086    0.028   1.028   1.148  2.964 0.003
Stage2                   -0.731  0.482    1.178   0.048   4.842 -0.620 0.535
Stage3                    0.624  1.866    1.161   0.192  18.163  0.537 0.591
Stage4                    3.346 28.381    1.310   2.176 370.147  2.553 0.011
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                          **
Stage2                         
Stage3                         
Stage4                        *
Rsquare = 0.286 (max possible = 7.59e-01 )
Likelihood ratio test p = 1.21e-04 
Wald test p = 4.71e-04 
Score (logrank) test p = 1.09e-07 

T cell CD8+_MCPCOUNTER in BRCA-LumA (n=568):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
547 patients with 62 dying ( 21 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.002 0.998    0.002   0.993   1.002 -0.970 0.332
Age                       0.045 1.046    0.011   1.024   1.069  4.092 0.000
Stage2                    0.482 1.619    0.360   0.799   3.277  1.338 0.181
Stage3                    0.962 2.616    0.400   1.195   5.725  2.406 0.016
Stage4                    2.006 7.431    0.544   2.556  21.603  3.684 0.000
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                         ***
Stage2                         
Stage3                        *
Stage4                      ***
Rsquare = 0.054 (max possible = 6.7e-01 )
Likelihood ratio test p = 1.3e-05 
Wald test p = 3.64e-06 
Score (logrank) test p = 2.73e-07 

T cell CD8+_MCPCOUNTER in BRCA-LumB (n=219):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
211 patients with 32 dying ( 8 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.007 0.993    0.005   0.984   1.002 -1.614 0.107
Age                       0.030 1.031    0.016   1.000   1.063  1.949 0.051
Stage2                    0.636 1.890    0.766   0.421   8.475  0.831 0.406
Stage3                    1.258 3.519    0.775   0.771  16.072  1.624 0.104
Stage4                    1.893 6.642    0.896   1.147  38.449  2.113 0.035
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                           ·
Stage2                         
Stage3                         
Stage4                        *
Rsquare = 0.075 (max possible = 7e-01 )
Likelihood ratio test p = 5.52e-03 
Wald test p = 1.1e-02 
Score (logrank) test p = 4.92e-03 

T cell CD8+_MCPCOUNTER in CESC (n=306):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age 
293 patients with 73 dying ( 13 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.001 0.999    0.001   0.997   1.000 -1.417 0.157
Age                       0.015 1.015    0.009   0.998   1.032  1.724 0.085
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                           ·
Rsquare = 0.021 (max possible = 9.11e-01 )
Likelihood ratio test p = 4.44e-02 
Wald test p = 7.84e-02 
Score (logrank) test p = 8.33e-02 

T cell CD8+_MCPCOUNTER in CHOL (n=36):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
36 patients with 18 dying ( 0 missing obs. )
                            coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER`   0.010 1.010    0.005   1.000   1.021  2.029 0.042
Age                        0.018 1.019    0.019   0.980   1.058  0.947 0.344
Stage2                     1.092 2.982    0.631   0.865  10.274  1.731 0.083
Stage3                   -19.256 0.000 6946.019   0.000     Inf -0.003 0.998
Stage4                     1.191 3.290    0.640   0.938  11.545  1.860 0.063
                         signif
`T cell CD8+_MCPCOUNTER`      *
Age                            
Stage2                        ·
Stage3                         
Stage4                        ·
Rsquare = 0.213 (max possible = 9.46e-01 )
Likelihood ratio test p = 1.25e-01 
Wald test p = 4.92e-01 
Score (logrank) test p = 1.24e-01 

T cell CD8+_MCPCOUNTER in COAD (n=458):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
267 patients with 62 dying ( 191 missing obs. )
                          coef     HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_MCPCOUNTER` 0.001  1.001    0.002   0.998   1.004 0.660 0.509
Age                      0.037  1.037    0.012   1.014   1.061 3.154 0.002
Stage2                   0.733  2.082    0.625   0.612   7.080 1.174 0.240
Stage3                   1.348  3.848    0.622   1.138  13.016 2.168 0.030
Stage4                   2.530 12.548    0.631   3.644  43.211 4.009 0.000
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                          **
Stage2                         
Stage3                        *
Stage4                      ***
Rsquare = 0.124 (max possible = 8.92e-01 )
Likelihood ratio test p = 1.24e-06 
Wald test p = 1.18e-06 
Score (logrank) test p = 8.46e-08 

T cell CD8+_MCPCOUNTER in DLBC (n=48):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age 
47 patients with 9 dying ( 1 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.003 0.997    0.002   0.994   1.001 -1.281 0.200
Age                      -0.012 0.988    0.025   0.941   1.038 -0.484 0.629
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                            
Rsquare = 0.052 (max possible = 6.72e-01 )
Likelihood ratio test p = 2.84e-01 
Wald test p = 4.08e-01 
Score (logrank) test p = 4.1e-01 

T cell CD8+_MCPCOUNTER in ESCA (n=185):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
160 patients with 63 dying ( 25 missing obs. )
                          coef     HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` 0.000  1.000    0.003   0.994   1.005 -0.154 0.878
Age                      0.005  1.005    0.011   0.984   1.027  0.451 0.652
Stage2                   0.786  2.195    0.555   0.739   6.518  1.416 0.157
Stage3                   1.723  5.601    0.570   1.832  17.124  3.022 0.003
Stage4                   2.483 11.983    0.645   3.385  42.422  3.850 0.000
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                            
Stage2                         
Stage3                       **
Stage4                      ***
Rsquare = 0.145 (max possible = 9.61e-01 )
Likelihood ratio test p = 1.36e-04 
Wald test p = 1.45e-04 
Score (logrank) test p = 2.03e-05 

T cell CD8+_MCPCOUNTER in GBM (n=153):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age 
150 patients with 120 dying ( 3 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u     z    p signif
`T cell CD8+_MCPCOUNTER` 0.009 1.009    0.005   1.000   1.018 1.880 0.06      ·
Age                      0.029 1.029    0.008   1.014   1.045 3.765 0.00    ***
Rsquare = 0.115 (max possible = 9.98e-01 )
Likelihood ratio test p = 1.08e-04 
Wald test p = 1.8e-04 
Score (logrank) test p = 1.54e-04 

T cell CD8+_MCPCOUNTER in HNSC (n=522):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
446 patients with 191 dying ( 76 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.003 0.997    0.001   0.995   1.000 -2.100 0.036
Age                       0.023 1.023    0.007   1.009   1.037  3.217 0.001
Stage2                    0.761 2.140    0.538   0.745   6.146  1.414 0.157
Stage3                    0.877 2.403    0.535   0.842   6.859  1.638 0.101
Stage4                    1.375 3.955    0.508   1.461  10.706  2.706 0.007
                         signif
`T cell CD8+_MCPCOUNTER`      *
Age                          **
Stage2                         
Stage3                         
Stage4                       **
Rsquare = 0.075 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.67e-06 
Wald test p = 1.79e-05 
Score (logrank) test p = 1.27e-05 

T cell CD8+_MCPCOUNTER in HNSC-HPV+ (n=98):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
67 patients with 24 dying ( 31 missing obs. )
                           coef           HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+_MCPCOUNTER` -0.014        0.986    0.005   0.976   0.996 -2.843
Age                      -0.019        0.982    0.022   0.941   1.024 -0.851
Stage2                   17.085 26287544.180 5499.406   0.000     Inf  0.003
Stage3                   17.562 42375907.188 5499.406   0.000     Inf  0.003
Stage4                   17.347 34163919.260 5499.406   0.000     Inf  0.003
                             p signif
`T cell CD8+_MCPCOUNTER` 0.004     **
Age                      0.395       
Stage2                   0.998       
Stage3                   0.997       
Stage4                   0.997       
Rsquare = 0.26 (max possible = 9.24e-01 )
Likelihood ratio test p = 1.18e-03 
Wald test p = 9.76e-01 
Score (logrank) test p = 6.41e-02 

T cell CD8+_MCPCOUNTER in HNSC-HPV- (n=422):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
379 patients with 167 dying ( 43 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.001 0.999    0.001   0.997   1.002 -0.435 0.664
Age                       0.027 1.027    0.008   1.012   1.043  3.488 0.000
Stage2                    0.505 1.657    0.546   0.569   4.826  0.925 0.355
Stage3                    0.720 2.054    0.538   0.716   5.894  1.338 0.181
Stage4                    1.247 3.481    0.509   1.283   9.442  2.450 0.014
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                         ***
Stage2                         
Stage3                         
Stage4                        *
Rsquare = 0.075 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.94e-05 
Wald test p = 9.16e-05 
Score (logrank) test p = 6.44e-05 

T cell CD8+_MCPCOUNTER in KICH (n=66):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
65 patients with 9 dying ( 1 missing obs. )
                           coef           HR se(coef)      95%CI_l      95%CI_u
`T cell CD8+_MCPCOUNTER` -0.017 9.830000e-01    0.062        0.871 1.110000e+00
Age                       0.040 1.041000e+00    0.028        0.984 1.100000e+00
Stage2                   15.697 6.563083e+06    0.846  1250274.671 3.445168e+07
Stage3                   16.626 1.661653e+07    0.778  3613952.625 7.640089e+07
Stage4                   19.442 2.777841e+08    0.896 47951299.997 1.609216e+09
                              z     p signif
`T cell CD8+_MCPCOUNTER` -0.271 0.786       
Age                       1.408 0.159       
Stage2                   18.555 0.000    ***
Stage3                   21.360 0.000    ***
Stage4                   21.693 0.000    ***
Rsquare = 0.323 (max possible = 6.61e-01 )
Likelihood ratio test p = 1.2e-04 
Wald test p = 4.23e-273 
Score (logrank) test p = 5.41e-11 

T cell CD8+_MCPCOUNTER in KIRC (n=533):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
526 patients with 172 dying ( 7 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` 0.000 1.000    0.000   0.999   1.001 -0.153 0.878
Age                      0.034 1.034    0.007   1.019   1.049  4.542 0.000
Stage2                   0.294 1.341    0.319   0.718   2.504  0.922 0.357
Stage3                   0.950 2.585    0.211   1.710   3.907  4.507 0.000
Stage4                   1.954 7.056    0.199   4.781  10.414  9.837 0.000
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                         ***
Stage2                         
Stage3                      ***
Stage4                      ***
Rsquare = 0.208 (max possible = 9.75e-01 )
Likelihood ratio test p = 8.06e-25 
Wald test p = 1.79e-24 
Score (logrank) test p = 1.7e-30 

T cell CD8+_MCPCOUNTER in KIRP (n=290):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
255 patients with 39 dying ( 35 missing obs. )
                           coef     HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER`  0.000  1.000    0.001   0.999   1.002  0.471 0.638
Age                       0.006  1.006    0.014   0.978   1.034  0.427 0.670
Stage2                   -0.037  0.964    0.784   0.207   4.477 -0.047 0.962
Stage3                    1.553  4.725    0.383   2.232  10.001  4.059 0.000
Stage4                    2.793 16.333    0.449   6.771  39.401  6.217 0.000
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                            
Stage2                         
Stage3                      ***
Stage4                      ***
Rsquare = 0.141 (max possible = 7.61e-01 )
Likelihood ratio test p = 2.61e-07 
Wald test p = 3.36e-08 
Score (logrank) test p = 7.11e-13 

T cell CD8+_MCPCOUNTER in LGG (n=516):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age 
511 patients with 125 dying ( 5 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u     z p signif
`T cell CD8+_MCPCOUNTER` 0.038 1.039    0.009   1.020   1.058 4.082 0    ***
Age                      0.056 1.057    0.007   1.042   1.073 7.495 0    ***
Rsquare = 0.132 (max possible = 9.13e-01 )
Likelihood ratio test p = 2.17e-16 
Wald test p = 4.2e-18 
Score (logrank) test p = 1.46e-19 

T cell CD8+_MCPCOUNTER in LIHC (n=371):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
340 patients with 116 dying ( 31 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_MCPCOUNTER` 0.000 1.000    0.002   0.996   1.004 0.052 0.958
Age                      0.012 1.012    0.007   0.997   1.027 1.607 0.108
Stage2                   0.319 1.375    0.251   0.841   2.249 1.270 0.204
Stage3                   0.993 2.698    0.215   1.769   4.116 4.607 0.000
Stage4                   1.687 5.406    0.600   1.666  17.538 2.810 0.005
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                            
Stage2                         
Stage3                      ***
Stage4                       **
Rsquare = 0.075 (max possible = 9.69e-01 )
Likelihood ratio test p = 7.32e-05 
Wald test p = 3.1e-05 
Score (logrank) test p = 1.01e-05 

T cell CD8+_MCPCOUNTER in LUAD (n=515):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
484 patients with 177 dying ( 31 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.002 0.998    0.001   0.996   1.000 -1.522 0.128
Age                       0.009 1.009    0.008   0.993   1.024  1.097 0.273
Stage2                    0.817 2.263    0.187   1.568   3.267  4.360 0.000
Stage3                    1.165 3.206    0.197   2.181   4.714  5.924 0.000
Stage4                    1.266 3.547    0.283   2.037   6.174  4.476 0.000
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                            
Stage2                      ***
Stage3                      ***
Stage4                      ***
Rsquare = 0.1 (max possible = 9.79e-01 )
Likelihood ratio test p = 8.15e-10 
Wald test p = 1.09e-09 
Score (logrank) test p = 1.24e-10 

T cell CD8+_MCPCOUNTER in LUSC (n=501):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
484 patients with 209 dying ( 17 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_MCPCOUNTER` 0.000 1.000    0.000   1.000   1.000 0.424 0.672
Age                      0.018 1.018    0.009   1.001   1.036 2.086 0.037
Stage2                   0.163 1.177    0.164   0.853   1.623 0.991 0.322
Stage3                   0.469 1.598    0.184   1.115   2.290 2.551 0.011
Stage4                   1.156 3.177    0.471   1.263   7.991 2.456 0.014
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                           *
Stage2                         
Stage3                        *
Stage4                        *
Rsquare = 0.028 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.77e-02 
Wald test p = 1.04e-02 
Score (logrank) test p = 7.79e-03 

T cell CD8+_MCPCOUNTER in MESO (n=87):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
86 patients with 73 dying ( 1 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER`  0.000 1.000    0.001   0.999   1.001 -0.010 0.992
Age                       0.019 1.019    0.015   0.990   1.050  1.283 0.199
Stage2                   -0.404 0.668    0.448   0.278   1.606 -0.901 0.367
Stage3                   -0.236 0.790    0.383   0.373   1.673 -0.616 0.538
Stage4                   -0.302 0.739    0.444   0.310   1.766 -0.679 0.497
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                            
Stage2                         
Stage3                         
Stage4                         
Rsquare = 0.032 (max possible = 9.98e-01 )
Likelihood ratio test p = 7.32e-01 
Wald test p = 7.23e-01 
Score (logrank) test p = 7.22e-01 

T cell CD8+_MCPCOUNTER in OV (n=303):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age 
302 patients with 183 dying ( 1 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_MCPCOUNTER` 0.001 1.001    0.001   0.999   1.002 1.101 0.271
Age                      0.030 1.031    0.007   1.016   1.045 4.083 0.000
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                         ***
Rsquare = 0.055 (max possible = 9.97e-01 )
Likelihood ratio test p = 2.02e-04 
Wald test p = 1.85e-04 
Score (logrank) test p = 1.7e-04 

T cell CD8+_MCPCOUNTER in PAAD (n=179):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
175 patients with 93 dying ( 4 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.002 0.998    0.003   0.993   1.003 -0.942 0.346
Age                       0.024 1.024    0.010   1.003   1.045  2.258 0.024
Stage2                    0.780 2.181    0.398   0.999   4.761  1.957 0.050
Stage3                    0.156 1.169    1.078   0.141   9.672  0.145 0.885
Stage4                    0.300 1.350    0.810   0.276   6.609  0.371 0.711
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                           *
Stage2                        ·
Stage3                         
Stage4                         
Rsquare = 0.07 (max possible = 9.91e-01 )
Likelihood ratio test p = 2.62e-02 
Wald test p = 4.79e-02 
Score (logrank) test p = 4.2e-02 

T cell CD8+_MCPCOUNTER in PCPG (n=181):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age 
181 patients with 7 dying ( 0 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.005 0.995    0.024   0.949   1.043 -0.214 0.831
Age                       0.023 1.024    0.024   0.976   1.073  0.972 0.331
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                            
Rsquare = 0.005 (max possible = 2.89e-01 )
Likelihood ratio test p = 6.13e-01 
Wald test p = 6.16e-01 
Score (logrank) test p = 6.1e-01 

T cell CD8+_MCPCOUNTER in PRAD (n=498):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age 
496 patients with 10 dying ( 2 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.005 0.995    0.015   0.966   1.024 -0.359 0.719
Age                       0.051 1.052    0.050   0.954   1.160  1.017 0.309
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                            
Rsquare = 0.003 (max possible = 1.68e-01 )
Likelihood ratio test p = 5.32e-01 
Wald test p = 5.42e-01 
Score (logrank) test p = 5.38e-01 

T cell CD8+_MCPCOUNTER in READ (n=166):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
82 patients with 14 dying ( 84 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.031 0.969    0.015   0.942   0.997 -2.139 0.032
Age                       0.141 1.151    0.047   1.050   1.263  2.984 0.003
Stage2                   -1.336 0.263    1.258   0.022   3.095 -1.062 0.288
Stage3                    0.578 1.783    0.823   0.356   8.939  0.703 0.482
Stage4                    0.397 1.487    0.946   0.233   9.490  0.420 0.675
                         signif
`T cell CD8+_MCPCOUNTER`      *
Age                          **
Stage2                         
Stage3                         
Stage4                         
Rsquare = 0.294 (max possible = 7.04e-01 )
Likelihood ratio test p = 2.86e-05 
Wald test p = 9.47e-03 
Score (logrank) test p = 1.08e-04 

T cell CD8+_MCPCOUNTER in SARC (n=260):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age 
257 patients with 99 dying ( 3 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.002 0.998    0.001   0.996   1.000 -1.486 0.137
Age                       0.023 1.023    0.008   1.007   1.039  2.858 0.004
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                          **
Rsquare = 0.04 (max possible = 9.77e-01 )
Likelihood ratio test p = 5.37e-03 
Wald test p = 7.61e-03 
Score (logrank) test p = 7.44e-03 

T cell CD8+_MCPCOUNTER in SKCM (n=471):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
407 patients with 192 dying ( 64 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.002 0.998    0.001   0.997   0.999 -3.196 0.001
Age                       0.019 1.019    0.005   1.009   1.029  3.631 0.000
Stage2                    0.189 1.208    0.216   0.791   1.847  0.875 0.381
Stage3                    0.594 1.811    0.200   1.224   2.680  2.973 0.003
Stage4                    1.209 3.349    0.349   1.691   6.634  3.467 0.001
                         signif
`T cell CD8+_MCPCOUNTER`     **
Age                         ***
Stage2                         
Stage3                       **
Stage4                       **
Rsquare = 0.112 (max possible = 9.92e-01 )
Likelihood ratio test p = 2.95e-09 
Wald test p = 4.31e-08 
Score (logrank) test p = 1.52e-08 

T cell CD8+_MCPCOUNTER in SKCM-Primary (n=103):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
95 patients with 26 dying ( 8 missing obs. )
                           coef           HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+_MCPCOUNTER` -0.001 9.990000e-01    0.002   0.994   1.004 -0.382
Age                       0.006 1.006000e+00    0.014   0.978   1.035  0.397
Stage2                   17.425 3.695181e+07 6205.493   0.000     Inf  0.003
Stage3                   18.075 7.080703e+07 6205.493   0.000     Inf  0.003
Stage4                   19.774 3.871789e+08 6205.493   0.000     Inf  0.003
                             p signif
`T cell CD8+_MCPCOUNTER` 0.702       
Age                      0.691       
Stage2                   0.998       
Stage3                   0.998       
Stage4                   0.997       
Rsquare = 0.112 (max possible = 8.67e-01 )
Likelihood ratio test p = 4.6e-02 
Wald test p = 4.79e-02 
Score (logrank) test p = 3.7e-03 

T cell CD8+_MCPCOUNTER in SKCM-Metastasis (n=368):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
312 patients with 166 dying ( 56 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.002 0.998    0.001   0.997   1.000 -2.899 0.004
Age                       0.021 1.021    0.006   1.010   1.033  3.804 0.000
Stage2                    0.079 1.083    0.227   0.694   1.690  0.350 0.726
Stage3                    0.529 1.698    0.204   1.137   2.534  2.590 0.010
Stage4                    0.977 2.656    0.396   1.223   5.768  2.468 0.014
                         signif
`T cell CD8+_MCPCOUNTER`     **
Age                         ***
Stage2                         
Stage3                        *
Stage4                        *
Rsquare = 0.125 (max possible = 9.95e-01 )
Likelihood ratio test p = 7.13e-08 
Wald test p = 6.71e-07 
Score (logrank) test p = 3.13e-07 

T cell CD8+_MCPCOUNTER in STAD (n=415):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
368 patients with 148 dying ( 47 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_MCPCOUNTER` 0.001 1.001    0.000   1.000   1.002 1.347 0.178
Age                      0.029 1.029    0.009   1.012   1.047 3.372 0.001
Stage2                   0.476 1.610    0.337   0.831   3.118 1.411 0.158
Stage3                   0.958 2.608    0.316   1.403   4.848 3.029 0.002
Stage4                   1.664 5.279    0.369   2.560  10.887 4.505 0.000
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                          **
Stage2                         
Stage3                       **
Stage4                      ***
Rsquare = 0.089 (max possible = 9.85e-01 )
Likelihood ratio test p = 2.12e-06 
Wald test p = 3.68e-06 
Score (logrank) test p = 1.63e-06 

T cell CD8+_MCPCOUNTER in TGCT (n=150):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
81 patients with 2 dying ( 69 missing obs. )
                           coef           HR  se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+_MCPCOUNTER` -0.006 9.940000e-01     0.016   0.963   1.026 -0.369
Age                      -0.204 8.150000e-01     0.177   0.576   1.154 -1.151
Stage2                   18.338 9.208921e+07 34187.362   0.000     Inf  0.001
Stage3                   41.243 8.155478e+17 81115.315   0.000     Inf  0.001
                             p signif
`T cell CD8+_MCPCOUNTER` 0.712       
Age                      0.250       
Stage2                   1.000   <NA>
Stage3                   1.000   <NA>
Rsquare = 0.086 (max possible = 1.32e-01 )
Likelihood ratio test p = 1.23e-01 
Wald test p = 8.57e-01 
Score (logrank) test p = 1.39e-01 

T cell CD8+_MCPCOUNTER in THCA (n=509):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
506 patients with 16 dying ( 3 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` 0.000 1.000    0.005   0.989   1.010 -0.043 0.966
Age                      0.150 1.162    0.028   1.100   1.227  5.387 0.000
Stage2                   0.197 1.218    1.015   0.167   8.902  0.195 0.846
Stage3                   0.232 1.261    0.813   0.256   6.204  0.285 0.776
Stage4                   0.891 2.438    0.854   0.457  13.010  1.043 0.297
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                         ***
Stage2                         
Stage3                         
Stage4                         
Rsquare = 0.109 (max possible = 2.9e-01 )
Likelihood ratio test p = 2.79e-11 
Wald test p = 1.06e-05 
Score (logrank) test p = 1.87e-11 

T cell CD8+_MCPCOUNTER in THYM (n=120):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age 
119 patients with 9 dying ( 1 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` 0.000 1.000    0.000   0.999   1.000 -2.063 0.039
Age                      0.008 1.008    0.033   0.945   1.075  0.248 0.804
                         signif
`T cell CD8+_MCPCOUNTER`      *
Age                            
Rsquare = 0.091 (max possible = 4.39e-01 )
Likelihood ratio test p = 3.53e-03 
Wald test p = 4.84e-02 
Score (logrank) test p = 8.73e-03 

T cell CD8+_MCPCOUNTER in UCEC (n=545):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age 
173 patients with 32 dying ( 372 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.004 0.996    0.003   0.989   1.002 -1.276 0.202
Age                       0.014 1.014    0.017   0.982   1.048  0.856 0.392
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                            
Rsquare = 0.02 (max possible = 7.9e-01 )
Likelihood ratio test p = 1.69e-01 
Wald test p = 2.65e-01 
Score (logrank) test p = 2.55e-01 

T cell CD8+_MCPCOUNTER in UCS (n=57):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age 
55 patients with 34 dying ( 2 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_MCPCOUNTER` -0.003 0.997    0.002   0.992   1.001 -1.576 0.115
Age                       0.044 1.046    0.022   1.001   1.092  2.020 0.043
                         signif
`T cell CD8+_MCPCOUNTER`       
Age                           *
Rsquare = 0.126 (max possible = 9.83e-01 )
Likelihood ratio test p = 2.47e-02 
Wald test p = 3.42e-02 
Score (logrank) test p = 2.94e-02 

T cell CD8+_MCPCOUNTER in UVM (n=80):
Model: Surv(OS, EVENT) ~ `T cell CD8+_MCPCOUNTER` + Age + Stage 
79 patients with 22 dying ( 1 missing obs. )
                          coef     HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_MCPCOUNTER` 0.006  1.006    0.002   1.001   1.011 2.486 0.013
Age                      0.042  1.043    0.020   1.003   1.086 2.100 0.036
Stage3                   0.111  1.117    0.477   0.439   2.845 0.232 0.816
Stage4                   3.848 46.881    1.208   4.390 500.657 3.184 0.001
                         signif
`T cell CD8+_MCPCOUNTER`      *
Age                           *
Stage3                         
Stage4                       **
Rsquare = 0.255 (max possible = 8.67e-01 )
Likelihood ratio test p = 1.14e-04 
Wald test p = 2.22e-04 
Score (logrank) test p = 3.09e-11 

T cell CD8+_QUANTISEQ in ACC (n=79):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age 
79 patients with 28 dying ( 0 missing obs. )
                         coef      HR se(coef) 95%CI_l      95%CI_u     z     p
`T cell CD8+_QUANTISEQ` 6.487 656.615   20.064   0.000 7.866909e+19 0.323 0.746
Age                     0.011   1.011    0.012   0.987 1.036000e+00 0.870 0.385
                        signif
`T cell CD8+_QUANTISEQ`       
Age                           
Rsquare = 0.011 (max possible = 9.35e-01 )
Likelihood ratio test p = 6.44e-01 
Wald test p = 6.45e-01 
Score (logrank) test p = 6.43e-01 

T cell CD8+_QUANTISEQ in BLCA (n=408):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
401 patients with 176 dying ( 7 missing obs. )
                          coef          HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_QUANTISEQ`  0.668       1.950    2.412   0.017 220.275 0.277 0.782
Age                      0.030       1.031    0.008   1.015   1.047 3.829 0.000
Stage2                  14.568 2121459.000 1909.578   0.000     Inf 0.008 0.994
Stage3                  14.997 3259302.217 1909.578   0.000     Inf 0.008 0.994
Stage4                  15.554 5687530.061 1909.578   0.000     Inf 0.008 0.994
                        signif
`T cell CD8+_QUANTISEQ`       
Age                        ***
Stage2                        
Stage3                        
Stage4                        
Rsquare = 0.113 (max possible = 9.91e-01 )
Likelihood ratio test p = 3.69e-09 
Wald test p = 2.23e-08 
Score (logrank) test p = 4.92e-09 

T cell CD8+_QUANTISEQ in BRCA (n=1100):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
1057 patients with 143 dying ( 43 missing obs. )
                          coef     HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -8.434  0.000    4.962   0.000   3.634 -1.700 0.089
Age                      0.033  1.034    0.007   1.020   1.048  4.774 0.000
Stage2                   0.564  1.758    0.279   1.017   3.038  2.021 0.043
Stage3                   1.233  3.432    0.294   1.928   6.107  4.193 0.000
Stage4                   2.402 11.044    0.361   5.439  22.422  6.647 0.000
                        signif
`T cell CD8+_QUANTISEQ`      ·
Age                        ***
Stage2                       *
Stage3                     ***
Stage4                     ***
Rsquare = 0.07 (max possible = 7.87e-01 )
Likelihood ratio test p = 4.14e-15 
Wald test p = 6.45e-18 
Score (logrank) test p = 5.03e-23 

T cell CD8+_QUANTISEQ in BRCA-Basal (n=191):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
185 patients with 26 dying ( 6 missing obs. )
                          coef           HR se(coef) 95%CI_l  95%CI_u      z
`T cell CD8+_QUANTISEQ` -9.474 0.000000e+00    8.366   0.000 1015.199 -1.132
Age                      0.010 1.010000e+00    0.016   0.978    1.043  0.626
Stage2                  18.918 1.645088e+08 6258.555   0.000      Inf  0.003
Stage3                  20.331 6.753926e+08 6258.555   0.000      Inf  0.003
Stage4                  21.750 2.792814e+09 6258.555   0.000      Inf  0.003
                            p signif
`T cell CD8+_QUANTISEQ` 0.257       
Age                     0.532       
Stage2                  0.998       
Stage3                  0.997       
Stage4                  0.997       
Rsquare = 0.14 (max possible = 7.08e-01 )
Likelihood ratio test p = 3.72e-05 
Wald test p = 1.12e-03 
Score (logrank) test p = 2.42e-07 

T cell CD8+_QUANTISEQ in BRCA-Her2 (n=82):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
75 patients with 16 dying ( 7 missing obs. )
                          coef     HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+_QUANTISEQ`  0.811  2.249   22.412   0.000 2.687365e+19  0.036
Age                      0.082  1.086    0.028   1.027 1.147000e+00  2.916
Stage2                  -0.767  0.465    1.160   0.048 4.509000e+00 -0.661
Stage3                   0.596  1.814    1.149   0.191 1.723900e+01  0.519
Stage4                   3.278 26.526    1.281   2.154 3.266880e+02  2.559
                            p signif
`T cell CD8+_QUANTISEQ` 0.971       
Age                     0.004     **
Stage2                  0.509       
Stage3                  0.604       
Stage4                  0.011      *
Rsquare = 0.286 (max possible = 7.59e-01 )
Likelihood ratio test p = 1.23e-04 
Wald test p = 4.58e-04 
Score (logrank) test p = 1.05e-07 

T cell CD8+_QUANTISEQ in BRCA-LumA (n=568):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
547 patients with 62 dying ( 21 missing obs. )
                          coef    HR se(coef) 95%CI_l    95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -4.154 0.016    8.226   0.000 157561.192 -0.505 0.614
Age                      0.045 1.046    0.011   1.023      1.068  4.066 0.000
Stage2                   0.475 1.608    0.360   0.795      3.254  1.321 0.187
Stage3                   0.915 2.496    0.395   1.150      5.418  2.313 0.021
Stage4                   2.012 7.479    0.544   2.573     21.744  3.695 0.000
                        signif
`T cell CD8+_QUANTISEQ`       
Age                        ***
Stage2                        
Stage3                       *
Stage4                     ***
Rsquare = 0.052 (max possible = 6.7e-01 )
Likelihood ratio test p = 1.94e-05 
Wald test p = 4.45e-06 
Score (logrank) test p = 3.43e-07 

T cell CD8+_QUANTISEQ in BRCA-LumB (n=219):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
211 patients with 32 dying ( 8 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -18.418 0.000   12.732   0.000 690.248 -1.447 0.148
Age                       0.031 1.032    0.016   1.001   1.064  1.996 0.046
Stage2                    0.694 2.001    0.768   0.445   9.006  0.904 0.366
Stage3                    1.269 3.557    0.776   0.777  16.292  1.634 0.102
Stage4                    1.970 7.170    0.895   1.240  41.468  2.200 0.028
                        signif
`T cell CD8+_QUANTISEQ`       
Age                          *
Stage2                        
Stage3                        
Stage4                       *
Rsquare = 0.072 (max possible = 7e-01 )
Likelihood ratio test p = 7.87e-03 
Wald test p = 1.2e-02 
Score (logrank) test p = 4.71e-03 

T cell CD8+_QUANTISEQ in CESC (n=306):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age 
293 patients with 73 dying ( 13 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -12.096 0.000    5.353   0.000   0.201 -2.260 0.024
Age                       0.015 1.015    0.009   0.998   1.032  1.736 0.083
                        signif
`T cell CD8+_QUANTISEQ`      *
Age                          ·
Rsquare = 0.037 (max possible = 9.11e-01 )
Likelihood ratio test p = 3.82e-03 
Wald test p = 1.74e-02 
Score (logrank) test p = 1.78e-02 

T cell CD8+_QUANTISEQ in CHOL (n=36):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
36 patients with 18 dying ( 0 missing obs. )
                           coef           HR se(coef) 95%CI_l      95%CI_u
`T cell CD8+_QUANTISEQ`  28.375 2.105157e+12   16.635   0.015 3.038624e+26
Age                       0.022 1.022000e+00    0.019   0.984 1.062000e+00
Stage2                    0.995 2.706000e+00    0.619   0.804 9.104000e+00
Stage3                  -17.583 0.000000e+00 6804.614   0.000          Inf
Stage4                    1.207 3.344000e+00    0.651   0.934 1.197400e+01
                             z     p signif
`T cell CD8+_QUANTISEQ`  1.706 0.088      ·
Age                      1.136 0.256       
Stage2                   1.608 0.108       
Stage3                  -0.003 0.998       
Stage4                   1.855 0.064      ·
Rsquare = 0.189 (max possible = 9.46e-01 )
Likelihood ratio test p = 1.83e-01 
Wald test p = 3.24e-01 
Score (logrank) test p = 2.01e-01 

T cell CD8+_QUANTISEQ in COAD (n=458):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
267 patients with 62 dying ( 191 missing obs. )
                         coef       HR se(coef) 95%CI_l      95%CI_u     z
`T cell CD8+_QUANTISEQ` 7.950 2834.579    8.978   0.000 1.242398e+11 0.885
Age                     0.036    1.036    0.012   1.013 1.060000e+00 3.043
Stage2                  0.745    2.107    0.625   0.619 7.167000e+00 1.193
Stage3                  1.351    3.860    0.622   1.142 1.304900e+01 2.173
Stage4                  2.556   12.884    0.633   3.727 4.454500e+01 4.039
                            p signif
`T cell CD8+_QUANTISEQ` 0.376       
Age                     0.002     **
Stage2                  0.233       
Stage3                  0.030      *
Stage4                  0.000    ***
Rsquare = 0.125 (max possible = 8.92e-01 )
Likelihood ratio test p = 1.08e-06 
Wald test p = 1.09e-06 
Score (logrank) test p = 7.66e-08 

T cell CD8+_QUANTISEQ in DLBC (n=48):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age 
47 patients with 9 dying ( 1 missing obs. )
                          coef    HR se(coef) 95%CI_l   95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -5.465 0.004    8.015   0.000 28102.058 -0.682 0.495
Age                     -0.014 0.986    0.026   0.937     1.037 -0.547 0.584
                        signif
`T cell CD8+_QUANTISEQ`       
Age                           
Rsquare = 0.015 (max possible = 6.72e-01 )
Likelihood ratio test p = 6.99e-01 
Wald test p = 7.16e-01 
Score (logrank) test p = 7.13e-01 

T cell CD8+_QUANTISEQ in ESCA (n=185):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
160 patients with 63 dying ( 25 missing obs. )
                          coef     HR se(coef) 95%CI_l     95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -3.489  0.031    8.903   0.000 1154851.604 -0.392 0.695
Age                      0.005  1.005    0.011   0.984       1.027  0.472 0.637
Stage2                   0.802  2.229    0.556   0.750       6.630  1.442 0.149
Stage3                   1.746  5.733    0.572   1.869      17.581  3.054 0.002
Stage4                   2.490 12.061    0.645   3.404      42.738  3.857 0.000
                        signif
`T cell CD8+_QUANTISEQ`       
Age                           
Stage2                        
Stage3                      **
Stage4                     ***
Rsquare = 0.146 (max possible = 9.61e-01 )
Likelihood ratio test p = 1.28e-04 
Wald test p = 1.36e-04 
Score (logrank) test p = 1.87e-05 

T cell CD8+_QUANTISEQ in GBM (n=153):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age 
150 patients with 120 dying ( 3 missing obs. )
                         coef       HR se(coef) 95%CI_l      95%CI_u     z    p
`T cell CD8+_QUANTISEQ` 7.128 1246.423   23.324   0.000 8.891117e+22 0.306 0.76
Age                     0.029    1.029    0.008   1.014 1.044000e+00 3.776 0.00
                        signif
`T cell CD8+_QUANTISEQ`       
Age                        ***
Rsquare = 0.099 (max possible = 9.98e-01 )
Likelihood ratio test p = 4e-04 
Wald test p = 7.94e-04 
Score (logrank) test p = 7.48e-04 

T cell CD8+_QUANTISEQ in HNSC (n=522):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
446 patients with 191 dying ( 76 missing obs. )
                           coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -10.846 0.000    5.048   0.000   0.386 -2.149 0.032
Age                       0.023 1.023    0.007   1.009   1.037  3.280 0.001
Stage2                    0.771 2.162    0.538   0.753   6.208  1.432 0.152
Stage3                    0.868 2.381    0.535   0.834   6.798  1.621 0.105
Stage4                    1.364 3.914    0.508   1.446  10.594  2.686 0.007
                        signif
`T cell CD8+_QUANTISEQ`      *
Age                         **
Stage2                        
Stage3                        
Stage4                      **
Rsquare = 0.075 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.68e-06 
Wald test p = 1.53e-05 
Score (logrank) test p = 1.06e-05 

T cell CD8+_QUANTISEQ in HNSC-HPV+ (n=98):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
67 patients with 24 dying ( 31 missing obs. )
                           coef           HR se(coef) 95%CI_l 95%CI_u      z
`T cell CD8+_QUANTISEQ` -56.668        0.000   19.698   0.000   0.000 -2.877
Age                      -0.021        0.979    0.022   0.938   1.022 -0.951
Stage2                   16.955 23090092.582 5332.118   0.000     Inf  0.003
Stage3                   17.456 38098024.761 5332.118   0.000     Inf  0.003
Stage4                   17.258 31267891.397 5332.118   0.000     Inf  0.003
                            p signif
`T cell CD8+_QUANTISEQ` 0.004     **
Age                     0.342       
Stage2                  0.997       
Stage3                  0.997       
Stage4                  0.997       
Rsquare = 0.261 (max possible = 9.24e-01 )
Likelihood ratio test p = 1.1e-03 
Wald test p = 1.22e-01 
Score (logrank) test p = 4.07e-02 

T cell CD8+_QUANTISEQ in HNSC-HPV- (n=422):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
379 patients with 167 dying ( 43 missing obs. )
                          coef    HR se(coef) 95%CI_l  95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -2.977 0.051    5.470   0.000 2306.659 -0.544 0.586
Age                      0.027 1.027    0.008   1.012    1.043  3.506 0.000
Stage2                   0.507 1.661    0.546   0.570    4.839  0.930 0.352
Stage3                   0.717 2.049    0.538   0.714    5.881  1.334 0.182
Stage4                   1.245 3.472    0.509   1.280    9.416  2.445 0.014
                        signif
`T cell CD8+_QUANTISEQ`       
Age                        ***
Stage2                        
Stage3                        
Stage4                       *
Rsquare = 0.075 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.84e-05 
Wald test p = 8.7e-05 
Score (logrank) test p = 6.15e-05 

T cell CD8+_QUANTISEQ in KICH (n=66):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
65 patients with 9 dying ( 1 missing obs. )
                          coef           HR se(coef)      95%CI_l       95%CI_u
`T cell CD8+_QUANTISEQ` 48.883 1.696798e+21  245.907        0.000 3.517102e+230
Age                      0.043 1.044000e+00    0.028        0.988  1.102000e+00
Stage2                  15.675 6.421802e+06    0.846  1224428.970  3.368063e+07
Stage3                  16.635 1.676249e+07    0.779  3640447.082  7.718308e+07
Stage4                  19.491 2.916468e+08    0.896 50334648.149  1.689846e+09
                             z     p signif
`T cell CD8+_QUANTISEQ`  0.199 0.842       
Age                      1.541 0.123       
Stage2                  18.539 0.000    ***
Stage3                  21.351 0.000    ***
Stage4                  21.744 0.000    ***
Rsquare = 0.322 (max possible = 6.61e-01 )
Likelihood ratio test p = 1.23e-04 
Wald test p = 1.86e-273 
Score (logrank) test p = 6.05e-11 

T cell CD8+_QUANTISEQ in KIRC (n=533):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
526 patients with 172 dying ( 7 missing obs. )
                         coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_QUANTISEQ` 0.507 1.661    1.361   0.115  23.938 0.373 0.709       
Age                     0.034 1.034    0.007   1.019   1.050 4.563 0.000    ***
Stage2                  0.277 1.320    0.318   0.707   2.463 0.872 0.383       
Stage3                  0.936 2.550    0.211   1.687   3.855 4.439 0.000    ***
Stage4                  1.936 6.929    0.200   4.678  10.263 9.658 0.000    ***
Rsquare = 0.208 (max possible = 9.75e-01 )
Likelihood ratio test p = 7.63e-25 
Wald test p = 1.85e-24 
Score (logrank) test p = 1.7e-30 

T cell CD8+_QUANTISEQ in KIRP (n=290):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
255 patients with 39 dying ( 35 missing obs. )
                          coef     HR se(coef) 95%CI_l  95%CI_u      z     p
`T cell CD8+_QUANTISEQ`  2.816 16.706    3.203   0.031 8893.628  0.879 0.379
Age                      0.006  1.006    0.014   0.979    1.035  0.453 0.650
Stage2                  -0.061  0.941    0.777   0.205    4.315 -0.079 0.937
Stage3                   1.557  4.746    0.383   2.240   10.056  4.064 0.000
Stage4                   2.803 16.492    0.450   6.826   39.851  6.227 0.000
                        signif
`T cell CD8+_QUANTISEQ`       
Age                           
Stage2                        
Stage3                     ***
Stage4                     ***
Rsquare = 0.142 (max possible = 7.61e-01 )
Likelihood ratio test p = 2.21e-07 
Wald test p = 3.15e-08 
Score (logrank) test p = 6.11e-13 

T cell CD8+_QUANTISEQ in LGG (n=516):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age 
511 patients with 125 dying ( 5 missing obs. )
                           coef           HR se(coef)      95%CI_l
`T cell CD8+_QUANTISEQ` 292.211 8.04507e+126   76.276 9.536365e+61
Age                       0.054  1.05600e+00    0.007 1.040000e+00
                              95%CI_u     z p signif
`T cell CD8+_QUANTISEQ` 6.786983e+191 3.831 0    ***
Age                      1.071000e+00 7.325 0    ***
Rsquare = 0.126 (max possible = 9.13e-01 )
Likelihood ratio test p = 1.01e-15 
Wald test p = 3.55e-18 
Score (logrank) test p = 3.37e-23 

T cell CD8+_QUANTISEQ in LIHC (n=371):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
340 patients with 116 dying ( 31 missing obs. )
                         coef     HR se(coef) 95%CI_l      95%CI_u     z     p
`T cell CD8+_QUANTISEQ` 3.055 21.217    7.613   0.000 64142938.485 0.401 0.688
Age                     0.012  1.012    0.007   0.997        1.027 1.618 0.106
Stage2                  0.314  1.368    0.251   0.836        2.239 1.248 0.212
Stage3                  0.990  2.691    0.216   1.764        4.106 4.593 0.000
Stage4                  1.697  5.457    0.601   1.681       17.710 2.825 0.005
                        signif
`T cell CD8+_QUANTISEQ`       
Age                           
Stage2                        
Stage3                     ***
Stage4                      **
Rsquare = 0.075 (max possible = 9.69e-01 )
Likelihood ratio test p = 6.85e-05 
Wald test p = 2.92e-05 
Score (logrank) test p = 9.45e-06 

T cell CD8+_QUANTISEQ in LUAD (n=515):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
484 patients with 177 dying ( 31 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -4.811 0.008    3.804   0.000  14.069 -1.265 0.206
Age                      0.009 1.009    0.008   0.994   1.024  1.127 0.260
Stage2                   0.823 2.277    0.187   1.578   3.288  4.393 0.000
Stage3                   1.163 3.198    0.197   2.175   4.703  5.907 0.000
Stage4                   1.275 3.580    0.283   2.057   6.232  4.510 0.000
                        signif
`T cell CD8+_QUANTISEQ`       
Age                           
Stage2                     ***
Stage3                     ***
Stage4                     ***
Rsquare = 0.099 (max possible = 9.79e-01 )
Likelihood ratio test p = 1.22e-09 
Wald test p = 1.61e-09 
Score (logrank) test p = 1.85e-10 

T cell CD8+_QUANTISEQ in LUSC (n=501):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
484 patients with 209 dying ( 17 missing obs. )
                         coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_QUANTISEQ` 0.889 2.433    2.052   0.044 135.897 0.433 0.665       
Age                     0.018 1.018    0.009   1.001   1.036 2.085 0.037      *
Stage2                  0.163 1.177    0.164   0.854   1.624 0.995 0.320       
Stage3                  0.467 1.595    0.184   1.113   2.287 2.541 0.011      *
Stage4                  1.166 3.208    0.466   1.288   7.994 2.503 0.012      *
Rsquare = 0.028 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.76e-02 
Wald test p = 1.04e-02 
Score (logrank) test p = 7.84e-03 

T cell CD8+_QUANTISEQ in MESO (n=87):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
86 patients with 73 dying ( 1 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_QUANTISEQ`  0.058 1.059    2.126   0.016  68.313  0.027 0.978
Age                      0.019 1.019    0.015   0.990   1.050  1.287 0.198
Stage2                  -0.403 0.668    0.448   0.278   1.607 -0.900 0.368
Stage3                  -0.237 0.789    0.383   0.372   1.672 -0.618 0.537
Stage4                  -0.301 0.740    0.444   0.310   1.767 -0.678 0.498
                        signif
`T cell CD8+_QUANTISEQ`       
Age                           
Stage2                        
Stage3                        
Stage4                        
Rsquare = 0.032 (max possible = 9.98e-01 )
Likelihood ratio test p = 7.32e-01 
Wald test p = 7.23e-01 
Score (logrank) test p = 7.22e-01 

T cell CD8+_QUANTISEQ in OV (n=303):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age 
302 patients with 183 dying ( 1 missing obs. )
                         coef    HR se(coef) 95%CI_l   95%CI_u     z p signif
`T cell CD8+_QUANTISEQ` 0.003 1.003    5.079   0.000 21099.867 0.001 1   <NA>
Age                     0.030 1.030    0.007   1.015     1.045 4.033 0    ***
Rsquare = 0.052 (max possible = 9.97e-01 )
Likelihood ratio test p = 3.2e-04 
Wald test p = 2.91e-04 
Score (logrank) test p = 2.67e-04 

T cell CD8+_QUANTISEQ in PAAD (n=179):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
175 patients with 93 dying ( 4 missing obs. )
                          coef    HR se(coef) 95%CI_l   95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -8.016 0.000    9.748   0.000 65464.338 -0.822 0.411
Age                      0.023 1.023    0.010   1.003     1.045  2.209 0.027
Stage2                   0.775 2.170    0.398   0.994     4.736  1.945 0.052
Stage3                   0.143 1.153    1.077   0.140     9.523  0.132 0.895
Stage4                   0.300 1.350    0.811   0.275     6.620  0.370 0.711
                        signif
`T cell CD8+_QUANTISEQ`       
Age                          *
Stage2                       ·
Stage3                        
Stage4                        
Rsquare = 0.069 (max possible = 9.91e-01 )
Likelihood ratio test p = 2.88e-02 
Wald test p = 5.24e-02 
Score (logrank) test p = 4.62e-02 

T cell CD8+_QUANTISEQ in PCPG (n=181):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age 
181 patients with 7 dying ( 0 missing obs. )
                          coef           HR se(coef) 95%CI_l      95%CI_u     z
`T cell CD8+_QUANTISEQ` 19.449 2.794966e+08   49.515   0.000 3.919368e+50 0.393
Age                      0.022 1.022000e+00    0.024   0.975 1.072000e+00 0.898
                            p signif
`T cell CD8+_QUANTISEQ` 0.694       
Age                     0.369       
Rsquare = 0.006 (max possible = 2.89e-01 )
Likelihood ratio test p = 5.97e-01 
Wald test p = 5.77e-01 
Score (logrank) test p = 5.64e-01 

T cell CD8+_QUANTISEQ in PRAD (n=498):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age 
496 patients with 10 dying ( 2 missing obs. )
                          coef    HR se(coef) 95%CI_l      95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -8.142 0.000   47.256   0.000 4.878689e+36 -0.172 0.863
Age                      0.052 1.053    0.050   0.956 1.161000e+00  1.046 0.296
                        signif
`T cell CD8+_QUANTISEQ`       
Age                           
Rsquare = 0.002 (max possible = 1.68e-01 )
Likelihood ratio test p = 5.64e-01 
Wald test p = 5.71e-01 
Score (logrank) test p = 5.67e-01 

T cell CD8+_QUANTISEQ in READ (n=166):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
82 patients with 14 dying ( 84 missing obs. )
                           coef    HR se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+_QUANTISEQ` -36.112 0.000   53.015   0.000 2.775522e+29 -0.681
Age                       0.126 1.134    0.046   1.037 1.240000e+00  2.759
Stage2                   -1.324 0.266    1.244   0.023 3.050000e+00 -1.064
Stage3                    0.282 1.326    0.813   0.269 6.528000e+00  0.347
Stage4                    0.294 1.342    0.927   0.218 8.261000e+00  0.317
                            p signif
`T cell CD8+_QUANTISEQ` 0.496       
Age                     0.006     **
Stage2                  0.287       
Stage3                  0.729       
Stage4                  0.751       
Rsquare = 0.231 (max possible = 7.04e-01 )
Likelihood ratio test p = 6.55e-04 
Wald test p = 3.41e-02 
Score (logrank) test p = 1.26e-03 

T cell CD8+_QUANTISEQ in SARC (n=260):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age 
257 patients with 99 dying ( 3 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -4.511 0.011    3.558   0.000  11.723 -1.268 0.205
Age                      0.022 1.023    0.008   1.007   1.039  2.807 0.005
                        signif
`T cell CD8+_QUANTISEQ`       
Age                         **
Rsquare = 0.037 (max possible = 9.77e-01 )
Likelihood ratio test p = 8.39e-03 
Wald test p = 1.09e-02 
Score (logrank) test p = 1.06e-02 

T cell CD8+_QUANTISEQ in SKCM (n=471):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
407 patients with 192 dying ( 64 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -5.903 0.003    1.685   0.000   0.074 -3.503 0.000
Age                      0.019 1.019    0.005   1.009   1.029  3.649 0.000
Stage2                   0.189 1.208    0.216   0.791   1.846  0.875 0.382
Stage3                   0.599 1.821    0.200   1.231   2.693  3.002 0.003
Stage4                   1.237 3.446    0.349   1.739   6.827  3.547 0.000
                        signif
`T cell CD8+_QUANTISEQ`    ***
Age                        ***
Stage2                        
Stage3                      **
Stage4                     ***
Rsquare = 0.119 (max possible = 9.92e-01 )
Likelihood ratio test p = 6.17e-10 
Wald test p = 1.68e-08 
Score (logrank) test p = 5.85e-09 

T cell CD8+_QUANTISEQ in SKCM-Primary (n=103):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
95 patients with 26 dying ( 8 missing obs. )
                          coef           HR se(coef) 95%CI_l   95%CI_u      z
`T cell CD8+_QUANTISEQ` -2.704 6.700000e-02    6.942   0.000 54265.614 -0.390
Age                      0.006 1.006000e+00    0.015   0.978     1.035  0.409
Stage2                  17.383 3.543969e+07 6207.125   0.000       Inf  0.003
Stage3                  18.040 6.830549e+07 6207.125   0.000       Inf  0.003
Stage4                  19.738 3.732173e+08 6207.125   0.000       Inf  0.003
                            p signif
`T cell CD8+_QUANTISEQ` 0.697       
Age                     0.683       
Stage2                  0.998       
Stage3                  0.998       
Stage4                  0.997       
Rsquare = 0.112 (max possible = 8.67e-01 )
Likelihood ratio test p = 4.59e-02 
Wald test p = 3.94e-02 
Score (logrank) test p = 3.67e-03 

T cell CD8+_QUANTISEQ in SKCM-Metastasis (n=368):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
312 patients with 166 dying ( 56 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -5.526 0.004    1.724   0.000   0.117 -3.204 0.001
Age                      0.021 1.022    0.006   1.010   1.033  3.805 0.000
Stage2                   0.080 1.084    0.227   0.694   1.692  0.354 0.723
Stage3                   0.535 1.707    0.204   1.144   2.547  2.618 0.009
Stage4                   1.010 2.745    0.396   1.263   5.964  2.550 0.011
                        signif
`T cell CD8+_QUANTISEQ`     **
Age                        ***
Stage2                        
Stage3                      **
Stage4                       *
Rsquare = 0.133 (max possible = 9.95e-01 )
Likelihood ratio test p = 1.75e-08 
Wald test p = 3e-07 
Score (logrank) test p = 1.33e-07 

T cell CD8+_QUANTISEQ in STAD (n=415):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
368 patients with 148 dying ( 47 missing obs. )
                         coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_QUANTISEQ` 0.767 2.152    2.605   0.013 355.028 0.294 0.769       
Age                     0.029 1.029    0.009   1.012   1.047 3.404 0.001     **
Stage2                  0.433 1.542    0.334   0.801   2.968 1.297 0.195       
Stage3                  0.916 2.499    0.313   1.353   4.616 2.925 0.003     **
Stage4                  1.619 5.047    0.365   2.469  10.320 4.436 0.000    ***
Rsquare = 0.085 (max possible = 9.85e-01 )
Likelihood ratio test p = 4.02e-06 
Wald test p = 6.08e-06 
Score (logrank) test p = 2.87e-06 

T cell CD8+_QUANTISEQ in TGCT (n=150):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
81 patients with 2 dying ( 69 missing obs. )
                           coef           HR  se(coef) 95%CI_l      95%CI_u
`T cell CD8+_QUANTISEQ` -18.304 0.000000e+00    76.297   0.000 9.871801e+56
Age                      -0.213 8.080000e-01     0.182   0.566 1.153000e+00
Stage2                   18.539 1.126078e+08 33804.391   0.000          Inf
Stage3                   41.353 9.106716e+17 80264.937   0.000          Inf
                             z    p signif
`T cell CD8+_QUANTISEQ` -0.240 0.81       
Age                     -1.174 0.24       
Stage2                   0.001 1.00   <NA>
Stage3                   0.001 1.00   <NA>
Rsquare = 0.084 (max possible = 1.32e-01 )
Likelihood ratio test p = 1.29e-01 
Wald test p = 8.43e-01 
Score (logrank) test p = 1.42e-01 

T cell CD8+_QUANTISEQ in THCA (n=509):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
506 patients with 16 dying ( 3 missing obs. )
                          coef    HR se(coef) 95%CI_l      95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -9.062 0.000   36.927   0.000 3.140144e+27 -0.245 0.806
Age                      0.150 1.162    0.028   1.100 1.228000e+00  5.353 0.000
Stage2                   0.191 1.211    1.015   0.166 8.845000e+00  0.189 0.850
Stage3                   0.230 1.259    0.811   0.257 6.171000e+00  0.284 0.776
Stage4                   0.870 2.387    0.852   0.450 1.266500e+01  1.022 0.307
                        signif
`T cell CD8+_QUANTISEQ`       
Age                        ***
Stage2                        
Stage3                        
Stage4                        
Rsquare = 0.109 (max possible = 2.9e-01 )
Likelihood ratio test p = 2.71e-11 
Wald test p = 1.27e-05 
Score (logrank) test p = 1.87e-11 

T cell CD8+_QUANTISEQ in THYM (n=120):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age 
119 patients with 9 dying ( 1 missing obs. )
                          coef    HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -3.298 0.037    1.664   0.001   0.963 -1.982 0.047
Age                      0.014 1.014    0.033   0.951   1.082  0.437 0.662
                        signif
`T cell CD8+_QUANTISEQ`      *
Age                           
Rsquare = 0.08 (max possible = 4.39e-01 )
Likelihood ratio test p = 6.91e-03 
Wald test p = 4.02e-02 
Score (logrank) test p = 9.23e-03 

T cell CD8+_QUANTISEQ in UCEC (n=545):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age 
173 patients with 32 dying ( 372 missing obs. )
                           coef    HR se(coef) 95%CI_l    95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -16.056 0.000   14.356   0.000 176473.776 -1.118 0.263
Age                       0.015 1.015    0.017   0.982      1.048  0.883 0.377
                        signif
`T cell CD8+_QUANTISEQ`       
Age                           
Rsquare = 0.016 (max possible = 7.9e-01 )
Likelihood ratio test p = 2.42e-01 
Wald test p = 3.33e-01 
Score (logrank) test p = 3.37e-01 

T cell CD8+_QUANTISEQ in UCS (n=57):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age 
55 patients with 34 dying ( 2 missing obs. )
                           coef    HR se(coef) 95%CI_l  95%CI_u      z     p
`T cell CD8+_QUANTISEQ` -19.176 0.000   13.717   0.000 2230.402 -1.398 0.162
Age                       0.045 1.046    0.022   1.002    1.093  2.036 0.042
                        signif
`T cell CD8+_QUANTISEQ`       
Age                          *
Rsquare = 0.11 (max possible = 9.83e-01 )
Likelihood ratio test p = 4.11e-02 
Wald test p = 4.63e-02 
Score (logrank) test p = 4.26e-02 

T cell CD8+_QUANTISEQ in UVM (n=80):
Model: Surv(OS, EVENT) ~ `T cell CD8+_QUANTISEQ` + Age + Stage 
79 patients with 22 dying ( 1 missing obs. )
                          coef          HR se(coef) 95%CI_l      95%CI_u     z
`T cell CD8+_QUANTISEQ` 19.394 2.64662e+08    7.527 103.604 6.760922e+14 2.576
Age                      0.043 1.04400e+00    0.020   1.004 1.087000e+00 2.131
Stage3                   0.093 1.09700e+00    0.479   0.429 2.803000e+00 0.194
Stage4                   3.804 4.48580e+01    1.210   4.186 4.807340e+02 3.143
                            p signif
`T cell CD8+_QUANTISEQ` 0.010      *
Age                     0.033      *
Stage3                  0.846       
Stage4                  0.002     **
Rsquare = 0.259 (max possible = 8.67e-01 )
Likelihood ratio test p = 9.25e-05 
Wald test p = 1.98e-04 
Score (logrank) test p = 2.65e-11 

T cell CD8+_TIMER in ACC (n=79):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age 
79 patients with 28 dying ( 0 missing obs. )
                     coef     HR se(coef) 95%CI_l  95%CI_u     z     p signif
`T cell CD8+_TIMER` 4.168 64.593    2.149   0.957 4360.554 1.939 0.052      ·
Age                 0.010  1.010    0.013   0.986    1.035 0.821 0.412       
Rsquare = 0.046 (max possible = 9.35e-01 )
Likelihood ratio test p = 1.53e-01 
Wald test p = 1.08e-01 
Score (logrank) test p = 1.11e-01 

T cell CD8+_TIMER in BLCA (n=408):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
401 patients with 176 dying ( 7 missing obs. )
                      coef          HR se(coef) 95%CI_l 95%CI_u     z     p
`T cell CD8+_TIMER`  0.682       1.978    0.391   0.919   4.258 1.744 0.081
Age                  0.031       1.032    0.008   1.016   1.048 3.924 0.000
Stage2              14.539 2061569.382 1900.333   0.000     Inf 0.008 0.994
Stage3              14.934 3060103.521 1900.333   0.000     Inf 0.008 0.994
Stage4              15.507 5425930.661 1900.333   0.000     Inf 0.008 0.993
                    signif
`T cell CD8+_TIMER`      ·
Age                    ***
Stage2                    
Stage3                    
Stage4                    
Rsquare = 0.119 (max possible = 9.91e-01 )
Likelihood ratio test p = 9.72e-10 
Wald test p = 6.6e-09 
Score (logrank) test p = 1.4e-09 

T cell CD8+_TIMER in BRCA (n=1100):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
1057 patients with 143 dying ( 43 missing obs. )
                      coef     HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -0.026  0.974    0.632   0.282   3.366 -0.041 0.967       
Age                  0.034  1.034    0.007   1.020   1.048  4.897 0.000    ***
Stage2               0.574  1.775    0.280   1.025   3.074  2.047 0.041      *
Stage3               1.226  3.409    0.294   1.915   6.066  4.170 0.000    ***
Stage4               2.428 11.342    0.361   5.586  23.027  6.721 0.000    ***
Rsquare = 0.067 (max possible = 7.87e-01 )
Likelihood ratio test p = 2.2e-14 
Wald test p = 1.55e-17 
Score (logrank) test p = 1.7e-22 

T cell CD8+_TIMER in BRCA-Basal (n=191):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
185 patients with 26 dying ( 6 missing obs. )
                      coef           HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_TIMER` -1.345 2.610000e-01    1.346   0.019   3.647 -0.999 0.318
Age                  0.017 1.017000e+00    0.017   0.984   1.052  1.013 0.311
Stage2              18.878 1.579423e+08 6197.569   0.000     Inf  0.003 0.998
Stage3              20.347 6.864685e+08 6197.569   0.000     Inf  0.003 0.997
Stage4              21.332 1.838979e+09 6197.569   0.000     Inf  0.003 0.997
                    signif
`T cell CD8+_TIMER`       
Age                       
Stage2                    
Stage3                    
Stage4                    
Rsquare = 0.137 (max possible = 7.08e-01 )
Likelihood ratio test p = 4.92e-05 
Wald test p = 1.52e-03 
Score (logrank) test p = 4.51e-07 

T cell CD8+_TIMER in BRCA-Her2 (n=82):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
75 patients with 16 dying ( 7 missing obs. )
                      coef     HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -0.564  0.569    2.908   0.002 169.972 -0.194 0.846       
Age                  0.081  1.084    0.028   1.027   1.145  2.922 0.003     **
Stage2              -0.808  0.446    1.171   0.045   4.422 -0.690 0.490       
Stage3               0.588  1.800    1.145   0.191  16.980  0.513 0.608       
Stage4               3.178 24.010    1.290   1.917 300.780  2.464 0.014      *
Rsquare = 0.287 (max possible = 7.59e-01 )
Likelihood ratio test p = 1.21e-04 
Wald test p = 4.41e-04 
Score (logrank) test p = 1.04e-07 

T cell CD8+_TIMER in BRCA-LumA (n=568):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
547 patients with 62 dying ( 21 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_TIMER` 0.782 2.186    0.996   0.310  15.400 0.785 0.432       
Age                 0.046 1.047    0.011   1.025   1.070 4.200 0.000    ***
Stage2              0.507 1.660    0.363   0.815   3.379 1.396 0.163       
Stage3              0.906 2.474    0.393   1.146   5.339 2.308 0.021      *
Stage4              2.080 8.006    0.548   2.736  23.426 3.797 0.000    ***
Rsquare = 0.053 (max possible = 6.7e-01 )
Likelihood ratio test p = 1.68e-05 
Wald test p = 3.23e-06 
Score (logrank) test p = 2.7e-07 

T cell CD8+_TIMER in BRCA-LumB (n=219):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
211 patients with 32 dying ( 8 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_TIMER` 1.304 3.684    1.425   0.225  60.212 0.915 0.360       
Age                 0.030 1.031    0.015   1.001   1.062 2.008 0.045      *
Stage2              1.056 2.876    0.770   0.636  13.012 1.372 0.170       
Stage3              1.535 4.642    0.786   0.994  21.680 1.952 0.051      ·
Stage4              2.232 9.320    0.884   1.649  52.668 2.526 0.012      *
Rsquare = 0.062 (max possible = 7e-01 )
Likelihood ratio test p = 1.83e-02 
Wald test p = 1.75e-02 
Score (logrank) test p = 7.26e-03 

T cell CD8+_TIMER in CESC (n=306):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age 
293 patients with 73 dying ( 13 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -1.229 0.292    0.685   0.076   1.120 -1.795 0.073      ·
Age                  0.015 1.015    0.009   0.998   1.032  1.676 0.094      ·
Rsquare = 0.024 (max possible = 9.11e-01 )
Likelihood ratio test p = 2.9e-02 
Wald test p = 4.78e-02 
Score (logrank) test p = 4.98e-02 

T cell CD8+_TIMER in CHOL (n=36):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
36 patients with 18 dying ( 0 missing obs. )
                       coef      HR se(coef) 95%CI_l     95%CI_u      z     p
`T cell CD8+_TIMER`   4.816 123.520    5.489   0.003 5803856.773  0.878 0.380
Age                   0.025   1.025    0.019   0.987       1.064  1.290 0.197
Stage2                0.996   2.708    0.632   0.784       9.353  1.576 0.115
Stage3              -15.915   0.000 6603.238   0.000         Inf -0.002 0.998
Stage4                1.133   3.104    0.640   0.885      10.879  1.770 0.077
                    signif
`T cell CD8+_TIMER`       
Age                       
Stage2                    
Stage3                    
Stage4                   ·
Rsquare = 0.149 (max possible = 9.46e-01 )
Likelihood ratio test p = 3.27e-01 
Wald test p = 5.2e-01 
Score (logrank) test p = 3.78e-01 

T cell CD8+_TIMER in COAD (n=458):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
267 patients with 62 dying ( 191 missing obs. )
                      coef     HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -0.267  0.766    1.092   0.090   6.506 -0.245 0.807       
Age                  0.037  1.038    0.012   1.014   1.062  3.148 0.002     **
Stage2               0.700  2.015    0.628   0.589   6.896  1.116 0.265       
Stage3               1.347  3.845    0.622   1.136  13.016  2.165 0.030      *
Stage4               2.500 12.179    0.631   3.538  41.921  3.964 0.000    ***
Rsquare = 0.123 (max possible = 8.92e-01 )
Likelihood ratio test p = 1.43e-06 
Wald test p = 1.3e-06 
Score (logrank) test p = 1.09e-07 

T cell CD8+_TIMER in DLBC (n=48):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age 
47 patients with 9 dying ( 1 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER`  1.148 3.151    1.590   0.140  71.035  0.722 0.470       
Age                 -0.006 0.994    0.026   0.944   1.047 -0.229 0.819       
Rsquare = 0.014 (max possible = 6.72e-01 )
Likelihood ratio test p = 7.14e-01 
Wald test p = 6.95e-01 
Score (logrank) test p = 6.91e-01 

T cell CD8+_TIMER in ESCA (n=185):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
160 patients with 63 dying ( 25 missing obs. )
                      coef     HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -0.047  0.954    0.975   0.141   6.450 -0.048 0.961       
Age                  0.005  1.005    0.011   0.984   1.027  0.443 0.657       
Stage2               0.781  2.184    0.557   0.733   6.508  1.402 0.161       
Stage3               1.716  5.561    0.573   1.810  17.084  2.996 0.003     **
Stage4               2.484 11.984    0.646   3.380  42.492  3.846 0.000    ***
Rsquare = 0.145 (max possible = 9.61e-01 )
Likelihood ratio test p = 1.38e-04 
Wald test p = 1.47e-04 
Score (logrank) test p = 2.06e-05 

T cell CD8+_TIMER in GBM (n=153):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age 
150 patients with 120 dying ( 3 missing obs. )
                     coef     HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_TIMER` 2.637 13.975    1.004   1.955  99.894 2.628 0.009     **
Age                 0.028  1.028    0.008   1.013   1.044 3.606 0.000    ***
Rsquare = 0.132 (max possible = 9.98e-01 )
Likelihood ratio test p = 2.42e-05 
Wald test p = 5.12e-05 
Score (logrank) test p = 5.98e-05 

T cell CD8+_TIMER in HNSC (n=522):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
446 patients with 191 dying ( 76 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_TIMER` 0.151 1.163    0.235   0.733   1.843 0.641 0.522       
Age                 0.023 1.023    0.007   1.009   1.037 3.249 0.001     **
Stage2              0.735 2.085    0.538   0.726   5.987 1.365 0.172       
Stage3              0.848 2.334    0.536   0.817   6.668 1.583 0.113       
Stage4              1.381 3.981    0.509   1.467  10.804 2.712 0.007     **
Rsquare = 0.064 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.69e-05 
Wald test p = 8.88e-05 
Score (logrank) test p = 5.9e-05 

T cell CD8+_TIMER in HNSC-HPV+ (n=98):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
67 patients with 24 dying ( 31 missing obs. )
                      coef           HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_TIMER`  0.964        2.622    0.753   0.600  11.467  1.280 0.200
Age                 -0.003        0.997    0.023   0.953   1.044 -0.115 0.909
Stage2              17.074 25999088.120 5346.867   0.000     Inf  0.003 0.997
Stage3              16.438 13764339.348 5346.867   0.000     Inf  0.003 0.998
Stage4              17.160 28332060.690 5346.867   0.000     Inf  0.003 0.997
                    signif
`T cell CD8+_TIMER`       
Age                       
Stage2                    
Stage3                    
Stage4                    
Rsquare = 0.076 (max possible = 9.24e-01 )
Likelihood ratio test p = 3.8e-01 
Wald test p = 6.58e-01 
Score (logrank) test p = 4.76e-01 

T cell CD8+_TIMER in HNSC-HPV- (n=422):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
379 patients with 167 dying ( 43 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_TIMER` 0.074 1.077    0.250   0.660   1.756 0.296 0.768       
Age                 0.027 1.027    0.008   1.012   1.042 3.452 0.001     **
Stage2              0.502 1.651    0.546   0.567   4.812 0.919 0.358       
Stage3              0.725 2.065    0.539   0.719   5.933 1.347 0.178       
Stage4              1.259 3.521    0.511   1.292   9.594 2.462 0.014      *
Rsquare = 0.074 (max possible = 9.9e-01 )
Likelihood ratio test p = 2.04e-05 
Wald test p = 9.55e-05 
Score (logrank) test p = 6.71e-05 

T cell CD8+_TIMER in KICH (n=66):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
65 patients with 9 dying ( 1 missing obs. )
                       coef           HR se(coef)     95%CI_l      95%CI_u
`T cell CD8+_TIMER` -11.784 0.000000e+00   13.155        0.00 1.200919e+06
Age                   0.035 1.036000e+00    0.028        0.98 1.095000e+00
Stage2               15.644 6.222582e+06    0.846  1185704.63 3.265613e+07
Stage3               16.631 1.669487e+07    0.782  3605347.33 7.730701e+07
Stage4               19.327 2.476386e+08    0.905 42060602.27 1.458012e+09
                         z     p signif
`T cell CD8+_TIMER` -0.896 0.370       
Age                  1.246 0.213       
Stage2              18.495 0.000    ***
Stage3              21.267 0.000    ***
Stage4              21.367 0.000    ***
Rsquare = 0.332 (max possible = 6.61e-01 )
Likelihood ratio test p = 8.1e-05 
Wald test p = 8.61e-269 
Score (logrank) test p = 3.55e-11 

T cell CD8+_TIMER in KIRC (n=533):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
526 patients with 172 dying ( 7 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -0.094 0.911    0.379   0.433   1.913 -0.248 0.805       
Age                  0.034 1.034    0.007   1.019   1.049  4.538 0.000    ***
Stage2               0.291 1.338    0.317   0.719   2.491  0.919 0.358       
Stage3               0.950 2.586    0.210   1.714   3.901  4.527 0.000    ***
Stage4               1.955 7.065    0.198   4.793  10.414  9.878 0.000    ***
Rsquare = 0.208 (max possible = 9.75e-01 )
Likelihood ratio test p = 7.91e-25 
Wald test p = 1.69e-24 
Score (logrank) test p = 1.62e-30 

T cell CD8+_TIMER in KIRP (n=290):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
255 patients with 39 dying ( 35 missing obs. )
                      coef     HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER`  0.759  2.135    0.390   0.993   4.590  1.943 0.052      ·
Age                  0.007  1.007    0.014   0.979   1.036  0.479 0.632       
Stage2              -0.131  0.877    0.773   0.193   3.992 -0.169 0.866       
Stage3               1.592  4.915    0.387   2.304  10.484  4.119 0.000    ***
Stage4               2.848 17.256    0.454   7.093  41.984  6.278 0.000    ***
Rsquare = 0.148 (max possible = 7.61e-01 )
Likelihood ratio test p = 9.87e-08 
Wald test p = 1.81e-08 
Score (logrank) test p = 2.37e-13 

T cell CD8+_TIMER in LGG (n=516):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age 
511 patients with 125 dying ( 5 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -2.114 0.121    0.802   0.025   0.582 -2.636 0.008     **
Age                  0.058 1.060    0.007   1.045   1.075  7.948 0.000    ***
Rsquare = 0.124 (max possible = 9.13e-01 )
Likelihood ratio test p = 2.13e-15 
Wald test p = 2.45e-15 
Score (logrank) test p = 4.27e-16 

T cell CD8+_TIMER in LIHC (n=371):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
340 patients with 116 dying ( 31 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_TIMER` 0.060 1.062    0.421   0.465   2.423 0.142 0.887       
Age                 0.012 1.012    0.007   0.997   1.027 1.609 0.108       
Stage2              0.317 1.373    0.251   0.839   2.247 1.263 0.207       
Stage3              0.993 2.699    0.215   1.769   4.117 4.609 0.000    ***
Stage4              1.686 5.400    0.600   1.666  17.504 2.811 0.005     **
Rsquare = 0.075 (max possible = 9.69e-01 )
Likelihood ratio test p = 7.26e-05 
Wald test p = 3.07e-05 
Score (logrank) test p = 9.98e-06 

T cell CD8+_TIMER in LUAD (n=515):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
484 patients with 177 dying ( 31 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_TIMER` 0.036 1.037    0.482   0.403   2.668 0.075 0.941       
Age                 0.009 1.009    0.008   0.993   1.024 1.112 0.266       
Stage2              0.826 2.284    0.187   1.582   3.297 4.408 0.000    ***
Stage3              1.182 3.262    0.196   2.220   4.793 6.023 0.000    ***
Stage4              1.304 3.685    0.282   2.119   6.408 4.621 0.000    ***
Rsquare = 0.095 (max possible = 9.79e-01 )
Likelihood ratio test p = 2.74e-09 
Wald test p = 3.34e-09 
Score (logrank) test p = 3.89e-10 

T cell CD8+_TIMER in LUSC (n=501):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
484 patients with 209 dying ( 17 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_TIMER` 0.423 1.526    0.432   0.655   3.557 0.980 0.327       
Age                 0.017 1.017    0.009   1.000   1.035 1.963 0.050      ·
Stage2              0.158 1.172    0.164   0.849   1.616 0.964 0.335       
Stage3              0.465 1.593    0.184   1.111   2.283 2.533 0.011      *
Stage4              1.220 3.388    0.463   1.368   8.394 2.637 0.008     **
Rsquare = 0.029 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.29e-02 
Wald test p = 7.65e-03 
Score (logrank) test p = 5.77e-03 

T cell CD8+_TIMER in MESO (n=87):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
86 patients with 73 dying ( 1 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -0.060 0.941    0.686   0.245   3.612 -0.088 0.930       
Age                  0.019 1.019    0.015   0.990   1.049  1.288 0.198       
Stage2              -0.408 0.665    0.450   0.275   1.607 -0.906 0.365       
Stage3              -0.236 0.790    0.382   0.373   1.671 -0.617 0.537       
Stage4              -0.305 0.737    0.446   0.308   1.765 -0.685 0.494       
Rsquare = 0.032 (max possible = 9.98e-01 )
Likelihood ratio test p = 7.31e-01 
Wald test p = 7.22e-01 
Score (logrank) test p = 7.21e-01 

T cell CD8+_TIMER in OV (n=303):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age 
302 patients with 183 dying ( 1 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -0.161 0.851    0.509   0.314   2.306 -0.317 0.751       
Age                  0.030 1.030    0.007   1.015   1.045  4.047 0.000    ***
Rsquare = 0.052 (max possible = 9.97e-01 )
Likelihood ratio test p = 3.04e-04 
Wald test p = 2.75e-04 
Score (logrank) test p = 2.54e-04 

T cell CD8+_TIMER in PAAD (n=179):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
175 patients with 93 dying ( 4 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER`  0.746 2.108    0.774   0.463   9.605  0.964 0.335       
Age                  0.025 1.026    0.011   1.005   1.047  2.426 0.015      *
Stage2               0.736 2.087    0.400   0.953   4.571  1.838 0.066      ·
Stage3              -0.012 0.988    1.077   0.120   8.164 -0.011 0.991       
Stage4               0.338 1.402    0.808   0.288   6.832  0.418 0.676       
Rsquare = 0.07 (max possible = 9.91e-01 )
Likelihood ratio test p = 2.67e-02 
Wald test p = 4.65e-02 
Score (logrank) test p = 4.22e-02 

T cell CD8+_TIMER in PCPG (n=181):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age 
181 patients with 7 dying ( 0 missing obs. )
                      coef    HR se(coef) 95%CI_l  95%CI_u      z     p signif
`T cell CD8+_TIMER` -0.664 0.515    4.567   0.000 3975.910 -0.145 0.884       
Age                  0.023 1.023    0.024   0.976    1.073  0.955 0.339       
Rsquare = 0.005 (max possible = 2.89e-01 )
Likelihood ratio test p = 6.28e-01 
Wald test p = 6.31e-01 
Score (logrank) test p = 6.26e-01 

T cell CD8+_TIMER in PRAD (n=498):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age 
496 patients with 10 dying ( 2 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -2.569 0.077    3.564   0.000  82.817 -0.721 0.471       
Age                  0.045 1.046    0.051   0.947   1.155  0.886 0.376       
Rsquare = 0.003 (max possible = 1.68e-01 )
Likelihood ratio test p = 4.34e-01 
Wald test p = 4.53e-01 
Score (logrank) test p = 4.49e-01 

T cell CD8+_TIMER in READ (n=166):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
82 patients with 14 dying ( 84 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -2.761 0.063    3.516   0.000  62.176 -0.785 0.432       
Age                  0.129 1.137    0.046   1.040   1.244  2.809 0.005     **
Stage2              -1.257 0.284    1.250   0.025   3.298 -1.005 0.315       
Stage3               0.366 1.441    0.815   0.292   7.124  0.448 0.654       
Stage4               0.213 1.237    0.936   0.198   7.751  0.228 0.820       
Rsquare = 0.231 (max possible = 7.04e-01 )
Likelihood ratio test p = 6.32e-04 
Wald test p = 2.79e-02 
Score (logrank) test p = 1.04e-03 

T cell CD8+_TIMER in SARC (n=260):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age 
257 patients with 99 dying ( 3 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_TIMER` 0.169 1.185    0.612   0.357   3.930 0.277 0.782       
Age                 0.021 1.021    0.008   1.005   1.037 2.599 0.009     **
Rsquare = 0.029 (max possible = 9.77e-01 )
Likelihood ratio test p = 2.27e-02 
Wald test p = 2.62e-02 
Score (logrank) test p = 2.63e-02 

T cell CD8+_TIMER in SKCM (n=471):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
407 patients with 192 dying ( 64 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -1.216 0.296    0.401   0.135   0.650 -3.032 0.002     **
Age                  0.019 1.019    0.005   1.009   1.029  3.636 0.000    ***
Stage2               0.270 1.310    0.215   0.859   1.998  1.254 0.210       
Stage3               0.636 1.890    0.200   1.278   2.795  3.187 0.001     **
Stage4               1.234 3.436    0.349   1.735   6.802  3.541 0.000    ***
Rsquare = 0.105 (max possible = 9.92e-01 )
Likelihood ratio test p = 1.39e-08 
Wald test p = 5.95e-08 
Score (logrank) test p = 3.31e-08 

T cell CD8+_TIMER in SKCM-Primary (n=103):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
95 patients with 26 dying ( 8 missing obs. )
                      coef           HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_TIMER` -3.426 3.300000e-02    2.218   0.000   2.513 -1.545 0.122
Age                  0.013 1.013000e+00    0.015   0.983   1.044  0.846 0.398
Stage2              17.157 2.825995e+07 6155.642   0.000     Inf  0.003 0.998
Stage3              17.770 5.216893e+07 6155.642   0.000     Inf  0.003 0.998
Stage4              20.089 5.305446e+08 6155.642   0.000     Inf  0.003 0.997
                    signif
`T cell CD8+_TIMER`       
Age                       
Stage2                    
Stage3                    
Stage4                    
Rsquare = 0.137 (max possible = 8.67e-01 )
Likelihood ratio test p = 1.55e-02 
Wald test p = 2.05e-02 
Score (logrank) test p = 1.62e-03 

T cell CD8+_TIMER in SKCM-Metastasis (n=368):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
312 patients with 166 dying ( 56 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -1.029 0.357    0.408   0.161   0.794 -2.525 0.012      *
Age                  0.021 1.021    0.006   1.010   1.032  3.798 0.000    ***
Stage2               0.156 1.169    0.226   0.750   1.821  0.688 0.491       
Stage3               0.571 1.769    0.204   1.186   2.640  2.794 0.005     **
Stage4               0.990 2.692    0.396   1.240   5.845  2.503 0.012      *
Rsquare = 0.113 (max possible = 9.95e-01 )
Likelihood ratio test p = 4.85e-07 
Wald test p = 1.48e-06 
Score (logrank) test p = 1.07e-06 

T cell CD8+_TIMER in STAD (n=415):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
368 patients with 148 dying ( 47 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_TIMER` 0.116 1.123    0.364   0.550   2.293 0.319 0.750       
Age                 0.029 1.029    0.009   1.012   1.047 3.407 0.001     **
Stage2              0.427 1.533    0.335   0.795   2.957 1.275 0.202       
Stage3              0.908 2.479    0.315   1.336   4.600 2.880 0.004     **
Stage4              1.612 5.015    0.365   2.451  10.259 4.415 0.000    ***
Rsquare = 0.085 (max possible = 9.85e-01 )
Likelihood ratio test p = 3.99e-06 
Wald test p = 5.94e-06 
Score (logrank) test p = 2.8e-06 

T cell CD8+_TIMER in TGCT (n=150):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
81 patients with 2 dying ( 69 missing obs. )
                      coef           HR  se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+_TIMER`  1.173 3.233000e+00    12.255   0.000 8.730918e+10  0.096
Age                 -0.213 8.080000e-01     0.189   0.557 1.171000e+00 -1.126
Stage2              18.494 1.076480e+08 33363.729   0.000          Inf  0.001
Stage3              41.369 9.257523e+17 84689.258   0.000          Inf  0.000
                        p signif
`T cell CD8+_TIMER` 0.924       
Age                 0.260       
Stage2              1.000   <NA>
Stage3              1.000   <NA>
Rsquare = 0.084 (max possible = 1.32e-01 )
Likelihood ratio test p = 1.32e-01 
Wald test p = 8.6e-01 
Score (logrank) test p = 1.41e-01 

T cell CD8+_TIMER in THCA (n=509):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
506 patients with 16 dying ( 3 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_TIMER` 0.109 1.115    1.851   0.030  41.983 0.059 0.953       
Age                 0.150 1.162    0.028   1.099   1.228 5.314 0.000    ***
Stage2              0.210 1.234    1.038   0.161   9.443 0.202 0.840       
Stage3              0.256 1.292    0.895   0.224   7.462 0.286 0.775       
Stage4              0.909 2.483    0.880   0.443  13.930 1.034 0.301       
Rsquare = 0.109 (max possible = 2.9e-01 )
Likelihood ratio test p = 2.79e-11 
Wald test p = 1.05e-05 
Score (logrank) test p = 1.61e-11 

T cell CD8+_TIMER in THYM (n=120):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age 
119 patients with 9 dying ( 1 missing obs. )
                       coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -10.994 0.000    6.316   0.000   3.996 -1.741 0.082      ·
Age                   0.012 1.012    0.031   0.953   1.076  0.399 0.690       
Rsquare = 0.102 (max possible = 4.39e-01 )
Likelihood ratio test p = 1.72e-03 
Wald test p = 1.28e-01 
Score (logrank) test p = 8.14e-03 

T cell CD8+_TIMER in UCEC (n=545):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age 
173 patients with 32 dying ( 372 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_TIMER` -1.735 0.176    1.790   0.005   5.890 -0.969 0.332       
Age                  0.013 1.013    0.016   0.981   1.046  0.793 0.428       
Rsquare = 0.014 (max possible = 7.9e-01 )
Likelihood ratio test p = 2.84e-01 
Wald test p = 3.99e-01 
Score (logrank) test p = 3.93e-01 

T cell CD8+_TIMER in UCS (n=57):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age 
55 patients with 34 dying ( 2 missing obs. )
                     coef    HR se(coef) 95%CI_l  95%CI_u     z     p signif
`T cell CD8+_TIMER` 2.080 8.005    3.175   0.016 4034.050 0.655 0.512       
Age                 0.046 1.047    0.022   1.002    1.094 2.036 0.042      *
Rsquare = 0.077 (max possible = 9.83e-01 )
Likelihood ratio test p = 1.09e-01 
Wald test p = 1.01e-01 
Score (logrank) test p = 9.76e-02 

T cell CD8+_TIMER in UVM (n=80):
Model: Surv(OS, EVENT) ~ `T cell CD8+_TIMER` + Age + Stage 
79 patients with 22 dying ( 1 missing obs. )
                     coef     HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_TIMER` 2.566 13.016    1.112   1.473 115.001 2.308 0.021      *
Age                 0.040  1.040    0.020   1.001   1.081 2.015 0.044      *
Stage3              0.148  1.160    0.471   0.461   2.919 0.315 0.753       
Stage4              3.820 45.615    1.206   4.288 485.238 3.167 0.002     **
Rsquare = 0.263 (max possible = 8.67e-01 )
Likelihood ratio test p = 7.55e-05 
Wald test p = 3.4e-04 
Score (logrank) test p = 8.64e-11 

T cell CD8+_XCELL in ACC (n=79):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age 
79 patients with 28 dying ( 0 missing obs. )
                       coef    HR se(coef) 95%CI_l   95%CI_u      z     p
`T cell CD8+_XCELL` -18.790 0.000   15.238   0.000 64596.336 -1.233 0.218
Age                   0.012 1.012    0.012   0.988     1.037  0.959 0.338
                    signif
`T cell CD8+_XCELL`       
Age                       
Rsquare = 0.037 (max possible = 9.35e-01 )
Likelihood ratio test p = 2.28e-01 
Wald test p = 3.18e-01 
Score (logrank) test p = 3.19e-01 

T cell CD8+_XCELL in BLCA (n=408):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
401 patients with 176 dying ( 7 missing obs. )
                      coef          HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_XCELL` -5.764       0.003    2.535   0.000   0.451 -2.274 0.023
Age                  0.031       1.031    0.008   1.015   1.047  3.898 0.000
Stage2              14.694 2407110.427 1906.115   0.000     Inf  0.008 0.994
Stage3              15.154 3812957.218 1906.115   0.000     Inf  0.008 0.994
Stage4              15.619 6068391.948 1906.115   0.000     Inf  0.008 0.993
                    signif
`T cell CD8+_XCELL`      *
Age                    ***
Stage2                    
Stage3                    
Stage4                    
Rsquare = 0.126 (max possible = 9.91e-01 )
Likelihood ratio test p = 2.07e-10 
Wald test p = 2.29e-09 
Score (logrank) test p = 4.44e-10 

T cell CD8+_XCELL in BRCA (n=1100):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
1057 patients with 143 dying ( 43 missing obs. )
                      coef     HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -2.587  0.075    1.858   0.002   2.870 -1.392 0.164       
Age                  0.033  1.034    0.007   1.020   1.048  4.805 0.000    ***
Stage2               0.553  1.738    0.279   1.005   3.004  1.978 0.048      *
Stage3               1.194  3.301    0.295   1.853   5.880  4.055 0.000    ***
Stage4               2.398 11.002    0.362   5.417  22.347  6.633 0.000    ***
Rsquare = 0.069 (max possible = 7.87e-01 )
Likelihood ratio test p = 7.54e-15 
Wald test p = 8.5e-18 
Score (logrank) test p = 7.21e-23 

T cell CD8+_XCELL in BRCA-Basal (n=191):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
185 patients with 26 dying ( 6 missing obs. )
                      coef           HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_XCELL` -4.851 8.000000e-03    3.495   0.000   7.376 -1.388 0.165
Age                  0.011 1.011000e+00    0.016   0.979   1.044  0.650 0.516
Stage2              18.818 1.488353e+08 6234.934   0.000     Inf  0.003 0.998
Stage3              20.176 5.783623e+08 6234.934   0.000     Inf  0.003 0.997
Stage4              22.149 4.159420e+09 6234.934   0.000     Inf  0.004 0.997
                    signif
`T cell CD8+_XCELL`       
Age                       
Stage2                    
Stage3                    
Stage4                    
Rsquare = 0.143 (max possible = 7.08e-01 )
Likelihood ratio test p = 2.79e-05 
Wald test p = 7.68e-04 
Score (logrank) test p = 1.87e-07 

T cell CD8+_XCELL in BRCA-Her2 (n=82):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
75 patients with 16 dying ( 7 missing obs. )
                      coef     HR se(coef) 95%CI_l    95%CI_u      z     p
`T cell CD8+_XCELL` -2.436  0.088    8.250   0.000 921734.189 -0.295 0.768
Age                  0.080  1.083    0.028   1.025      1.144  2.844 0.004
Stage2              -0.783  0.457    1.154   0.048      4.388 -0.678 0.498
Stage3               0.558  1.747    1.149   0.184     16.611  0.486 0.627
Stage4               3.156 23.478    1.264   1.973    279.417  2.498 0.013
                    signif
`T cell CD8+_XCELL`       
Age                     **
Stage2                    
Stage3                    
Stage4                   *
Rsquare = 0.287 (max possible = 7.59e-01 )
Likelihood ratio test p = 1.18e-04 
Wald test p = 4.03e-04 
Score (logrank) test p = 9.19e-08 

T cell CD8+_XCELL in BRCA-LumA (n=568):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
547 patients with 62 dying ( 21 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -0.172 0.842    2.796   0.004 202.001 -0.061 0.951       
Age                  0.045 1.046    0.011   1.024   1.069  4.092 0.000    ***
Stage2               0.470 1.600    0.359   0.791   3.236  1.308 0.191       
Stage3               0.894 2.444    0.393   1.132   5.277  2.275 0.023      *
Stage4               2.024 7.569    0.544   2.604  21.998  3.718 0.000    ***
Rsquare = 0.052 (max possible = 6.7e-01 )
Likelihood ratio test p = 2.19e-05 
Wald test p = 4.62e-06 
Score (logrank) test p = 3.59e-07 

T cell CD8+_XCELL in BRCA-LumB (n=219):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
211 patients with 32 dying ( 8 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -7.413 0.001    5.336   0.000  21.016 -1.389 0.165       
Age                  0.032 1.033    0.016   1.001   1.065  2.036 0.042      *
Stage2               0.688 1.989    0.767   0.442   8.947  0.896 0.370       
Stage3               1.252 3.496    0.775   0.765  15.980  1.614 0.107       
Stage4               1.946 6.998    0.896   1.209  40.502  2.172 0.030      *
Rsquare = 0.071 (max possible = 7e-01 )
Likelihood ratio test p = 8.2e-03 
Wald test p = 1.39e-02 
Score (logrank) test p = 5.06e-03 

T cell CD8+_XCELL in CESC (n=306):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age 
293 patients with 73 dying ( 13 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -8.437 0.000    3.128   0.000   0.100 -2.698 0.007     **
Age                  0.015 1.015    0.009   0.998   1.033  1.758 0.079      ·
Rsquare = 0.047 (max possible = 9.11e-01 )
Likelihood ratio test p = 8.97e-04 
Wald test p = 6.47e-03 
Score (logrank) test p = 4.98e-03 

T cell CD8+_XCELL in CHOL (n=36):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
36 patients with 18 dying ( 0 missing obs. )
                       coef       HR se(coef) 95%CI_l      95%CI_u      z     p
`T cell CD8+_XCELL`   7.191 1327.518    7.721   0.000 4.952007e+09  0.931 0.352
Age                   0.018    1.018    0.019   0.980 1.057000e+00  0.916 0.360
Stage2                0.961    2.614    0.622   0.772 8.853000e+00  1.544 0.123
Stage3              -19.791    0.000 6596.329   0.000          Inf -0.003 0.998
Stage4                1.143    3.136    0.649   0.879 1.119700e+01  1.760 0.078
                    signif
`T cell CD8+_XCELL`       
Age                       
Stage2                    
Stage3                    
Stage4                   ·
Rsquare = 0.15 (max possible = 9.46e-01 )
Likelihood ratio test p = 3.22e-01 
Wald test p = 5.25e-01 
Score (logrank) test p = 3.77e-01 

T cell CD8+_XCELL in COAD (n=458):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
267 patients with 62 dying ( 191 missing obs. )
                     coef      HR se(coef) 95%CI_l     95%CI_u     z     p
`T cell CD8+_XCELL` 5.740 310.971    4.424   0.053 1813542.540 1.297 0.195
Age                 0.035   1.036    0.012   1.012       1.060 3.002 0.003
Stage2              0.757   2.131    0.624   0.627       7.242 1.212 0.225
Stage3              1.376   3.958    0.622   1.170      13.396 2.212 0.027
Stage4              2.581  13.208    0.634   3.812      45.758 4.071 0.000
                    signif
`T cell CD8+_XCELL`       
Age                     **
Stage2                    
Stage3                   *
Stage4                 ***
Rsquare = 0.127 (max possible = 8.92e-01 )
Likelihood ratio test p = 7.99e-07 
Wald test p = 9.08e-07 
Score (logrank) test p = 6.11e-08 

T cell CD8+_XCELL in DLBC (n=48):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age 
47 patients with 9 dying ( 1 missing obs. )
                      coef    HR se(coef) 95%CI_l   95%CI_u      z     p signif
`T cell CD8+_XCELL` -4.083 0.017    6.798    0.00 10303.938 -0.601 0.548       
Age                 -0.012 0.988    0.025    0.94     1.038 -0.493 0.622       
Rsquare = 0.012 (max possible = 6.72e-01 )
Likelihood ratio test p = 7.55e-01 
Wald test p = 7.6e-01 
Score (logrank) test p = 7.57e-01 

T cell CD8+_XCELL in ESCA (n=185):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
160 patients with 63 dying ( 25 missing obs. )
                     coef     HR se(coef) 95%CI_l  95%CI_u     z     p signif
`T cell CD8+_XCELL` 1.201  3.324    2.959   0.010 1097.600 0.406 0.685       
Age                 0.005  1.005    0.011   0.983    1.026 0.427 0.669       
Stage2              0.759  2.136    0.554   0.721    6.326 1.370 0.171       
Stage3              1.686  5.398    0.569   1.771   16.454 2.965 0.003     **
Stage4              2.481 11.948    0.644   3.381   42.226 3.851 0.000    ***
Rsquare = 0.146 (max possible = 9.61e-01 )
Likelihood ratio test p = 1.29e-04 
Wald test p = 1.38e-04 
Score (logrank) test p = 1.9e-05 

T cell CD8+_XCELL in GBM (n=153):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age 
150 patients with 120 dying ( 3 missing obs. )
                      coef          HR se(coef) 95%CI_l      95%CI_u     z
`T cell CD8+_XCELL` 16.871 21231721.35   12.479   0.001 8.889818e+17 1.352
Age                  0.029        1.03    0.008   1.014 1.045000e+00 3.816
                        p signif
`T cell CD8+_XCELL` 0.176       
Age                 0.000    ***
Rsquare = 0.107 (max possible = 9.98e-01 )
Likelihood ratio test p = 2.08e-04 
Wald test p = 3.88e-04 
Score (logrank) test p = 3.46e-04 

T cell CD8+_XCELL in HNSC (n=522):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
446 patients with 191 dying ( 76 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -4.902 0.007    1.817   0.000   0.261 -2.698 0.007     **
Age                  0.024 1.024    0.007   1.010   1.038  3.385 0.001     **
Stage2               0.740 2.097    0.538   0.730   6.019  1.376 0.169       
Stage3               0.819 2.267    0.535   0.794   6.472  1.530 0.126       
Stage4               1.303 3.679    0.509   1.358   9.967  2.562 0.010      *
Rsquare = 0.082 (max possible = 9.9e-01 )
Likelihood ratio test p = 3.88e-07 
Wald test p = 3.92e-06 
Score (logrank) test p = 2.69e-06 

T cell CD8+_XCELL in HNSC-HPV+ (n=98):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
67 patients with 24 dying ( 31 missing obs. )
                       coef           HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_XCELL` -23.415        0.000    8.019   0.000   0.000 -2.920 0.004
Age                  -0.017        0.983    0.021   0.943   1.025 -0.804 0.421
Stage2               17.095 26566612.577 5527.975   0.000     Inf  0.003 0.998
Stage3               16.980 23666289.837 5527.975   0.000     Inf  0.003 0.998
Stage4               17.278 31888162.625 5527.975   0.000     Inf  0.003 0.998
                    signif
`T cell CD8+_XCELL`     **
Age                       
Stage2                    
Stage3                    
Stage4                    
Rsquare = 0.277 (max possible = 9.24e-01 )
Likelihood ratio test p = 5.89e-04 
Wald test p = 9.37e-02 
Score (logrank) test p = 2.11e-02 

T cell CD8+_XCELL in HNSC-HPV- (n=422):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
379 patients with 167 dying ( 43 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -2.520 0.080    1.914   0.002   3.425 -1.317 0.188       
Age                  0.028 1.028    0.008   1.013   1.044  3.620 0.000    ***
Stage2               0.489 1.630    0.546   0.560   4.749  0.896 0.370       
Stage3               0.690 1.993    0.538   0.694   5.725  1.281 0.200       
Stage4               1.203 3.329    0.510   1.225   9.047  2.358 0.018      *
Rsquare = 0.079 (max possible = 9.9e-01 )
Likelihood ratio test p = 9.05e-06 
Wald test p = 4.21e-05 
Score (logrank) test p = 3.12e-05 

T cell CD8+_XCELL in KICH (n=66):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
65 patients with 9 dying ( 1 missing obs. )
                         coef           HR se(coef)      95%CI_l      95%CI_u
`T cell CD8+_XCELL` -1530.092 0.000000e+00 1498.772        0.000          Inf
Age                     0.050 1.051000e+00    0.030        0.992 1.114000e+00
Stage2                 15.386 4.808597e+06    0.843   922142.683 2.507487e+07
Stage3                 16.181 1.065045e+07    0.779  2312231.649 4.905738e+07
Stage4                 19.348 2.528335e+08    0.888 44360388.701 1.441033e+09
                         z     p signif
`T cell CD8+_XCELL` -1.021 0.307       
Age                  1.682 0.093      ·
Stage2              18.260 0.000    ***
Stage3              20.764 0.000    ***
Stage4              21.789 0.000    ***
Rsquare = 0.344 (max possible = 6.61e-01 )
Likelihood ratio test p = 4.67e-05 
Wald test p = 1.28e-266 
Score (logrank) test p = 4.85e-11 

T cell CD8+_XCELL in KIRC (n=533):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
526 patients with 172 dying ( 7 missing obs. )
                     coef    HR se(coef) 95%CI_l 95%CI_u     z     p signif
`T cell CD8+_XCELL` 0.257 1.293    0.828   0.255   6.549 0.311 0.756       
Age                 0.034 1.034    0.007   1.019   1.050 4.562 0.000    ***
Stage2              0.279 1.322    0.318   0.709   2.467 0.878 0.380       
Stage3              0.938 2.554    0.211   1.689   3.861 4.445 0.000    ***
Stage4              1.938 6.943    0.201   4.687  10.286 9.664 0.000    ***
Rsquare = 0.208 (max possible = 9.75e-01 )
Likelihood ratio test p = 7.78e-25 
Wald test p = 1.85e-24 
Score (logrank) test p = 1.73e-30 

T cell CD8+_XCELL in KIRP (n=290):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
255 patients with 39 dying ( 35 missing obs. )
                      coef      HR se(coef) 95%CI_l   95%CI_u      z     p
`T cell CD8+_XCELL`  5.453 233.566    2.321   2.469 22097.204  2.349 0.019
Age                  0.009   1.009    0.015   0.981     1.038  0.610 0.542
Stage2              -0.253   0.777    0.791   0.165     3.663 -0.319 0.750
Stage3               1.543   4.679    0.383   2.209     9.911  4.029 0.000
Stage4               2.866  17.559    0.454   7.217    42.724  6.317 0.000
                    signif
`T cell CD8+_XCELL`      *
Age                       
Stage2                    
Stage3                 ***
Stage4                 ***
Rsquare = 0.153 (max possible = 7.61e-01 )
Likelihood ratio test p = 5.33e-08 
Wald test p = 1.11e-08 
Score (logrank) test p = 1.01e-13 

T cell CD8+_XCELL in LGG (n=516):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age 
511 patients with 125 dying ( 5 missing obs. )
                       coef           HR se(coef) 95%CI_l       95%CI_u     z
`T cell CD8+_XCELL` 111.751 3.410062e+48  180.459   0.000 1.378682e+202 0.619
Age                   0.057 1.059000e+00    0.007   1.044  1.074000e+00 7.809
                        p signif
`T cell CD8+_XCELL` 0.536       
Age                 0.000    ***
Rsquare = 0.112 (max possible = 9.13e-01 )
Likelihood ratio test p = 6.58e-14 
Wald test p = 5.69e-14 
Score (logrank) test p = 8.56e-15 

T cell CD8+_XCELL in LIHC (n=371):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
340 patients with 116 dying ( 31 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -1.886 0.152    2.525   0.001  21.404 -0.747 0.455       
Age                  0.012 1.012    0.007   0.997   1.026  1.606 0.108       
Stage2               0.321 1.379    0.251   0.843   2.254  1.280 0.200       
Stage3               0.976 2.653    0.216   1.736   4.054  4.510 0.000    ***
Stage4               1.672 5.320    0.600   1.641  17.251  2.785 0.005     **
Rsquare = 0.076 (max possible = 9.69e-01 )
Likelihood ratio test p = 5.57e-05 
Wald test p = 2.57e-05 
Score (logrank) test p = 8.15e-06 

T cell CD8+_XCELL in LUAD (n=515):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
484 patients with 177 dying ( 31 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -3.106 0.045    1.750   0.001   1.381 -1.775 0.076      ·
Age                  0.010 1.010    0.008   0.995   1.026  1.281 0.200       
Stage2               0.821 2.272    0.187   1.573   3.281  4.378 0.000    ***
Stage3               1.145 3.143    0.197   2.136   4.625  5.809 0.000    ***
Stage4               1.263 3.536    0.283   2.031   6.155  4.465 0.000    ***
Rsquare = 0.102 (max possible = 9.79e-01 )
Likelihood ratio test p = 5.38e-10 
Wald test p = 8.94e-10 
Score (logrank) test p = 9.89e-11 

T cell CD8+_XCELL in LUSC (n=501):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
484 patients with 209 dying ( 17 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -0.422 0.655    1.550   0.031  13.672 -0.273 0.785       
Age                  0.018 1.018    0.009   1.001   1.036  2.080 0.037      *
Stage2               0.164 1.178    0.164   0.854   1.625  0.999 0.318       
Stage3               0.471 1.602    0.184   1.117   2.297  2.562 0.010      *
Stage4               1.187 3.277    0.462   1.326   8.099  2.571 0.010      *
Rsquare = 0.028 (max possible = 9.9e-01 )
Likelihood ratio test p = 1.84e-02 
Wald test p = 1.09e-02 
Score (logrank) test p = 8.25e-03 

T cell CD8+_XCELL in MESO (n=87):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
86 patients with 73 dying ( 1 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -0.261 0.770    2.224   0.010  60.236 -0.117 0.907       
Age                  0.019 1.019    0.015   0.990   1.049  1.270 0.204       
Stage2              -0.405 0.667    0.448   0.277   1.604 -0.905 0.366       
Stage3              -0.234 0.791    0.383   0.374   1.675 -0.612 0.540       
Stage4              -0.304 0.738    0.444   0.309   1.763 -0.683 0.494       
Rsquare = 0.032 (max possible = 9.98e-01 )
Likelihood ratio test p = 7.3e-01 
Wald test p = 7.21e-01 
Score (logrank) test p = 7.2e-01 

T cell CD8+_XCELL in OV (n=303):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age 
302 patients with 183 dying ( 1 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -4.273 0.014    3.914   0.000  29.901 -1.092 0.275       
Age                  0.030 1.030    0.007   1.016   1.045  4.102 0.000    ***
Rsquare = 0.056 (max possible = 9.97e-01 )
Likelihood ratio test p = 1.62e-04 
Wald test p = 1.45e-04 
Score (logrank) test p = 1.32e-04 

T cell CD8+_XCELL in PAAD (n=179):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
175 patients with 93 dying ( 4 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -4.356 0.013    3.232   0.000   7.243 -1.347 0.178       
Age                  0.023 1.024    0.010   1.003   1.045  2.243 0.025      *
Stage2               0.780 2.182    0.398   1.000   4.762  1.960 0.050      ·
Stage3               0.256 1.292    1.081   0.155  10.756  0.237 0.813       
Stage4               0.286 1.331    0.810   0.272   6.510  0.353 0.724       
Rsquare = 0.077 (max possible = 9.91e-01 )
Likelihood ratio test p = 1.57e-02 
Wald test p = 3.28e-02 
Score (logrank) test p = 2.86e-02 

T cell CD8+_XCELL in PCPG (n=181):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age 
181 patients with 7 dying ( 0 missing obs. )
                       coef           HR se(coef)      95%CI_l       95%CI_u
`T cell CD8+_XCELL` 136.533 1.973888e+59   54.968 3.211731e+12 1.213126e+106
Age                   0.032 1.033000e+00    0.026 9.810000e-01  1.087000e+00
                        z     p signif
`T cell CD8+_XCELL` 2.484 0.013      *
Age                 1.221 0.222       
Rsquare = 0.027 (max possible = 2.89e-01 )
Likelihood ratio test p = 8.43e-02 
Wald test p = 4.35e-02 
Score (logrank) test p = 1.3e-02 

T cell CD8+_XCELL in PRAD (n=498):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age 
496 patients with 10 dying ( 2 missing obs. )
                      coef    HR se(coef) 95%CI_l      95%CI_u      z     p
`T cell CD8+_XCELL` -0.489 0.613   15.421   0.000 8.211098e+12 -0.032 0.975
Age                  0.052 1.053    0.050   0.956 1.161000e+00  1.044 0.297
                    signif
`T cell CD8+_XCELL`       
Age                       
Rsquare = 0.002 (max possible = 1.68e-01 )
Likelihood ratio test p = 5.73e-01 
Wald test p = 5.8e-01 
Score (logrank) test p = 5.77e-01 

T cell CD8+_XCELL in READ (n=166):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
82 patients with 14 dying ( 84 missing obs. )
                       coef    HR se(coef) 95%CI_l      95%CI_u      z     p
`T cell CD8+_XCELL` -17.185 0.000   42.289   0.000 3.409248e+28 -0.406 0.684
Age                   0.126 1.135    0.046   1.037 1.241000e+00  2.759 0.006
Stage2               -1.265 0.282    1.242   0.025 3.220000e+00 -1.019 0.308
Stage3                0.291 1.337    0.816   0.270 6.621000e+00  0.356 0.722
Stage4                0.333 1.395    0.931   0.225 8.646000e+00  0.358 0.720
                    signif
`T cell CD8+_XCELL`       
Age                     **
Stage2                    
Stage3                    
Stage4                    
Rsquare = 0.227 (max possible = 7.04e-01 )
Likelihood ratio test p = 7.65e-04 
Wald test p = 4.01e-02 
Score (logrank) test p = 1.6e-03 

T cell CD8+_XCELL in SARC (n=260):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age 
257 patients with 99 dying ( 3 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -2.118 0.120    1.792   0.004   4.030 -1.182 0.237       
Age                  0.022 1.022    0.008   1.006   1.038  2.757 0.006     **
Rsquare = 0.035 (max possible = 9.77e-01 )
Likelihood ratio test p = 1.07e-02 
Wald test p = 1.28e-02 
Score (logrank) test p = 1.25e-02 

T cell CD8+_XCELL in SKCM (n=471):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
407 patients with 192 dying ( 64 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -4.257 0.014    1.105   0.002   0.124 -3.852 0.000    ***
Age                  0.018 1.018    0.005   1.008   1.029  3.527 0.000    ***
Stage2               0.138 1.149    0.217   0.751   1.757  0.639 0.523       
Stage3               0.565 1.760    0.200   1.190   2.603  2.830 0.005     **
Stage4               1.238 3.449    0.349   1.739   6.838  3.545 0.000    ***
Rsquare = 0.12 (max possible = 9.92e-01 )
Likelihood ratio test p = 5.01e-10 
Wald test p = 5.76e-09 
Score (logrank) test p = 2.35e-09 

T cell CD8+_XCELL in SKCM-Primary (n=103):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
95 patients with 26 dying ( 8 missing obs. )
                      coef           HR se(coef) 95%CI_l 95%CI_u      z     p
`T cell CD8+_XCELL` -1.292 2.750000e-01    4.131   0.000 902.979 -0.313 0.755
Age                  0.005 1.005000e+00    0.014   0.977   1.034  0.347 0.729
Stage2              17.390 3.568142e+07 6205.123   0.000     Inf  0.003 0.998
Stage3              18.039 6.823982e+07 6205.123   0.000     Inf  0.003 0.998
Stage4              19.746 3.761858e+08 6205.123   0.000     Inf  0.003 0.997
                    signif
`T cell CD8+_XCELL`       
Age                       
Stage2                    
Stage3                    
Stage4                    
Rsquare = 0.111 (max possible = 8.67e-01 )
Likelihood ratio test p = 4.7e-02 
Wald test p = 4.03e-02 
Score (logrank) test p = 3.78e-03 

T cell CD8+_XCELL in SKCM-Metastasis (n=368):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
312 patients with 166 dying ( 56 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -4.152 0.016    1.159   0.002   0.153 -3.582 0.000    ***
Age                  0.021 1.021    0.006   1.010   1.032  3.702 0.000    ***
Stage2               0.025 1.025    0.228   0.656   1.602  0.110 0.913       
Stage3               0.499 1.648    0.204   1.104   2.459  2.445 0.014      *
Stage4               1.017 2.765    0.396   1.271   6.012  2.565 0.010      *
Rsquare = 0.136 (max possible = 9.95e-01 )
Likelihood ratio test p = 1.07e-08 
Wald test p = 1.09e-07 
Score (logrank) test p = 5.56e-08 

T cell CD8+_XCELL in STAD (n=415):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
368 patients with 148 dying ( 47 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -0.021 0.979    1.505   0.051  18.717 -0.014 0.989       
Age                  0.029 1.029    0.009   1.012   1.047  3.372 0.001     **
Stage2               0.437 1.548    0.335   0.804   2.983  1.306 0.191       
Stage3               0.921 2.512    0.314   1.357   4.651  2.932 0.003     **
Stage4               1.618 5.043    0.365   2.466  10.312  4.433 0.000    ***
Rsquare = 0.085 (max possible = 9.85e-01 )
Likelihood ratio test p = 4.18e-06 
Wald test p = 6.21e-06 
Score (logrank) test p = 2.94e-06 

T cell CD8+_XCELL in TGCT (n=150):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
81 patients with 2 dying ( 69 missing obs. )
                       coef           HR  se(coef) 95%CI_l      95%CI_u      z
`T cell CD8+_XCELL` -61.661 0.000000e+00   124.131   0.000 7.611675e+78 -0.497
Age                  -0.197 8.210000e-01     0.174   0.584 1.155000e+00 -1.133
Stage2               17.429 3.711128e+07 27016.427   0.000          Inf  0.001
Stage3               39.642 1.645385e+17 57837.929   0.000          Inf  0.001
                        p signif
`T cell CD8+_XCELL` 0.619       
Age                 0.257       
Stage2              0.999       
Stage3              0.999       
Rsquare = 0.089 (max possible = 1.32e-01 )
Likelihood ratio test p = 1.09e-01 
Wald test p = 8.21e-01 
Score (logrank) test p = 1.42e-01 

T cell CD8+_XCELL in THCA (n=509):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
506 patients with 16 dying ( 3 missing obs. )
                      coef    HR se(coef) 95%CI_l      95%CI_u      z     p
`T cell CD8+_XCELL` -4.716 0.009   15.838   0.000 2.708752e+11 -0.298 0.766
Age                  0.151 1.163    0.028   1.100 1.228000e+00  5.363 0.000
Stage2               0.187 1.205    1.014   0.165 8.802000e+00  0.184 0.854
Stage3               0.212 1.236    0.812   0.252 6.078000e+00  0.261 0.794
Stage4               0.854 2.350    0.855   0.440 1.255000e+01  0.999 0.318
                    signif
`T cell CD8+_XCELL`       
Age                    ***
Stage2                    
Stage3                    
Stage4                    
Rsquare = 0.109 (max possible = 2.9e-01 )
Likelihood ratio test p = 2.66e-11 
Wald test p = 1.21e-05 
Score (logrank) test p = 1.87e-11 

T cell CD8+_XCELL in THYM (n=120):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age 
119 patients with 9 dying ( 1 missing obs. )
                      coef    HR se(coef) 95%CI_l 95%CI_u      z     p signif
`T cell CD8+_XCELL` -0.477 0.621    3.580   0.001 691.976 -0.133 0.894       
Age                  0.054 1.055    0.033   0.989   1.127  1.614 0.106       
Rsquare = 0.035 (max possible = 4.39e-01 )
Likelihood ratio test p = 1.23e-01 
Wald test p = 1.64e-01 
Score (logrank) test p = 1.38e-01 

T cell CD8+_XCELL in UCEC (n=545):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age 
173 patients with 32 dying ( 372 missing obs. )
                      coef    HR se(coef) 95%CI_l  95%CI_u      z     p signif
`T cell CD8+_XCELL` -5.077 0.006    6.251   0.000 1305.912 -0.812 0.417       
Age                  0.015 1.015    0.016   0.983    1.048  0.905 0.366       
Rsquare = 0.01 (max possible = 7.9e-01 )
Likelihood ratio test p = 4.07e-01 
Wald test p = 4.57e-01 
Score (logrank) test p = 4.5e-01 

T cell CD8+_XCELL in UCS (n=57):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age 
55 patients with 34 dying ( 2 missing obs. )
                      coef    HR se(coef) 95%CI_l     95%CI_u      z     p
`T cell CD8+_XCELL` -8.903 0.000   14.257   0.000 1.85884e+08 -0.624 0.532
Age                  0.045 1.046    0.023   1.001 1.09300e+00  1.986 0.047
                    signif
`T cell CD8+_XCELL`       
Age                      *
Rsquare = 0.079 (max possible = 9.83e-01 )
Likelihood ratio test p = 1.03e-01 
Wald test p = 1.09e-01 
Score (logrank) test p = 1.04e-01 

T cell CD8+_XCELL in UVM (n=80):
Model: Surv(OS, EVENT) ~ `T cell CD8+_XCELL` + Age + Stage 
79 patients with 22 dying ( 1 missing obs. )
                     coef       HR se(coef) 95%CI_l      95%CI_u     z     p
`T cell CD8+_XCELL` 9.046 8486.642    3.784   5.105 14109722.849 2.391 0.017
Age                 0.042    1.043    0.020   1.003        1.085 2.098 0.036
Stage3              0.162    1.175    0.472   0.466        2.966 0.342 0.732
Stage4              3.804   44.886    1.213   4.165      483.746 3.136 0.002
                    signif
`T cell CD8+_XCELL`      *
Age                      *
Stage3                    
Stage4                  **
Rsquare = 0.253 (max possible = 8.67e-01 )
Likelihood ratio test p = 1.27e-04 
Wald test p = 2.65e-04 
Score (logrank) test p = 3.31e-11 
